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ABSTRACT 
 
 
      The mycobacterial cell wall metabolites have always imposed great challenges to 
researchers due to their unusual complexity and structural diversity. A lot of research 
efforts have been directed towards the evaluation of these metabolites and the role they 
play in the pathogenesis and virulence of different serious human pathogens including 
Mycobacterium tuberculosis the causative agent of tuberculosis (TB). In the genomic era, 
it is crucial to develop new methodologies to analyze these components from a global 
perspective in a comprehensive and well-validated manner.  
 
     Towards this end, we developed a rapid NMR-based approach to produce metabolic 
profiles in the form of 2D1H-13C HSQC maps. Due to NMR low sensitivity, we used   
13C-isotope enrichment strategy to improve the detection threshold of NMR. We 
developed and investigated the use of three NMR-based profiles. The first is for the cell 
wall associated lipids, the second is for covalently bound mycolic acids and the third 
deals with the complex cell wall polysaccharides. Key structural features and major lipid 
species were readily identifiable using this technique. This approach can be used for 
observing changes in the cell wall due to drug treatment, gene mutation and changes in 
the physiological environment, species characterization and screening for virulence factor 
expression. It also allows for rapid comparative analysis of several cell wall metabolites 
within the same sample. 
  
     We have used this approach to evaluate the structural diversity displayed in the cell 
wall metabolites among different Mycobacteria from different clades. We have 
successfully used the same technique to monitor changes in the carbohydrate and lipid 
pools from Mycobacteria grown under laboratory conditions that simulate latency and 
resuscitation from latency. Moreover, we were also able to use such technique to screen 
for virulence factor in several M. tuberculosis clinical isolates.  
 
      Although we have successfully developed and used an NMR approach for metabolite 
analysis, NMR however remains less sensitive than other spectroscopic techniques like 
mass spectrometry(MS). The high sensitivity of MS makes it one of the best candidates 
for metabolomic studies. However in case of cellular lipids, the low polarity and the 
variable ionization potential deter its routine use for lipid analysis. Certain metabolites 
that have low cellular abundance and good ionizability are better analyzed through an 
MS-based approach. Mycolactones of M. ulcerans and other closely related species are 
good examples for such metabolites and in this work we have demonstrated the utility of 
MS as a tool for screening for mycolactones from both bacterial culture and tissue 
samples.  
 
     Metabolomics is currently a rapidly growing field and many researchers have directed 
their attention in developing the right research tools to explore it. Spectroscopic methods 
along with chromatographic methods have been in the front of this vigorous research 
effort. The work presented here represents an innovative attempt to utilize such  
v 
 
techniques to investigate the metabolome of some of the most serious human pathogens 
and discusses the potential area where the application of these techniques can be the most 
useful. 
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CHAPTER 1. INTRODUCTION 
 
 
     Mycobacterium, the single genus of the family Mycobacteriaceae, is described as rod-
shaped Gram positive aerobic to microarophilic bacilli with GC- rich DNA. 
Taxonomically, it is placed in the same suborder Corynebacterianeae with Corynbacteria, 
Nocardia and Rhodoccoci which are all referred to as Actinomycetales.1 In general, 
Mycobacteria are ubiquitous organisms that can be isolated from tap water, house dust 
and soil but few are clinically important pathogens that are associated with serious health 
problems.2-5 Others are emerging as opportunistic pathogens and are increasingly 
imposing new health challenges.6 For many years, the diagnostic feature that was used to 
describe Mycobacteria was its “acid-fastness”, a phrase that refers to the ability of the 
stained bacilli to resist decolorization by acidic ethanol when exposed to cationic 
triphenyl methane dyes such as fuschin.7 The chemical nature of this interaction has been 
widely speculated but with contradicting evidence pointing in different directions, it 
remains a debatable research point.8-10 
 
     Historically, several classifications of Mycobacteria have been used and most have 
relied on a specific morphological feature or a biochemical reaction. The most acceptable 
nowadays is the traditional classification of Mycobacteria into slow growers and fast 
growers subgroups1 (excluding the uncultivable M. leprae). This traditional classification 
is surprisingly in agreement with modern 16S rRNA-based classification.11 In addition, 
most pathogenic Mycobacteria fall in the slow growers subgroup with few exceptions.1 
Other classic descriptions such as atypical Mycobacteria and chromogenic Mycobacteria 
have become increasingly outdated and clinically irrelevant as they are biased to a single 
feature like the frequent association with mammalian diseases or the ability to produce 
certain pigments.7 
 
     In the clinic, the most important mycobacterium is that of M. tuberculosis, the 
causative agent of tuberculosis (TB), a disease that consumes around two million lives 
every year.12 Other common mycobacterial human pathogens are M. leprae the causative 
agent of leprosy, M. marinum an intracellular pathogen that causes granulomateous skin 
infection13 and M. ulcerans a pathogen responsible for the Buruli ulcer endemic in some 
tropical regions.14 However, with an expanding population of immunocompromised 
patients, infections with environmental Mycobacteria that do not cause diseases to human 
under normal conditions have been on the rise.15 Diseases caused by these opportunistic 
Mycobacteria have contributed to the mortality and morbidity of thousands of cases of 
HIV patients. Such infections happen through unavoidable routine activities and can 
result in either tuberculosis like pulmonary symptoms, lymphaniditis or more severe 
systemic mycobacteriosis.16 Most common among these infections are infections with 
Mycobacterium avium complex (MAC) which includes mainly M. avium and M. 
intracellulare.12,17 
 
     Some fast growers, like members of M. fortuitum complex, M. abscessus and M. 
chelonae, have also been isolated from the sputum of immunocompromised patients.18 
Most other fast growers, however, are saprophytic species like M. smegmatis and M. 
 
 
1
phlei that rarely cause diseases in humans but are used in the laboratory as surrogates to 
Mycobacterium tuberculosis which can only be handled in biosafety level-3 facilities to 
provide maximum protection to researchers and laboratory workers and limit the spread 
of this infectious agent. 
 
 
1.1 History of Mycobacteria 
 
     Mycobacteria pathogens were among the first microorganisms to be discovered as the 
causative agents of human diseases. Indeed, the first human pathogen to be described was 
that of Mycobacterium leprae the etiological cause of leprosy when in 1873 Gerhard 
Hansen reported the presence of rod shaped “infectious substance” in the tissue of 
infected patients without identifying it as bacteria.19 It was not until 1880 that Albert 
Neisser have stained and identified the bacilli as the etiological cause of leprosy. During 
the time of Neisser’s successful characterization, the work that led to the ground breaking 
discovery of Mycobacterium tuberculosis as the causative agent of tuberculosis was also 
taking place. On March 24, 1882, Robert Koch, the father of microbiology, gave one of 
the most important lectures in medical history to announce his discovery of the causative 
agent of TB.20 In his lecture that evening, Koch illustrated to his audience how he 
successfully isolated, stained and cultured the tubercle’s bacilli.21 Koch was awarded the 
Nobel Prize for “his investigations and discoveries in relation to tuberculosis" in 1905.22 
 
     But long before Koch made his discovery, Mycobacteria species and their associated 
diseases have existed throughout human history. Molecular evidence of tuberculosis was 
found in Egyptian mummies.23,24 Chinese, Indian and Egyptian scriptures dated as far 
back as to 4000B.C contained description of both tuberculosis and leprosy.20 It is 
estimated that TB alone, also known as consumption or white plague, has consumed at 
least one billion human lives between 1700 and 1900.20 Other mycobacterial diseases 
have surfaced more recently. The third most common mycobacterial disease, Buruli 
ulcer, was not defined and its causative agent M. ulcerans has not been described until 
1948 despite some initial reporting of an ulcerative skin disease in Uganda by Sir Robert 
Cook in 1897.25,26 With the progress of scientific research tools and the ever-rapid 
accumulation of human knowledge, the genus mycobacterium now includes nearly 80 
species, the majority of them were discovered during the last five decades although most 
have existed since prehistoric times.   
 
 
1.2 Current Burden of Mycobacteria 
 
     The single most important species of the genus mycobacterium is M. tuberculosis, a 
single species that infects one third of the world population and is responsible for nearly 
two million deaths every year due to tuberculosis (TB).12 The World Health Organization 
(WHO) estimates that M. tuberculosis infects more than one person every second 
worldwide with the latent form of the disease. Among those infected, 10% will develop 
an active infectious form of the disease in their lifetime and can infect 10-15 persons a 
year if left untreated.27  
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     Despite the long history of human encounter with TB, the fight against this pathogen 
has not been won yet especially with constant emergence of new challenges. Of the nine 
million new cases reported every year, more than 70% of these cases are reported in Asia 
and sub-Saharan Africa where the failure to control TB infection is attributed to the 
HIV/AIDS epidemic in this region.28,29 It is estimated that one third of HIV patients are 
co-infected with TB which is considered the number one killer of HIV patients.30 This 
co-infection also makes it 800 times more likely for an individual to develop an active 
form of the disease and thus spread the TB infection.30 With the devastating human 
health cost comes also a great economic burden as 80% of TB patients are between 15 
and 49 years of age amidst their productive life and are in most cases the only supporters 
of  their large families.31 
 
     In the last two decades, we were confronted with another challenge with the spread of 
multi drug resistant TB (MDR-TB) and more recently extensively drug resistance TB 
(XDR-TB)32 which has in turn complicated the HIV/TB problem.33,34 MDR-TB is a form 
of the disease caused by strains that resist treatment with more than one of the frontline 
anti-tuberculosis drugs. For example, an MDR-TB strain resistant to both rifampin and 
isoniazid (INH) was associated with an outbreak in New York City in the early 1990s 
that grabbed scientists’ attention and caused public panic.35 XDR-TB is a term introduced 
in 2006 to describe another form of the disease caused by strains that are resistant to both 
rifampin and INH in addition to key second line anti-TB treatment including a 
fluroquinolone and one injectable drug from the aminoglycosides and capreomycin 
group.34,36 Although anti-TB drugs have been in use since the 1940s, the current 
repertoire of anti-TB drugs has now limited capabilities and low potential to provide a 
tool for eradicating TB. Many global health initiatives have been launched in the recent 
years to counteract the spread of this disease and help treat the millions affected by it. 
Yet, there has been no significant down turn in the global rates of incidence or mortality 
due to tuberculosis.  
 
     On the other hand, the prevalence of two other mycobacterial human diseases (leprosy 
and Buruli ulcer) stands at about 250,000 cases worldwide with their associated cost of 
treatment and lost productivity.37,38 Being limited in their geographic distribution to the 
tropical regions, these diseases receive limited attention from both research and health 
organizations despite the fact that a lot of questions remain regarding disease 
transmission and the availability of limited treatment options.  
 
     It is also worth mentioning that at least thirty Mycobacteria species are known to 
cause diseases to domestic and wild animals and have significant economic implications. 
This group includes M. bovis, Mycobacterium marinum, M. fortuitum, M. chelonae and 
M. avium subsp paratuberculosis among others. M. bovis is the cause of tuberculosis in 
cows while M. avium subsp. paratuberculosis is believed to be the causative agents of 
Johne’s disease in cattle and some evidence points to a role of this organism in human 
Crohn’s disease, a painful chronic disease that affect 500,000 in the US alone.39,40 
Systemic mycobacteriosis is considered a major problem for aquatic animals. A number 
of Mycobacteria that are natural habitat of water are known to cause systemic infections 
in fish.41 Recently, a new species, M. pseudoshotsii, was identified as the cause of an 
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endemic mycobacteriosis in the sea striped bass in Chesapeake Bay.42,43 So, in addition to 
the negative human health impact of Mycobacteria, there are both economic and 
environmental burdens that threaten our aquatic and agricultural reserves. 
 
 
1.3 The Pathogenesis of Mycobacterium tuberculosis 
 
     Beside the fact that Mycobacterium tuberculosis is the main cause of pulmonary 
tuberculosis, it is also responsible for another serious form of tuberculosis, disseminated 
or extra pulmonary tuberculosis, in neonates and severely immune-compromised 
patients.44,45 In the disseminated form of TB, the bacilli can escape the lungs and 
disseminate to other organs through the lymph system most commonly bones and 
joints.46 Both the pulmonary and the extra-pulmonary diseases spread through inhalation 
of the bacterium.  A host can inhale contaminated droplets produced through the 
coughing and sneezing of an infected individual who spreads a load of Mycobacteria into 
the atmosphere where the bacilli can survive for several hours.47 It is estimated that the 
infectious dose to the new host can be as low as a single bacterium. 
 
     Once inhaled, the bacilli travel deep into the airways where they are engulfed by 
alveolar macrophages in an attempt to destroy the invading pathogen.48,49 However, the 
TB bacilli have the ability to survive and replicate inside these macrophages by inhibiting 
maturation and acidification the phagosome.50 At this stage, multiple cytokines are 
released by the infected macrophages (TNF-α is the most important). This cytokine 
cascade recruits successive waves of CD4+, CD8+ and natural killers T-cells to contain 
the infection. As these cells start to surround the infected macrophages, they initiate the 
formation of a well organized pulmonary lesion (known as tubercle or granuloma) the 
pathological signature of tuberculosis.49 Once the infected macrophages are surrounded 
with T-cells, the immune response to the infection is suppressed through the secretion of 
INF-γ from these cells. With time progression, the peripheries of these tubercles become 
surrounded by fibrous cuff and the blood supply to the lesion diminishes.51 The bacilli at 
the core of these lesions can remain viable for extended period of time (dormant bacilli) 
but in a contained phase where the host cannot transmit the infection to others (latent 
infection).51,52 Reports indicate that one third of the world population are infected with 
this latent form of the disease and that between 5-10% of these individuals will develop 
an active form of the disease later on their life time.52,53 
 
     The activation of a latent infection is usually a result of a deteriorating host immune 
system that can be related to malnutrition, co-infection with HIV, immunosuppressive 
therapy or other factors. For example, when the CD4+ cell count diminishes as a result of 
HIV infection, the granuloma can no longer be contained and its walls rupture allowing 
the migration of the free bacilli to the airways. At this point, the acid fast bacilli start to 
appear in the patient sputum and the host becomes infective to those who are in close 
contact.49 Usually six to eight weeks of anti-tuberculosis therapy (rifampin, INH, 
pyrazinamide and ethambutol or RIPE) are necessary to clear the sputum but four more 
months of therapy (rifampin and INH) are still required to eliminate all loci of infectious 
bacteria with all different populations to deter the development of resistance.54-56 
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1.4 Mycobacteria Cell Envelope 
 
     The persistence of TB as a major health problem is attributed to the ability of 
Mycobacteria to adapt to different environmental conditions inside and outside the 
human body.57 Not only can M. tuberculosis survive and resist the killing mechanism 
inside human macrophages, but it also has the capacity to slow down its metabolism and 
replication to stay hidden from the host immune system for extended periods of time. 
Still at this latent phase, Mycobacteria retain the ability to monitor the host immune 
system and remain in a state of preparedness to be activated once host defense 
mechanisms are compromised.53  
 
     For a better understanding of Mycobacteria pathogenicity, it is crucial to examine its 
cell wall as it accounts for 60% of the bacterial cell weight and is commonly believed to 
be partially responsible for Mycobacteria drug resistance and virulence. Like all 
eubacteria, the Mycobacteria cell is surrounded by a peptidoglycan–based cell wall, but a 
unique and very complex cell wall assures its survival and resistance to different killing 
mechanisms by the host immune system (Figure 1.1). The cell wall of Mycobacteria (and 
in fact all actinomycetales) is classified on a chemical basis as chemotype IV cell wall.58 
In addition to the plasma membrane and the peptidoglycan, chemotype IV is 
characterized by the presence of a special polysaccharide structure known as 
arabinogalactan (AG). This arabinogalactan is terminally substituted with long chain fatty 
acids that vary in length based on the bacterial species and tend to form an outer lipid 
layer that function as a permeability barrier.59,60 The total composition of the cell wall 
will be discussed in more details below. 
 
 
1.4.1 The Plasma Membrane 
 
1.4.1.1 Membrane general features 
 
     The plasma membrane of Mycobacteria has all the general features recognized in the 
membranes of other prokaryotes. It has the general arrangement of a phospholipids 
bilayer. The phospholipids of the plasma membrane are mainly derivatives of 
phosphatidic acids59 (Figure 1.2). The most abundant of which is bis-phosphatidyl 
glycerol, also known as cardiolipin.61 Other phospholipids include phosphatidyl 
ethanolamine, phosphatidyl inositol and its corresponding mannosides PIMs, which are 
located mainly in the membrane outer leaflets. The fatty acid substitutions in all 
membrane phospholipids are mainly palmitic (C-16), hexadecenoic (unsaturated C-16), 
oleic (C-20) and tuberculostearic acids (methylated C-20).62  
 
     The plasma membrane also contains a number of associated components that perform 
different cell membrane functions, menaquinone for electron transport, carotenoids for 
photolysis protection, and glcosyl phosphopolyprenols which serve as carriers and 
intermediates in the process of cell wall biosynthesis.63 Porin-like proteins are also 
essential in the membrane and usually span the entire cell wall to allow the selective  
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Figure 1.1 Schematic Presentation of the Cell Wall of Mycobacteria 
 
Reprinted with permission. Riley, L.W. Of mice, men, and elephants: Mycobacterium 
tuberculosis cell envelope lipids and pathogenesis. J. Clinical Invest 11, 1575-8 (2006).64  
 
 
 
 
 
 
Figure 1.2 Phospholipids of the Mycobacterial Plasma Membrane 
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passage of hydrophilic nutrients through the permeability barrier of mycolic acids and the 
hydrophobic lipids enclosed within.59,60 
 
1.4.1.2 Phosphatidyl myo inositol mannosides (PIMs) 
 
     These are highly abundant phospholipids that are located in the plasma membrane 
(mainly the outer leaflet) of actinomycetes. Their chemical structure has been well 
established and was shown to consist of phosphatidyl inositol which is glycosidically 
linked at positions 2 and 6 to two mannose residues to form phosphatidyl inositol 
dimannoside (PIM2)65 (Figure 1.3). The Mannose residue at 6- position can be further 
glycosylated with 1-4 mannose residues to form tri, tetra, penta and hexa derivatives 
(PIM3, PIM4, PIM5 and PIM6 respectively).66,67 Variability in the acylation patterns of 
PIMs has been recognized lately and has received considerable research effort. Beside the 
two lipids chains of the phosphatidic acid, the existence of multi acylated PIMs was 
reported by several researchers.68,69 In fact, among PIMs isolated from M. bovis BCG, tri 
and tetra acylated PIM2 and PIM6 were found to be the most abundant.66 
 
     PIMs are known to react with toll like receptors-2 (TLR-2) thus activating the host 
innate immune response.66 Other studies have suggested the involvement of PIMs in the 
recruitment of natural killer T-cells.70 Some of the molecular basis of these activities can 
be explained through the high affinity interaction between the lipid chain of PIMs and the 
human CDb1 receptors.71 The hydrophobic nature of this interaction unequivocally 
explains the loss of biological activity of PIMs if they are subjected to alkaline 
hydrolysis.72 
 
 
1.4.2 The Peptidoglycan Mycolyl Arabinogalactan Complex (PG-mAG) 
 
     The covalently bound PG-mAG complex can be isolated from the cells in a pure form 
and it is described as the cell wall skeleton. A summary of the main structural features of 
individual parts of the cell wall skeleton is discussed below. 
 
1.4.2.1 Peptidoglycan (PG) 
 
     Peptidoglycans provide the bacterial cells with the rigidity necessary to maintain a 
defined shape. They are universal in their distribution among bacteria with few 
exceptions such as mycoplasma.73 The peptidoglycan of Mycobacteria is classified as AIγ 
type, in which the glycan strands of alternating N-acetyl muramic acid and N-acetyl 
glucosamine are connected via cross linkage between two peptide chains of L-alanyl-D-
isoglutaminyl-meso-diaminopimelyl-D-alanine. The two peptide chains are connected 
between one diaminopimelyl of one strand and D- alanine of the other strand.58 This type 
of PG is common among bacteria but that of Mycobacteria has several characteristics to 
it.74 First, about 30% of the muramic acid residues are N-glycolylated instead of N-
acylated.75 Second, the peptide chain link can be between two molecules of D-
aminopimelic acid (DAP) instead of the more common DAP/D-alanine link. Peptide 
chain cross linkage in general occurs with a higher than normal frequency in  
 
 
7
  
 
Figure 1.3 Structure of Tetracylated PIM6 
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mycobacterial PG (75% cross- linkage compared to 25% in case of E. coli).73,76 Third, the 
amino acids of the peptide chain display different chemical modifications, some DAP 
residues can be amidated while the L-alanine as well as the D-glutamate residues can be 
substituted with glycine.77 The likely purpose of these modifications of the peptidoglycan 
is to provide the cell wall with more rigidity and chemical stability.73 
 
1.4.2.2 Arabinogalactan (AG) 
 
     Outside the PG and covalently attached to it, is the complex polysaccharide of 
arabinogalactan (AG).78 The link between PG and AG is thought to be through a 
disaccharide phosphate linker of rhamnose and N-acylated glucosamine where a 
furanogalactan residue is linked to the 4-position of the rhammonose residue in the linker 
region to form a  polysaccharide chain of β-D-Galf-(1→5)-β-D-Galf-(1→4)-α-l-Rhap-
(1→3)-α-d-GlcNAc-1-P which then attaches to the PG through about 10%-12% of 
muramic acid residues of PG.79  
 
     The building units of the AG complex, i.e. arabinose and galactose, are both in the 
unusual furanose ring structure.80 The galactan chain of AG consists of 25 residues of 
alternating 1→5 and 1→6 linked β-D-Galf78,81 (Figure 1.4). Hepta-arabinan chains are 
frequently attached to some of the 6- linked galactose units through a 1→6 glycosidic 
linkage.82,83 These arabinan chains are further branched through an α-3,5 Araf residue to 
two tetra arabinan chains. The short tetra arabinan chains terminate with a branched 
arabinan moiety of six arabinose units known as Ara6.84 In addition to the two basic 
saccharide units, a succinyl residue or a galactose amine residue can be attached to the C-
2 oxygen of the inner 3,5-α-D-Araf  residue at the arabinan branching points.84 At the 
terminal end of the Ara6 structure mycolic acids are esterified to position-6 of the 
terminal β-D-Araf.  
 
1.4.2.3 Mycolic acids 
 
     The mycolic acids attached to the mAG-PG complex are very long fatty acids that are 
limited in their distribution to the actinomycetals. They are chemically described as α-
alkyl-β-hydroxy fatty acids with two alkyl branches; a shorter unsubstituted α-branch and 
the longer β-branch or meromycolate chain.85 This structural feature remains valid among 
Corynebacteria, Mycobacteria and Nocardia but mycobacterial mycolic acids are 
characterized by having the longest carbon chain with an average length between 70-90 
carbons.86,87 
 
     Variations in the substitution of the meromycolate chain are responsible for the 
presence of several types of mycolic acids.88-90 Unsaturation is the most common 
substitution among fast growing Mycobacteria as well as non-Mycobacteria 
actinomycetals. The name α-mycolates is used to describe molecules where the chain 
substitution is either unsaturation or cyclopropation.91 In α-mycolates the double bonds or 
cyclopropyl rings can be either in cis or trans configuration with the trans substitution 
adjacent to a methyl group (Figure 1.5). Other types of mycolic acids usually contain one 
cycloprpopyl ring together with an oxygenated functional groups like hydroxyl, epoxy, 
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Figure 1.4 Schematic Presentation of the Structure of Mycobacteria AG 
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Figure 1.5 Major Types of Cell Wall Mycolic Acids 
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keto or methoxy groups and are commonly known as oxygenated mycolic acids. These 
oxygenated mycolic acids always contain a methyl branch next to the oxygenated 
function as well.90,91  
 
     Mycolic acids that terminate the arabinogalactan are tightly packed to form an outer 
pseudomembrane layer that appears as an electron transparent zone in the electron 
micrograph.92 Variation in both the chain length and the distribution of different types of 
mycolic acids in a certain species have had implication on the taxonomical classification 
of actinomycetals.93,94  
 
 
1.4.3 Extractable Cell Wall Lipids 
 
     Apart from the cell wall skeleton, the cell envelope of Mycobacteria contains some 
lipids of unusual structures that are believed to play an important role in virulence and 
pathogenicity. The general agreement is that these lipids are loosely attached to the 
mycobacterial cells by hydrophobic forces that keep these lipids within the lipid pseudo-
membrane of mycolic acids.92 It was the common belief that these lipids do not exhibit a 
particular arrangement but recent evidence by improved microscopy techniques has 
argued for an organized lipid bilayer structure in the outer membrane.95 
 
    The different chemical nature and structural diversity exhibited by these lipids suggests 
a different biological role for each chemical class of lipids. In favor of this argument is 
the fact that certain classes of lipids can be remarkably abundant in one species yet 
completely absent from others. Even within a single class of lipids, inter-species and 
inter-strain variations do exist.96,97 Over the past few decades, researchers have gathered 
information that displays the unique structural diversity of the cell wall lipids. The 
relatively polar glycolipids of the cell wall include trehalose esters, lipooligosaccharides, 
phenolic glycolipids and glycopeptidolipids. More hydrophobic lipids are also found 
associated with the cell wall and these include triacyl glycerols, wax esters, mycocerosic 
and phthiocerol derivatives and acylated glycerophospholipids.  
 
     With the wealth of research on the role of different cell wall lipids and the conflicting 
results it produces, it is crucial to develop a consensus on their biological activities. For 
example, one of the most ubiquitous glycolipids, known as trehalose dimycolate (TDM), 
has been associated with serious pathological and immunological effects that contradict 
its universal distribution among both pathogenic and non pathogenic Mycobacteria.98 On 
the other hand, it can be argued that subtle differences in the mycolic acids substitution 
within the TDM molecules among different species can account for some variation in 
their biological activity.64,99 The cell wall fractions also include some proteins and 
lipoproteins that can be involved in membrane transport functions. A brief description of 
the major extractable cell wall lipids is outlaid in the following sections. 
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1.4.3.1 Lipomannans LM and lipoarabinomannans (LAM) 
 
     These are immunogenic lipoglycans that are interspersed within the cell wall and are t 
thought to be partially surface-exposed.100 Degradative analysis of cell wall LAM 
indicated the presence of glycerol, inositol, arabinose, mannose and phosphate in addition 
to a variety of fatty acids.80 Detailed structural analysis of these glycolipids concluded 
that they are multiglycosylated derivatives of PIMs which strongly suggests that they 
may have the same cellular location as PIMs, i.e. they are anchored to the outer leaflet of 
the cell membrane via their phosphatidyl inositol portion.  
 
     Unlike PIMs the mannan part of both LAM and LM is further extended to a backbone 
of repetitive units of α-(1→6) D-Manp (Figure 1.6) which are frequently substituted at 
the C2- position (C3-position in few cases) with another Manp residue.101,102 In the case 
of LAM, this mannose-based backbone is further substituted with a number of arabinan 
side chains of α-(1→5)D-Araf units.103 These side chains are further substituted at 
different points with shorter arabinan chains. The arabibnan chains are terminated with 
one of two arabinan moieties the first is a linear chain of α-(1→5) Araf (Ara4) and the 
second is a branched moiety similar to the Ara6 of AG.104 
 
     Based on the substitution of the terminal arabinose residue, LAM can be classified 
into three classes. The first is manLAM where the arabinose reducing terminal is capped 
with one to three mannose residues as it is the case in both M. tuberculosis and M. 
bovis.104-106 The second type is most common among fast growing Mycobacteria such as 
M. smegmatis where the arabinose termini are partially capped with phosphoinositol 
forming PiLAM.107 The third type is devoid of both mannose and phosphoinositol caps 
such as in M. chelonae and is called araLAM.108 On the other hand, Lipomannan (LM) as 
the name indicates is devoid of any arabinose residues and can be considered as a 
biosynthetic intermediate of LAM.100 Despite that, the two lipoglycans display different 
immune-modulatory properties. While manLAM is thought to down regulate the 
inflammatory response to subvert the host immune response and inhibit lysosome 
phagosome fusion,100,109-111 evidence points to a role of LM in triggering a potent 
proinflammatory response (induction of TNF-α, IL-8 andIL-12) and stimulating innate 
immune response through TLR-2.111,112  
 
1.4.3.2 Acylated trehalose (ATs) 
 
     Trehalose is a non reducing disaccharide formed through α,α-1,1glycosidic linkage of 
two α-glucose units. The most studied acylated trehaloses are 6,6’-trehalose dimycolates  
(TDM), also known as cord factor (Figure 1.7). TDM was first reported in M. 
tuberculosis when many researchers have attributed the virulence of the tubercle bacilli to 
this molecule as they associated it with the ability of virulent Mycobacteria to form 
serpentine cords (hence the name cord factor). Further research has proved that TDMs 
have a more ubiquitous distribution as they exist in other non pathogenic Mycobacteria as 
well as Corynebacteria and Nocardia.60,97 Yet, there is no shortage of reports about the 
biological activities attributed to TDM that range from inducing Th1 response and 
initiating granuloma formation to desiccation resistance.98,113,114 Results from in vivo  
 
 
13
 
 
Figure 1.6 Schematic Representation of the Cell Wall manLAM 
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Figure 1.7 Representative Examples of Acylated Trehalose 
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experiments to investigate the exact role of TDM in Mycobacteria pathogensis point in 
many different directions which leaves a lot of doubt about the pathological function of 
these molecules. It is clearly established, however, that the monomer unit of TDM, 
glucose monomycolate (GMM), is one of the ligand to human CD1b receptors.71,115 
 
     Beside cord factor, other forms of ATs exist in some mycobacterial species (some are 
shown in Figure 1.7). These include trehalose monomycolate (TMM), 2,3-diacyl 
trehalose, triacyl trehalose and pentaacylated trehaloses.116-119 Most of these acylated 
trehaolse derivatives are esterified with methyl-branched fatty acids such as 
tuberculostearic, phthieonic, mycocerosic and phthioceranic acids.  
 
     Other trehalose esters can be restricted in distribution to certain species. For example 
Mycobacterium phlei is characterized by the presence of special trehalose phleates, a 
family of lipids that consists of a trehalose sugar esterified by multiple molecules of 
polyunsaturated fatty acid (phleic acid).96,120 The most abundant of which is the fully 
acylated trehalose octaphleate which contains 40 double bonds. So far, trehalose phleates 
have been shown to be restricted in their distribution to M. phlei.63 
 
1.4.3.3 Sulfated glycolipids (SL) 
 
     Sulfolipids or sulfatides are ATs that were discovered during the search for the acidic 
substance responsible for the reactivity of virulent M. tuberculosis towards staining with 
the cationic phenazine dye neutral red.121-123 They consist of a family of acylated 
trehalose sulfate the most abundant of which is SL-1 (2,3,6.6’-tetraacyl  
trehalose-2’-sulfate)121 as shown in Figure 1.8. The esterification of trehalose sulfolipids 
includes always a palmitic or stearic acid at C2 position while other substitutions are long 
methyl-branched fatty acids of phthioceranate or hydroxyphthioceranate. Four other 
sulfolipids were isolated namely SL-I’, SL-II, SL-II’ and SL-III.63 
 
     Until now, sulfolipids are thought to be limited in their distribution among 
Mycobacteria to a limited number of pathogenic species. Interestingly, the avirulent  
 
 
 
 
Figure 1.8 Structure of SL-1 
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strain M. tuberculosis H37Ra was found to be devoid of all major sulfolipids.124 Although 
initial reports indicated a major role of sulfolpids in the virulence of M. tuberculosis,125 
this claim has been recently refuted by mutation studies that used sulfolipid deficient 
strains.126,127 
 
1.4.3.4 Lipooligosaccharides (LOS) 
 
     The term is used to describe a variety of glycolipids that have been identified among 
several species of Mycobacteria and share a common core structure. The core of these 
LOS is based on a polyacylated trehalose to which other sugar residues are glycosidically 
linked.128,129 Like most glycolipids, LOS are considered as major antigenic components 
of the mycobacterial cell wall and their antigenic properties are mainly associated with 
the terminal sugar. Some of these sugars are very rare and are specific to distinct species 
like the N-acyl kansosamine sugar isolated from of M. kansasii LOS.130 The variability 
among LOS in the types of sugars substituents and their acylation patterns make these 
compounds valuable tools in serotypying.  
 
     LOS are often substituted with methyl branched fatty acids but substitution with other 
groups have also been reported such as substitution with pyruvic acid in the case of M. 
smegmatis.129,131 LOS seem to have a ubiquitous distribution as they have been reported 
in several pathogenic as well as non pathogenic Mycobacteria including M. kansasii, M. 
malmoense, M. szulgai, M. gordonae, M. butyricum, M. marinum and M. tuberculosis 
Canetti strain.120,132-136 
 
1.4.3.5 Phthienoic and mycocerosic acids 
 
     Phthienoic, also known as mycolipenic acids, are odd numbered dextrarotatory methyl 
branched acids of average carbon chain length between 25 and 31 carbons.63 Cason and 
Sumrell were able to isolate a dozen of these acids and concluded that they have an α,β 
unsaturated acid moiety together with three or four methyl branches in the carbon 
chain.137,138 These fatty acids were originally isolated from the phosphatide fractions of 
M. tuberculosis but were also found in small number of slow growing 
Mycobacteria.139,140   
 
     Some variabilities in the structure of these acids were reported (Figure 1.9). These 
variations include the presence of hydroxyl group (hydroxyphthienoic acid) and presence 
of unsaturation (mycolipdienoic acid). It is important to point out that cellular phthienoic 
acids and their analogs are rarely found in a free state instead they are usually esterified 
to sugars mainly trehalose or long chain fatty alcohols.116,141  
 
     Another class of methyl branched fatty acids, mycocerosic or mycoceranic acids, are 
distinguished from phthienoic acids by being levorotatory. They exist in the cell wall 
esterified by long chain fatty alcohols, phthiocerols. They are usually 30-32 carbons in 
length with tetra methyl substitution at positions 2, 4, 6 and 8.  Being structurally similar 
to phthienoic acids, both lipids have been implicated in some of the inflammatory 
characteristic of tuberculosis lesions.142 
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Figure 1.9 Examples of Phthienoic and Mycocerosic Acids 
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1.4.3.6 Phthiocerol diesters 
 
     The phthiocerol family consists of a mixture of long chain β diols that exist in the 
mycobacterial envelope in diester form. Closely related to this family are phenol  
phthiocerols which are basically aromatic derivatives of phthiocerol143,144 (Figure 1.10). 
Phthiocerol and their aromatic derivatives are found only in the cell wall of few 
Mycobacteria usually esterified to the multimethylated fatty acids mentioned above 
(namely mycocerosic and phthienoic acids). This group of lipids is produced mainly by 
slow growing pathogenic Mycobacteria which include M. tuberculosis, M. bovis, M. 
kansasii, M. marinum and M. ulcerans.145 Also, they were reported in the uncultivable M. 
leprae and the non pathogenic M. gastri.145  
 
      In order to validate the role of phthiocerol derivatives in Mycobacteria virulence, 
Goren and colleagues have compared the virulence and pathogenicity of M. tuberculosis 
H37Rv and a mutant deficient in the synthesis of phthiocerol esters in aerogenic infection 
model using Guinea pigs.146 The mutant strain was less virulent and was drastically 
unable to maintain the surface tubercles which were almost cleared within 50 days.146 
 
1.4.3.7 Phenolphthiocerol glycolipids (PGL) 
 
     This group of lipids carries a great structural similarity to the phthiocerol diesters but 
they are synthesized by only a limited number of Mycobacteria species and some specific 
strains of certain species.59,147 The chemical structure of these lipids consists of the same 
core as phthiocerol diesters where the phthiocerol chain is terminated by a phenolic ring 
but in PGLs this ring is further substituted through glycosidical linkage with one or more 
sugar residues (Figure 1.11).  
 
     When first reported, PGL were named mycosides. Mycosides A, B and G were 
isolated from M. tuberculosis strain Canetti, M. bovis and M. marinum respectively and 
were shown to have very similar aglycon part.145,148,149 However, mycoside A is 
terminated with a trisaccharide of methylated sugars,150 151,152 while mycoside B and G 
are terminated with a single sugar residue, 2-O-methylrhamnose and 3-O-methyl 
rhamnose respectively.145,148 The use of the term mycosides has faded and now these 
molecules are more likely to be called phenolic glycolipids (PGL). Recently, evidence 
has suggested the association of PGL with increased virulence of some strains of M. 
tuberculosis due to some immune-modulatory properties linked to this molecule.153 
 
1.4.3.8 Glycopeptidolipids (GPL) or “mycoside C” 
 
     Glycopeptidolipids were isolated initially from M. avium, M. intracellulare and M. 
scrofulacceum (MAIS subgroup) and later more lipids with similar structure were 
isolated from other Mycobacteria from different clades.154,155 C-mycosides are generally 
characterized by a peptide core of D-aminoacids mainly D-phe-D-alloThe-D-Ala and this 
small peptide sequence is usually terminated at the carboxy end with an L-alaninol or 
ethanolamine substituent156 (Figure 1.12). The “tetrapeptide core” is further substituted 
through its N-terminus, the D-phenylalanine residue, to a long chain fatty acid.157 
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Figure 1.10 Structure of Phthiocerol Derivatives 
 
 
20
 
 
Figure 1.11 Structures of Some PGL from Different Mycobacteria 
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Figure 1.12 The Tetrapeptide Core of GPL 
 
 
     There are two main sites for glycosylation in the PGL core. The first one is at the 
hydroxyl group of L-alaninol which is usually monoglycosylated with O-methylated -L-
rhamnose and the other is at the D-allotheronine site where one or more sugar residue can 
be attached starting with a 6-deoxy L-talose.155,157 The presence of an oligosaccharide 
attached to the L-talose residue is associated with eliciting a strong strain specific 
immune response to M. avium and M. avium complex.96 Thus these oligosaccharides are 
the main tool used for serotyping M. avium complex clinical isolates.16  
 
1.4.3.9 Triacyl glycerols (TAG) 
 
     Triacyl glycerols constitute about 5-10% of the cellular mass of M. tuberculosis when 
it is grown in the presence of glycerol.158 However, this percentage is greatly reduced 
when the glycerol in the media is totally replaced by glucose.159,160 TAGs are ubiquitous 
among all Mycobacteria and can be extracted from both the cell wall fraction of the 
bacilli as well as the cytoplasmic fraction.7 The accumulation of TAG in fat bodies or 
lipid vacuoles has been observed in M. tuberculosis, M. marinum, M. bovis, M. kansasii 
as well as Corynebacterium sp. when their growth was stimulated by the addition of a 
lipid substance in the growth media such as Tween 80.7 
 
     The acyl substitution of mycobacterial TAG exhibits little variation among different 
species. Position-1 is often substituted with stearic, tuberculostearic or oleic acid. 
Position-2 is usually esterified with C16 fatty acids while longer chain fatty acids C20-  
C32 are located in position-3.161 The metabolic turnover for TAG was found to be very 
rapid for actively grown bacteria which suggest that they may serve as biosynthetic 
precursors or temporary energy storage for the bacterial cell.63 
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1.4.3.10 Mycobactins and carboxymycobactins 
 
      Mycobactins (Figure 1.13) were discovered in the 1950s as the growth factors 
necessary to cultivate M. avium subsp paratuberculosis.162,163 They are hybrid peptide-
polyketide iron chelating compounds secreted by Mycobacteria to sequester iron during 
iron limiting conditions such as in the case of competing with its host for a limited iron 
supply. 
 
     The basic iron chelating nucleus of these molecules is 2-hydroxyphenyloxazoline ring 
which is biosynthesized from salicylic acid condensation with serine or threonine 
residue.164 The serine residue is further linked to a small chain of two lysine residues and 
one hydroxyl acid. To attain lipid solubility, the side chain nitrogen of one of the lysine 
residues is substituted with long alkyl chain (C20 or longer). Mycobactins can bind one 
iron atom per molecule through the coordination of the iron atom by the two hydroxamic 
acid groups and the hydroxyl group of the salicylic acid residue.164,165 
 
     Several mycobactins have been isolated from different Mycobacteria and were 
designated by letters e.g. mycobactins P, T, S, M and H.163,166,167 Each species produces 
its own collection from these mycobactins. Carboxymycobactins are chemical analogues 
of mycobactin molecules that are excreted outside the cells (exomycobactins). To 
improve their water solubility, the long alkyl chain is replaced in carboxymycobactins by 
a shorter chain that terminates with a carboxylic group.168,169 
 
1.4.3.11 Carotenoids 
 
     These colorful polyene compounds (Figure 1.14) are usually associated with plants 
and fungi that are capable of photosynthesis.170 However, some species of Mycobacteria 
demonstrate the ability to produce these caratenoid pigments either in a constitutive 
(scotochromogens such as M. phlei and M. gordonae) or inducible way 
(photochromogens such as M. kansasii and M. marinum.7,63 The biosynthesis of the β-
carotene pigments from isoprenene units includes several intermediates such as the 
colorless phytoene and the pink colored lycopene.  
 
     The distribution of these carotenoids among Mycobacteria depends on both the 
species and its growth conditions. For example, M. kansasii which produces extracellular 
β-carotene crystals is thought to produce mainly oxygenated carotenoids (Xanthins) only 
when they are exposed to lights.7 These pigments are believed to protect cells against 
oxidation that can be induced by UV exposure or chemical dyes such as toluidine blue.171 
 
1.4.3.12 Menaquinones 
 
     Menaquinones, 2-methyl-3polyprenyl-1,4 naphthaquinone, are key components of the 
respiratory chain of all Gram positive bacteria including Mycobacteria. Menaquinones 
nomenclature (Figure 1.15) follows the general formula of menaquinine-X (Hy), where 
(X) is the number of isoprene units attached at position 3 of the ring and (y) is the number 
of hydrogen atoms that saturate that chain.172 Variation in the number of isoprene units 
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Figure 1.13 General Structure of Mycobactins 
 
 
 
 
 
 
Figure 1.14 Structure of Some Examples of Carotenoids 
 
 
 
 
 
 
Figure 1.15 General Structure of Menaquinone 
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and the degree of unsaturation led researchers to use menaquinones as taxonomical 
markers in the classification and identification of actionmycetes.172 
 
      Among Mycobacteria, menaquinone-9 (H2) is the most abundant and has the widest 
distribution with limited amounts of menaquinone-8(H2) and menaquinone-7(H2) 
reported in some species. This also distinguish Mycobacteria from Corynbacterium 
dephteriae which contains mainly menaquinone-8(H2).173 
 
 
1.5 Role of the Mycobacterial Cell Wall in Virulance 
 
     The unusual complexity of the Mycobacteria cell wall necessitates that a significant 
part of its genome is dedicated to genes that participate in the biosynthesis of all of its 
unique components. This in turn imposes a metabolic burden on the bacterial cell and 
requires the devotion of large amount of energy for its assembly. Despite such 
evolutionary pressure, the structure of the cell wall is well conserved among most 
Mycobacteria. All of this suggests the importance of each single component of the cell 
wall to the survival of these organisms.  
 
     As previously discussed, there are several unique characteristics to the mycobacterial 
cell wall. For example, in the mycobacterial PG, both the glycan and the peptide branches 
have been modified to confer superior rigidity and chemical stability to the cell wall.73 
The AG complex adds more strength to the cell wall and serves another important 
function by anchoring the mycolic acids to the cell skeleton.60 These Mycolic acids are 
the main permeability barrier for the penetration of most chemotherapeutic agents thus 
rendering Mycobacteria resistant to most commonly used antibiotics and antiseptics.59,60 
 
     Loosely bound mycobacterial lipids that are located at the surface of the bacterial 
envelope can easily diffuse and interact freely with the host's immune system. Some of 
the glycolipids associated with the cell wall have already been shown through in vitro and 
less frequently in vivo experiments to interfere with the host defense mechanisms and 
many are thought to represent potential virulence factors. For example, TDM was shown 
to produce toxicity in mice but not in other animal species. GPL are well recognized as 
antigens that are used for serotyping of M. avium complex and are thought to enhance the 
survival of M. avium inside the macrophages.120,155 Phenolic glycolipids (PGL) are 
known as the main antigenic component of M. leprae and are now thought to play an 
important role in the hypervirulence of M. tuberculosis W-Beijing strain.143,144,153 They 
have also been proved to posses the capability of modulating the early host immune 
response.174 In most of these cases however, clear undisputable evidence is lacking, 
which underscores the importance of more thorough studying of these exotic molecules 
preferably through the use of a more global approach. 
 
     Overall, there is no shortage of evidence to indicate a significant role of the cell wall 
in the virulence and pathogenesis of Mycobacteria. Many in vivo experiments have 
demonstrated a powerful host immune response upon the injection of different cell wall 
components.50,98,100,111,113,120,155,175-177 In fact, cell free preparations of M. bovis BCG cell  
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wall skeleton have demonstrated some anti neoplastic properties and have recently found 
a place in immunotherapeutics.178-180 The immunostimulatory activity of M. bovis BCG 
cell wall preparations has been previously attributed to TDM181,182 and in a more recent 
study to a newly discovered monomycolated glycerol lipid.183  
 
 
1.6 Mycobacterial Cell Wall as Diagnostic and Taxonomic Tool 
 
     Long before the rise of rapid genomic sequencing and other genetics tools, the 
characterization of Mycobacteria was based mainly on the biochemical analysis of its cell 
wall components.184 The most abundant lipids of the cell wall, mycolic acids, exhibit 
enough structural diversity among different Mycobacteria which led to the use of mycolic 
acid patterns obtained through different chromatographical techniques as biochemical 
criteria for the taxonomical classification of Mycobacteria.86,93,185 
 
     Few decades ago, simple chemical hydrolysis of the mAG complex followed by 
separation with thin layer chromatography (TLC) was used to resolve the pool of mycolic 
acid in two directions. The 2D-TLC patterns produced through these procedures can be 
diagnostic for every species.185 This technique has found some application in the 
mycobacteriology research for a certain period of time.186 Later with the spread of non 
tubercular mycobacrterial infections, the need for a powerful diagnostic tool pushed for 
further improvement of such concept through the use of GC and HPLC. Both methods 
afforded a much better resolution of the mycolic acid pool and were thus used as a 
reliable tool in both the taxonomy of Mycobacteria and the characterization of clinical 
isolates from tuberculosis patients.94,184,187 
 
 
1.7 Analysis of the Mycobacterial Cell Wall 
 
 
1.7.1 Analysis of Peptidoglycan Structure 
 
     The general structure of PG shows relatively little variability among bacterial species.  
Routine procedures have been used to detect the amino acid sequence of the peptide 
chain and the saccharide units of the glycan chain. Due to its location beneath complex 
layers of lipids and polysaccharide, several procedures including delipidization, 
deproteinzation, and lysozyme digestion are necessary before PG analysis.188 
 
     Both enzymatic and chemical hydrolysis are used to break down the cell wall skeleton 
to yield smaller analyzable fragments of the PG polymer. Subsequent chromatographic 
procedures are then used to separate the oligosaccharide and the peptide fragments and 
these fragments are then sequenced through HPLC.58 Earlier attempts have used D-
cycloserine to inhibit peptidoglycan crosslinking allowing the accumulation of 
peptidoglycan precursors to facilitate their analysis. However, such treatment resulted in 
some artifacts that led to few misinterpretation of the PG structure of Mycobacteria.73 
Later, milder hydrolytic procedures and coupling of the HPLC to advanced MS 
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techniques have provided a more quantitative analysis of the peptide and saccharide 
residues of the PG macromolecules which is responsible for our current understanding of 
the special feature of mycobacterial peptidoglycan.74,75 
 
 
1.7.2 Analysis of Arabinogalactan Complex 
 
1.7.2.1 Degradative analysis 
 
     The original strategy for AG analysis included harsh chemical hydrolysis to release 
the arabinogalactan complex from the cell wall through delipidation and hydrolysis with 
1N sodium hydroxide.80 The hydrolytic step is followed by neutralization, dialysis 
against pure water and AG precipitation by 80% ethanol. Successive column 
chromatography on Dowex and DEAE cellulose removes proteins and yields pure 
fraction of AG and arabinomannan. Further steps of hydrolysis and derivatization are 
then necessary to break down the polymers into small sugar fragments that can be 
analyzed using GC/MS or HPLC/MS.80 These long analytical procedures require a large 
cell mass of about 800 grams. Yet, a lot of information regarding the sugar linkage and 
the branching pattern of the cell wall polysaccharides can be lost during the harsh 
chemical treatment.  
 
     A milder protocol was introduced by Daffe et al in 1990 that included the production 
of high quality cell wall preparation through sonication and treatment with surfactant 
such as triton-x.81-83 Extraction with SDS was then necessary to remove associated 
proteins. The cell wall preparation produced was per-O-methylated using dimethyl 
sulfinyl carbanions then partially hydrolyzed with trifloroacetic acid. The partial 
hydrolysis resulted in random glycosidic cleavage at different positions of the AG chain 
to produce different fragments. Upon reduction of these fragments with Na BD4, 43 
different alditol fragments were produced which can be differentiated through analysis 
via GC/MS.81 Through this methodology, linkages and branching within the AG complex 
were elucidated.79 Later, the same method with few modifications was used to establish 
the type of linkage between the PG and the mAG complex.  
 
1.7.2.2 Solid state NMR HR-MAS for elucidation of AG 
 
     The previously discussed procedures have established the structure of AG, its sugar 
composition, linkage type and branching pattern. This well documented research paved 
the way for a faster method for screening the structure of AG without long hydrolytic 
procedures through the use of solid state NMR spectroscopy. While solution NMR was 
used to establish the configuration and linkage type of the predigested fragments, high 
resolution magic angle spinning (HR-MAS) can be used with live bacterial cell to 
analyze intact AG molecule through the production of 1H-13C HSQC maps.189,190 Due to 
the dynamics of HR-MAS acquisition, the HSQC spectrum of live bacteria preferentially 
contains signals of arabinogalactan and lipoarabinomannan rather than lipids and mycolic 
acids. This is due to several factors concerning the short T2-relaxation time of lipids and 
their slow molecular tumbling in the absence of organic solvents. 
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     Different residues of arabinose and galactose at specific branching points and with 
variable substitution were represented by distinct signals in the HR-MAS spectrum.189 
These signals can be used as indicators for the presence or absence of specific branching 
points or substituents. The method requires supplementing the culture with 13C-carbon 
source like glucose and glycerol to obtain good quality spectra in a reasonably short time. 
After enrichment, 30-40 mgs of culture is sufficient for simultaneous structural analysis 
of both AG and LAM.189,190 
 
 
1.7.3 Free Lipid Extraction 
 
     Any biochemical approach for studying lipid composition and function has to start 
with an extraction process to remove the lipids from the cell wall. Two main 
methodologies have been used for this purpose. First is the Folch’s protocol developed by 
Jordi Folch in 1956 which uses a mixture of chloroform: methanol 2:1 v/v for lipid 
extraction.191 As he described it, an excessive amount of solvents is usually used for 
extraction (twenty times the volume of the cell pellet). Then the extraction step is 
followed by washing steps using a solvent mixture of chloroform: methanol: water 
3:48:47. This ratio is critical to reduce loss of the lipids to the aqueous layer that 
separates from the lipid organic layer upon centrifugation.191 
 
      The second protocol is the method developed by Bligh and Dyer in 1959 which was 
proposed as a modification of the Folch’s to avoid excessive solvent use.192 This protocol 
is better suited for extraction of tissues with more moisture and low lipid content and was 
proved to be more efficient in extracting polar lipids. It was also simplified from the 
Folch’s protocol to avoid the multiple washing steps through using an extraction solvent 
with higher methonal ratio then adding more chloroform and water to achieve biphasic 
solution. Lipid extraction is first achieved using a mixture of chloroform:methanol 1:2 . 
Subsequently, chloroform and water are added to the final lipid extract to bring the total 
solvent ratio to chloroform:methanol:water 2:2:1.8 which renders the extract biphasic. 
The two layers are then separated by centrifugation. The upper aqueous upper layer 
(devoid of lipid content) is then discarded.  
 
     It is to be noted though that both protocols were originally designed for the extraction 
of membrane lipids from animal tissues which are not covalently bound to the cells.191,192 
In the case of Mycobacteria both methods can serve the purpose of extracting only 
loosely attached free lipids. In order to perform mycolic acid analysis, the extraction 
procedures has to be preceded by a step of alkali or acid hydrolysis to release the 
covalently bound mycolic acids from the arabinogalactan complex. 
 
 
1.7.4 Mycolic Acid Extraction 
 
     Mycolic acids in Mycobacteria are present in two forms; A minor fraction is esterfied 
to sugars mainly in the form of trehalose mono and dimycolates, while most of the cell 
wall mycolic acids are covalently bound to the PG-mAG complex.59 In order to analyze 
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the total mycolic acids pool, the covalently bound fraction has to be released in a free 
extractable form. This is achieved through either acid or alkaline hydrolysis. Alkaline 
hydrolysis (saponification) produces the highest yield and is the most frequently 
used.90,94,187 It includes three consecutive steps of hydrolysis, neutralization and 
extraction. Methanolic or ethanolic potassium hydroxide can be used for saponification 
followed by acidification of the saponified wax with HCl to release mycolic acids.193 At 
this point, the free mycolic acids are readily extractable with an organic solvent such as 
diethyl ether or chloroform.193 For analytical characterization by GC or HPLC, the 
mycolic acids have to be derivatized to their methyl esters.194 Esterification is performed 
by a methylating agent such as iodomethane or diazomethane.  
 
     Alternatively,  mycolic acids can be extracted through methanolic acid hydrolysis.195 
In this case, a mixture of methanol, sulfuric acid and toluene or methanol/6N HCl can be 
used to release mycolic acid esters which can then be extracted with n-hexane. Both 
alkaline and acid hydrolysis have been proven effective in preparation of high quality 
mycolic acid extracts. They also proved to be amenable to scaling down. Few milligrams 
of cells were satisfactory in obtaining a reproducible HPLC or GC mycolic acid pattern in 
both cases.196 
 
 
1.7.5 Lipid Analysis 
 
     After the initial extraction, different bioanalytical methodologies can be applied to 
create a “lipid profile”. The ideal bioanalytical technique to be used for such purpose 
should result in a lipid profile that would represent the lipid pool of the original sample in 
both qualitative and quantitative manner. In most cases however, a combination of 
techniques is required to fully analyze a complex and diverse mixture of lipids such as 
that of the mycobacterial cell wall. The fact that these lipids represent a wide spectrum of 
physical properties (different degrees of polarity, ionization potential and extraction 
accessibility) make it especially challenging for a single technique to overcome this 
complexity.  
 
     The range of techniques that have been used for this purpose included traditional 
chromatographic techniques (TLC, GC and HPLC), lipid radiolabeling strategies and 
most recently spectrometric techniques such as MS and NMR. Both spectroscopic 
techniques have been traditionally reserved for structural elucidation of individual lipid 
molecules. But with the advancement in both MS and NMR fields and the development 
of robust statistical methodologies, these two methods are increasingly being applied for 
comprehensive lipid analysis studies. 
 
     Because of their abundance and diversity among different species, mycolic acids 
received the most attention towards their identification and analysis. Almost the full 
range of chromatographic techniques has been applied for this purpose. Due to its 
simplicity and low cost, TLC was the first chromatographic technique to be used in 
producing mycolic acid patterns. After considerable success and wide application, 
 
 
29
problems of low resolution had to be addressed through the introduction of more 
sophisticated and powerful chromatographic techniques such as HPLC and capillary GC. 
 
1.7.5.1 Simple thin layer chromatography (TLC) 
 
     TLC was the earliest technique used to detect and classify bacteria based on their 
mycolic acid patterns. When mycolic acids are extracted as mentioned in section 1.7.4. 
The methyl mycolate esters (usually derivatized by the use of iodomethane) can be 
separated on thin layer chromatography plates both in one dimension but preferably in 
two dimensions.185,197 The sensitivity of detection can be enhanced by incorporating 
strategies such as radiolabelling and silver impregnation.198,199 Further modification of 
the solvent system through the addition of small amount of acid has eliminated the need 
for esterification steps. The most commonly used TLC protocol for mycolic acid analysis 
now includes two successive developments first in heptane:diethylether:acetic acid 94:5:1 
for half length  then for the full length in petroleum ether: acetic acid 98:2.198 
 
1.7.5.2 2D-TLC systems 
 
     Dobson et al introduced the first small scale procedures for comparative analysis of 
mycobacterial lipids. The methodology was meant to address the full polarity range of 
mycobacterial lipids by using a sequential solvent extraction to fractionate the loosely 
bound lipids to polar and non-polar pools. These two lipid pools were then analyzed 
using five different chromatographical developing systems with increasing solvent 
polarity.200 In the non-polar lipid fraction, two developing systems of low polarity were 
used to detect triacyl glycerols, menaquinones and phthicerol waxes. By increasing the 
polarity of the two developing systems, a diverse group of glycolipids were resolved 
using three other solvent systems with increasing solvent polarity. This group includes 
acylated trehalose, phenolic glycolipids and sulfolipids. In the polar lipid fraction, 
glycopeptidelipids, phosphatidylinositol mannosides and other polar glycolipids were 
resolved using two relatively polar developing systems.  
 
      The fact that this method does not rely on specific analytical equipment allowed its 
wide use by microbiologists. As a result, this method has found application in 
comparative analysis of different strains, investigating the effect of growth condition in 
lipid biosynthesis and probing gene functions by providing evidence for inhibition of the 
biosynthesis of a certain molecule as a result of gene knockout. However it was obvious 
that the low detection sensitivity allowed the method to be capable only of detecting 
abundant lipid species and thus it was only useful when gross changes in the lipid pools 
were expected. An additional step of acidic or alkaline methanolysis is necessary if the 
method is to be used to analyze the lipid pool of covalently bound fatty acids.  
 
1.7.5.3 Gas chromatography (GC) 
 
     Gas chromatography has been a major research tool in identification and structural 
characterization of Mycobacteria cell wall components. The use of capillary GC/MS is 
indispensible for the proper identification of the cell wall glycolipids as it is the method 
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of choice for identification of the type of the glycol part and the nature of the glycosidic 
linkage that exist in a molecule.81 However, the initial introduction of GC in the 
mycobacterial research field was only to be used as a tool for identification of 
Mycobacteria among other microorganisms through pyrolsis.201-203 The concept of using 
GC in the identification of mycobacterial clinical isolates remains popular among 
researchers although nowadays it is done through fatty acids pattern rather than pyrolsis 
products.204,205 The diverse repertoire of fatty acids and alcohols that make up the 
complex cell wall lipids produces a distinct lipid profile that can be used as a finger print 
to differentiate between  species of Mycobacteria.193 
 
     For this type of analysis, the cellular fatty acid pool is released from the cells through 
organic solvent extraction and then esterfied through the process of alkaline 
methanolysis.193,205 These methyl esters are then analyzed by capillary GC/MS to produce 
a specific fatty acid profile that can be used to distinguish between Mycobacteria and 
other closely related actinomycetes.193,205 Due to its accuracy and reproducibility, this 
protocol has been further developed to include full automation and standardization of the 
extraction and analytical procedure along with a database that includes fatty acid profiles 
for most Gram positive and Gram negative bacteria. This fully automated computer 
assisted identification system is now commercialized under the name Sherlock Microbial 
Identification System® (SMIS) which is commonly used for simple identification of 
microorganisms.206 Comparison between the automated system and the use of 
conventional GC analysis of fatty acids methyl esters found that they both produced 
similar results when used to identify 68 Mycobacteria clinical isolates.205 
 
1.7.5.4 High performance liquid chromatography (HPLC) 
 
     The center for disease control and prevention (CDC) has incorporated the use of 
HPLC as a standard procedure for Mycobacteria classification and diagnosis in 1990.187 
This procedure employs HPLC to produce a well-resolved chromatogram of the cellular 
mycolic acid pool that is species specific and thus can be used as a diagnostic tool in 
dealing with mycobacterial infections. After initial steps of saponification followed by 
acidification and extraction into chloroform, the saponified wax (mycolic acids) are 
derivatized using p-bromphenacylbromide, 4-bromomethyl-6,7-dimethoxycoumarin, 9-
anthryldiazomethane or other fluorescent reagent to maximize sensitivity to UV 
detection.94,207-209 These derivatives are then separated by C18-reverse phase column with 
a methanol/dichloromethane gradient to produce a chromatogram that is unique for a 
particular species. Two internal standards of different molecular weights are added to aid 
in the pattern comparisons and recognition, a process that can be achieved visually or 
through computer-assisted pattern recognitions.187,209 
 
     The utilization of HPLC for mycolic acid analysis has been modified over a 
considerable period of time to develop into a protocol that can be highly reproducible and 
easily automated. Initial problems of long extraction procedures, low sensitivity and 
subjective process of manual pattern recognition have been successfully overcome.210 
The result of these refinements is a standard protocol that can decisively identify any of 
the mycolic acid producing actionmycetes within 40 minutes analysis time and with 98% 
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accuracy.187,211 More recently it has been used in some academic setting as a tool to 
assess the drug susceptibility of certain clinical isolates.212 
 
1.7.5.5 Mass spectrometry (MS)  
 
     Coupled with GC or HPLC, mass spectrometryhas found great use in the structural 
determination of many Mycobacteria lipid classes. Since the development of soft 
ionization techniques such as electrspray ionization (ESI-MS), fast atom bombardment 
(FAB-MS) and matrix assisted laser desorption ionization (MALDI), MS has been used 
in sequencing both the peptide and oligosaccharides component of the lipid cell 
wall.81,102,133,157,213,214 With the great advancement in MS, analysis of complex biological 
mixture without prior separation is now attainable. Soft ionization techniques that 
produce minimal fragmentation can produce a relatively simple spectrum for a biological 
mixture. In addition, advancement in resolving techniques and the availability of different 
analyzers with ultrahigh resolution capability that can reach a value of 100,000 in some 
cases have offered better accuracy in mass determination that can reach 1ppm. 
 
     In a recent example of the utilization of MS in the analysis of mycobacterial lipids, 
Cox et al has coupled the soft ionization of ESI ion source to the super resolving power 
of ion cyclotron analyzer to directly analyze a crude mixture of mycobacterial lipids 
using Fourier transform ion cyclotron resonance (FT-ICR)-MS.215 The technique was 
applicable both to cells grown in vitro and in vivo using ten milliliters of bacterial culture 
or bacilli isolated from infected mouse lung. The entire free lipid pool was 
simultaneously monitored and a number of metabolic changes in this pool were identified 
as a result of gene mutation or limitation in the availability of biosynthetic precursors. 
With the privilege of having a comprehensive look at the entire lipid pool, the researchers 
were able for the first time to identify compensatory mechanism and metabolic coupling 
of two Mycobacteria virulence factors PDIM and SL-1. These metabolic processes were 
also detected in an in vivo model of mycobacterial infection in mice. Changes in lipid 
metabolism related to both the relative abundance of the lipid produced and its specific 
structural modification such as variation in lipid chain length were also detected.215 
However, some problems were reported by the researchers concerning the inability to 
recover low abundant lipids after in vivo infection as they were below the limits of 
detection by this technique. But the relative simplicity of the technique and the wealth of 
structural information it can offer promises a wide range of future application. A wider 
application of such method in the mycobacteriology research can be hampered by the 
limited access to such mass analyzer for most laboratory microbiologists.   
 
     Another elegant application of MS in Mycobacteria lipid analysis was proposed by 
Wenk and colleagues.216 In his research, the mass spectrometry analysis of Mycobacteria 
lipids was preceded by a separation step using HPLC. The HPLC was integrated in that 
system to allow the analysis of low abundant lipids which may not be detected by MS if 
analyzed within a mixture of other highly abundant lipids. The ion source chosen was 
ESI which beside its soft ionization advantages, is better suited to coupling with 
HPLC.216 A potential problem of peak broadening and ion suppression during mass 
analysis was partially overcome by the use of piperidine in the HPLC mobile phase. The 
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addition of piperidine in the mobile phase enhanced ionization and conferred an increase 
in sensitivity by 2-10 folds. But the choice of relatively high pH mobile phase 
necessitated the use of special reverse phase column that can withstand these conditions. 
An isocratic elution scheme of 15mM piperidine in a mixture of chloroform: methanol 
1:1 was used to effectively separate the mycobacterial lipids over a period of 85 minutes. 
 
     The mass analysis of the effluent from the capillary column was achieved using Q-tof 
mass analyzer operating in the negative mode where most of the membrane and the cell 
wall phospholipids can effectively ionize. Another advantage of this method is that 
mycolic acids can be directly analyzed after hydrolysis without the need of a 
derivatization steps as it is normally required for GC or HPLC-based mycolic acid 
profiling. The technique was presented as a “non targeted readout” methodology which 
can be used for the analysis of paired samples (i.e. control versus treated) and was 
applied by the authors to study the changes in the mycolic acid pool between replicating 
and dormant M. bovis BCG in a qualitative and semi quantitative manner.216 The 
limitation of the method however remains in the low ion response for some groups of 
non-polar lipids which includes for example acyl glycerols and PDIM. 
 
1.7.5.6 Nuclear magnetic resonance (NMR) 
 
     Nuclear magnetic resonance has provided researchers with plethora of structural 
information about Mycobacteria cell wall components that is unmatched by any other 
technique. NMR has been an indispensible tool for structural elucidation of all the cell 
wall components that we came to know. Gross structural features such as the nature of 
functional groups and the degrees of unsaturation are readily detected by NMR as well as 
more fine structural features such as the configuration of double bonds and the anomeric 
carbon of sugar residues. Such information can be obtained with relative ease through 
analysis of NMR coupling constants. However, NMR use has always been restricted by 
its relative low sensitivity. This hurdle is likely to be of less significance in the near 
future with the frequent use of very sensitive sample probe (e.g. cryogenic probe) and the 
development of smarter pulse sequence. Nevertheless, in the past two decades NMR has 
found great application in the biological field. For Mycobacteria, an HR-MAS based 
methodology was developed that uses live bacterial cells to monitor metabolic changes in 
polysaccharide components of the cell wall (mainly AG and LAM).189 This type of 
application is likely to remain of limited use in lipid analysis due to irregularities in 
molecular tumbling and relaxation that can be expected from relatively high molecular 
weight lipids when dealing with the condition of solid state NMR.  
 
 
1.8 Current Challenges in Mycobacteria Research 
 
     Tuberculosis remains the leading cause of death from a bacterial infection. Large 
efforts have been directed to combat this devastating disease and limit its progression 
worldwide. Despite these efforts, TB has claimed 1.7 million lives and spread to nine 
million individuals during the year 2006.12 Until the dynamics of the battle between 
humans and the tubercle bacilli change significantly, it is likely that TB world causalities 
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will remain at the same level that we experience today. The first step in eliminating this 
disease is through new treatment regimens that include an arsenal of drugs with new 
molecular targets and novel mechanisms of actions. For development of such drugs, 
researchers in the mycobacteriology field need innovative approaches to achieve a better 
understanding of this successful pathogen and its challenging capabilities. Some of these 
challenges are summarized below. 
 
 
1.8.1 Mycobacteria Latency and Persistence 
 
     We are aware that during infection Mycobacteria adapt a complex life cycle in which 
the bacterial population responds to changes in its surrounding environment by shifting 
between different metabolic states.49,52,53,217,218 In establishing a new infection, the 
bacteria are dividing rapidly inside the human alveolar macrophages in aerobic but acidic 
condition and remain essentially accessible for chemotherapeutic agents.49 However in 
case of inactive infection, the bacilli remain isolated inside the tubercle structure and so 
they enter a state of latency (limited cell division) and shift most of the metabolic 
processes to more of an anerobic nutrient-deprived life style.52,219 Due to their isolated 
location inside the TB granuloma with limited blood supply, halted replication and 
adaptation to slow metabolic rates, latent bacilli show tolerability to chemotherapy.73,220 
Upon reactivation and liquefaction of the organized tubercle structure, the bacilli start to 
rapidly grow and spread to new infection loci as well as to new hosts.49,51 
 
     Reports have shown that latent bacilli isolated from an intact tubercle are viable but 
uncultivable in the laboratory under normal growth conditions.52 Innovative ways to 
study the metabolic shifting during the process of latency and subsequent re-activation is 
necessary to define all elements involved in these processes. A potential success in 
identifying new molecular targets essential for this process can lead to the emergence of a 
new class of anti TB drug candidates. Such drugs that abolish Mycobacteria ability to 
persist in latent state or to be activated to an infectious state will effectively reduce the 
length of treatment regimens, limit the spread of the infection and significantly reduce the 
world repertoire of the infectious bacilli. 
 
 
1.8.2 Mycobacteria Virulence 
 
     Despite decades devoted to studying virulence determinants of the tubercle bacilli, 
there has not been a major breakthrough in that field. Our inability to this day to list with 
clarity the Mycobacteria virulence factors remains frustrating at best despite the 
availability of complete genome sequences for several virulent and avirulant strains of M. 
tuberculosis.221-224  
 
     This underscores the need to complete the gene annotation of M. tuberculosis genome 
which possesses many unique genes some of which may have direct involvement in 
virulence. It is also important to carry out comparative genomics studies aimed at 
explaining variability in strain virulence among different clinical isolates and different 
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lineages. Another aspect concerning Mycobacteria virulence is to identify cellular 
components that participate in host-pathogen interactions and to define signaling 
pathways that mediate cell entry and promote bacteria survival inside macrophages. 
Research done so far in this area has implicated several cell wall lipids such as PIM and 
manLAM in triggering the host immune response and halting the process of phagosomal 
maturation respectively.66,110,111 
 
 
1.8.3 Mycobacteria Drug Resistance 
 
     Tuberculosis is no longer the incurable epidemic (white plague) it once was which 
claimed millions of life in Europe in the 19th century.20 We owe this to the development 
of several anti-TB drugs starting with streptomycin in 1944.21 However, the current 
regimen for TB treatment remains exceptionally long (the short treatment course last for 
six months and involves four drugs), which results in poor adherence of TB patients to 
that long and seemingly unnecessary course.54,55 When a patient stops his treatment 
improperly due to relief of symptoms, the bacterial growth is only partially suppressed 
allowing the enrichment of the bacterial population with naturally occurring resistant 
mutants. Once the resistant strains are activated again, the infection is exceptionally hard 
to treat and typically requires two years of therapy with the possibility of spreading the 
infection to others during this period.34 MDR-TB now has a global distribution while the 
more serious XDR-TB is being reported in several countries including the United 
States.15,34,36 Several questions remain on the best way to curb the spread of such 
dangerous strains as well as to the molecular basis to this sort of multiple drug resistance. 
 
 
1.8.4 NTM Infections and Emerging Mycobacterial Diseases 
 
      The incidence of non tuberculous Mycobacteria (NTM) lung disease is alarmingly on 
the rise.15 The term NTM is generally used to describe Mycobacteria species other than 
that of the M. tuberculosis complex and M. leprae. 4 These NTM are ubiquitous 
environmental organisms that we are exposed to everyday as they exist in the soil and 
water.2,225 M. avium has been known to have the ability to colonize parts of the human 
body such as  the urinary and respiratory tract without causing diseases.16 However, 
individuals infected with HIV are especially vulnerable to infection with these organisms 
due to their severely compromised immune system. The most prevalent NTM infections 
among HIV patients are the disseminated infection with members of M. avium complex 
or MAC.226 Most recently, cases of NTM lung disease are being reported in several 
western countries in individuals with no history of immune-suppression or HIV 
infections.16,227 We have limited understanding of the pathogencity of these bacteria and 
the disposing factors (other than HIV) that can make an individual vulnerable to these 
infections. All members of MAC complex produce highly antigenic glycopeptidolipids 
GPL but until now these fascinating molecules have not been shown to play a specific 
role in virulence and pathogenicity.155 Other less common NTM do not make these 
haptens but are still capable of producing serious infections in some individuals.228-230 
More research is necessary to define the molecular basis underlying the infectivity of 
 
 
35
NTM and the host pathogen interaction associated with them. Such effort are likely to 
reveal interesting new pathways in which Mycobacteria surface components can interact 
with the host cells and how these events affect the clinical outcome. 
 
     In certain areas of the globe, there is a growing number of cases of infections with 
another mycobacterium species. Buruli ulcer (BU), caused by M. ulcerans, is now 
reported in more than thirty countries with the highest incidence rate in West Africa.14,38  
Once not recognized by physicians and scientists, BU infections have been emerging 
rapidly as a serious health concern during the 1980s. In response to the emergence of this 
disease, WHO has launched the Global Buruli Ulcer Initiative in 1998 to raise awareness 
of the disease and encourage scientific research to further define the disease and its 
causative agent and help find new treatment options for the thousands affected by it. 
 
     Due to the prevalence of BU in relatively poor and remote communities, the exact 
incidence rate of BU is not completely known. Also, prevention strategies are hard to 
implement since the mode of transmission of M. ulcerans has not been established yet. 
Beside our need to understand disease transmission and pathology, there is an urgent 
demand to develop new treatments and vaccines to counteract the emergence of such 
devastating illness. One of the remarkable breakthroughs in our understanding of BU was 
the establishment of M. ulcerans virulence factors. In 1999, George, KM et al reported 
the identification and chemical characterization of mycolactone A/B, a macrolide toxin 
secreted by M. ulcerans that produced the same pathological features as BU in animal 
models.231  
 
 
1.9 Purpose of This Study 
 
     Our understanding of the mycobacterial cell wall, its biosynthesis, structural features 
and the role each cell component plays in the pathogenicity is largely based on data 
obtained through multivariate experiments that evaluate a single molecule at a time. A 
better way to study the mycobacterial cells should include a global approach to provide a 
panoramic view of as many metabolites as possible simultaneously and avoid the 
drawbacks of dissecting cell metabolites on multiple experiments. The key focus of the 
research project discussed in this dissertation is to utilize the analytical power of NMR 
spectroscopy to develop a new methodology for global analysis of Mycobacteria lipid 
pool as a complementary technique to the previously developed HR-MAS that focuses 
mainly on the cell wall polysaccharides. The two techniques share a similar strategy of 
13C-isotope enrichment and reliance on 1H-13C 2D-HSQC experiments.  When combined 
together the two techniques will provide a comprehensive analysis of major cell wall 
components in reasonably short time period and with minimal sample manipulation.  
 
     The goals of this research were outlined to insure the simplicity of the new 
methodology which will make it available to a wide spectrum of investigators. The 
results obtained from such techniques have to be easily analyzed and standardized to 
allow valid comparison of results obtained by different research groups. The following 
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chapters offer a thorough discussion of the experimental design and the results obtained 
towards achieving the main goals of this research which include 
 
•  Development of a lipid profiling technique with an optimized extraction, 
acquisition and analysis protocols that insure the reproducibility of the results. 
•  Validation of the methodology in providing unbiased representation of the cellular 
lipid pools of several Mycobacteria species. 
•  Combination of the method with HR-MAS technique for qualitative and 
quantitative monitoring of adaptive changes in the cell wall metabolites when cells 
are grown under stress conditions. 
• Evaluation and application of MS and NMR-based techniques in targeted as well 
as non-targeted lipid analysis. 
 
CHAPTER 2. DEVELOPMENT OF A NEW METHOD FOR ANALYSIS OF 
MYCOBACTERIA LIPID POOL1 
 
 
2.1 Introduction 
 
     The cell wall of Mycobacteria has a very complex and unique structure with notably 
high lipid content. Great research efforts have been directed to the characterization of the 
individual components of the cell wall and investigating the role of these components in 
Mycobacteria pathogenicity and virulence. Early attempts for global analysis of the 
mycobacterial lipidome began in the 1960s during the search for a proper taxonomical 
tool to assign newly discovered species in their right taxonomical order and to help 
identify clinical isolates to the species level.86,233,234 A major breakthrough in this field 
was achieved by Dobson and Minnikin who reported five 2D-TLC systems in the 1980s 
to analyze the mycobacterial lipidome.200 Despite its wide application, this methodology 
remained less than satisfactory. Problems associated with poor staining, low sensitivity 
and limited resolution on one hand and the recent advancement of bioanalytical tools on 
the other, have fueled a research effort for new methodologies to study the mycobacterial 
lipidome.  
 
     Recently, two new methodologies based on mass spectrometry have been described. 
The first uses Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR)-
MS.215 The second uses prior separation with HPLC followed by analysis with 
electrospray ionization HPLC/ESI-MS.216 These analytical techniques are highly 
sensitive, however, they require significant sample manipulation to overcome the 
phenomena of ion suppression within the lipid mixtures thus are best used for the analysis 
of readily ionizable molecules.215,216 
 
     All these methodologies offer great tools to investigate adaptive changes in 
mycobacterial lipid pools. Such techniques can be used to study the mode of action of 
anti-tuberculosis drugs, determine gene function, understand the stringent response of 
Mycobacteria under stress conditions that resemble its in vivo environment, and to 
investigate differences between species or strains of Mycobacteria. To maximize their 
benefit, these lipidomics techniques are best used in complementary fashion and together 
with other genomics and proteomic methods. As it is the case with other “omics” 
techniques, the great utility of these methods is that they provide a wealth of information 
regarding the total composition of the lipid pools, from which a small number of 
candidate molecules can then be defined for more comprehensive follow up studies 
through purification and isolation of such molecules of interests. 
 
     The method being developed in this dissertation focuses on the application of NMR 
spectroscopy as a complementary tool that can be utilized to rapidly analyze the pool of 
                                                 
1 Parts of this chapter are adapted with permission. Mahrous, E.A., Lee, R.E. & Lee, R.E. 
Lipid profiling using two dimensional heteronuclear single quantum coherence NMR. in 
Lipidomics: Methods and Protocols (Humana Press, New York, 2009). In press.232 
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membrane and surface free lipids directly. Considered as a universal technique, the use of 
NMR can be successful in certain areas where other analytical methods have failed. As 
NMR measures properties of nuclei rather than the physical property of the entire 
molecule, NMR signals are less likely to be affected by the different physicochemical 
properties exhibited by different classes of lipids (Molecular weight, polarity, ionization 
potential, etc). This uniformity of response is advantageous because it limits artifacts and 
confers quantitative representation of all lipids regardless of their structures. However, 
several challenges exist for using NMR to study complex pools of metabolites. The first 
of which is the low sensitivity associated with NMR analysis. This can be partially 
overcome by enriching the cell lipidome with 13C-isotope through the replacement of the 
carbon source in the growth media with 13C-labeled lipid precursors. The second 
challenge is the complexity and the frequent overlapping of signals in the NMR 
spectrum. This problem can be addressed through the use of two and three dimensional 
NMR. Two dimensional 1H-13C heteronuclear single quantum coherence (2D-HSQC) 
NMR can be used to rapidly generate lipid profiles with acceptable resolution, while 
more sophisticated three dimensional experiments can be used to resolve the lipid profile 
and help assign signals in the 2D-HSQC spectrum when necessary.   
 
     Beside the choice of the appropriate NMR pulse sequence, analysis of such complex 
data requires extra consideration and efforts. To insure data quality, signals in the NMR 
spectra need to be referenced in both their chemical shift and relative intensity to an 
internal reference that produces a discrete signal in the 2D-HSQC NMR spectrum. To 
enhance reproducibility, external references may be required to calibrate the NMR 
spectrometer and account for any observed variation due to instability of the high 
frequency magnet over time. The data must then be normalized based on these internal 
and external standards using suitable software which confers robust analysis of large data 
sets.  
 
     Other than NMR acquisition criteria, several parameters regarding cell growth 
conditions and extraction procedures can also contribute to the quality of the lipid 
profiling process.  The extent of 13C-enrichment is controlled by several factors including 
the type of growth media, size and strategy of inoculation, the concentration and the 
nature of 13C-sources used. On the other hand, extraction procedures can be affected by 
the type of extraction solvent, temperature and duration of extraction and the ratio 
between cell weight and the volume of solvent used.  Hence, several manipulations 
within the growth and extraction strategy can be sought to target the analysis of specific 
subpopulation.  
 
 
2.2 Materials and Methods 
 
 
2.2.1 Strains and Growth Conditions 
 
     M. smegmatis and M. bovis were grown in liquid growth media at 36.5°C with 
continuous shaking at 250 rpm. Middlebrook 7H9 was used for growing the bacilli after 
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addition of 10% ADG supplement and 0.05% Tween-80. For 13C-enrichment, the main 
carbon source (dextrose and glycerol) were replaced with 13C6-dextrose and 13C3-glycerol 
respectively. For method development, M. smegmatis mc2155 and M. bovis BCG were 
used as surrogate for M. tuberculosis. M. smegmatis was inoculated at a starting O.Dλ600 
of 0.005 while M. bovis BCG was inoculated at starting O.Dλ600 of 0.05.   
 
 
2.2.2 Total Lipid Extraction and Fractionation 
 
     Cell cultures were harvested by centrifugation at 3700xg for 10 minutes at room 
temperature. The cell pellet was washed twice with 5 milliliters of deuterium oxide (D2O) 
and the supernatant was removed by repetitive centrifugation and decantation in between. 
One milliliter of D2O was used to transfer the washed cell pellet to a pre-weighed micro-
centrifuge tube. The cell suspension was then centrifuged at 21,000xg for ten minutes and 
all remaining D2O was carefully removed. For total lipid extraction, a 2:1 mixture of 
CDCl3:CD3OD was added to the washed cell pellet (3µl per 1mg) of wet cell weight. 
DMSO was added in certain experiment to be used as an internal standard to a final 
concentration of 4, 8 and 16mM. The extraction was achieved at 37°C with continuous 
shaking for 20, 40, 90 and 120 minutes. 
 
     For fractionation of the cellular lipid into polar and non polar fraction, two layers were 
separated by direct centrifugation of the cell suspension at 21,000xg for 10 minutes. The 
aqueous upper layer (polar lipids) and the organic lower layer (apolar lipid) were 
separately transferred to 5mm NMR tube for analysis. For analysis of the total lipidome, 
extra CD3OD was added to the extraction mixture (1µl per 1mg of cells) to bring it to a 
single phase solution. Then the extract was separated from the cell debris by 
centrifugation as above. In some instances, other extraction solvents were also used such 
as acetone-d6 and benzene-d6. 
 
 
2.2.3 Mycolic Acid Extraction 
 
     Delipidated cell pellets were re-suspended in two mls of 1M methanolic KOH. The 
cell suspension was heated in a screw capped glass tubes at 70°C for 16 hours with 
continuous stirring. After the alkaline hydrolysis, the extract was cooled down and 
neutralized with concentrated HCl to release free mycolic acids. The extract was then 
diluted with four volumes of deionzied water before being extracted twice with one 
volume of diethyl ether. The combined ether extract was washed with deionized water 
and brought to dryness under vacuum using a rota-evaporator at 40°C. For NMR 
analysis, the mycolic acid residue was dissolved in a 1:1 mixture of CD3OD:CDCl3.   
 
  
2.2.4 NMR Acquisition and Data Processing  
 
     All NMR experiments were done using Varian-Inova 500MHz spectrometer equipped 
with a 5mm triple resonance trpfg probe. 2D-HSQC pulse sequences were done at 24°C 
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for 256 increments and 2, 4, 12 or 60 transients after each sample was tuned, shimmed 
and locked separately. Other acquisition parameters were optimized for each sample as 
well. Felix-NMR 2007 were used to process and analyze the data after referencing to the 
DMSO peak at δ1H=2.67, δ13C=39.4 ppm.  
 
 
2.3 Results 
 
 
2.3.1 Production of NMR Profiles and Assigning Signals of Some Cell Wall Lipids 
 
     The isotope enrichment strategy greatly enhanced the signal intensity and conferred a 
good spectrum in a relatively short acquisition time. A good quality 2D spectrum was 
attainable in 20 or 40 minutes. However, observation of some less abundant lipid species 
necessitated a longer acquisition time of 90 minutes (Figure A.1). Signals in the HSQC 
spectrum were well dispersed and can be categorized into three main regions; the most up 
field region (δ1H, -0.5-3.0 ppm) representing the aliphatic chain of the lipid molecules, 
the far down field region (δ1H, 5.2-8.5 ppm) representing unsaturated and aromatic 
substructures and the middle region (δ1H, 3.0-5.4 ppm) which was crowded with signals 
mainly from the sugar residues of different glycolipids (Figure 2.1). Although there is 
significant crowding of some signal areas of the HSQC spectrum, since every molecule is 
represented by multiple signals, we found that at least one or two signals from each lipid 
molecules of interest did not overlap with other signals (examples are shown in Figure 
2.1). Therefore, the presence or absence and the relative quantity of a certain molecule 
can be readily determined by these diagnostic biomarker peaks (Table 2.1). When 
possible, it is useful to identify and utilize multiple biomarker signals for a certain 
molecule of interest to confer a greater degree of confidence in the data interpretation and 
hence limit the possibility of artifacts from unidentified overlapping species.   
 
 
2.3.2 Effect of Different Growth Conditions 
 
     It has been reported that the composition of the cellular lipid pool can change 
depending on the growth conditions including the type of carbon sources used in the 
growth media.158,159 Glycerol grown Mycobacteria usually accumulate large amounts of 
acylated glycerols, while cells that depend in their growth on glucose as the main carbon 
source tend to form less acylated glycerol and more of the acylated hexoses.159,235 We 
observed similar changes in the growth of M. smegmatis in Middlebrook 7H9 media 
when the growth media was supplemented with either 13C6-dextrose or 13C3-glycerol as 
shown in Figure 2.2. 
 
     Some differences were also observed between the lipid profiles of cells growing in 
liquid media, Middlebrook 7H9, and that growing in a parallel solid media, Middlebrook 
7H11 agar. In the case of M. bovis BCG, we reported a general increase in the production 
of triacyl glycerols, phenolic glycolipids (mycoside B) and methyl-branched fatty acids in 
cells grown on solid media (Figure 2.3). On the other hand, the production of  
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Figure 2.1 2D-HSQC Lipid Profile of M. bovis BCG 
 
1H-13C HSQC spectrum of the 2:1 v/v CDCl3:CD3OD extract of M. bovis BCG. The 
extract was obtained as described in the text (section 2.2.2).  For illustration, three 
biomarker signals for menaquinones are shown (signals Ia-c), and two biomarker signals 
are shown for trehalose dimycolate (signals IIa,b) including the diastereotopic CH2 of the 
cis cyclopropyl ring. Signal III indicates the signal for DMSO, which was included as an 
internal standard during the extraction.  The total sample preparation time including 
extraction was two hours. Total NMR acquisition time was 1 hour and 40 minutes 
(ni=256, nt=10). 
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Table 2.1 Chemical Shift Values of Major Lipid Biomarkers 
 
Description δ1H 
ppm 
δ13C  
ppm 
Description δ1H 
ppm 
δ13C 
ppm 
TAGa   Mycobactinsb   
CH-glycerol 5.30 69.31 aromatic CH 7.15 130.73 
CH2-glycerol 4.38, 
4.19 62.43 
aromatic CH 6.81 115.86 
CH2CO fatty acids 2.35 34.18 PDIMc   
 
acylated trehalosea 
  CH2-CH-COOR 0.96, 
1.23 45.54 
trehalose-C6 CH2 4.21, 
4.44 63.08 
CH2-CH-COOR 4.87 71.55 
trehalose- anomeric 5.13 93.65 Methylated fatty 
acidsc 
  
Fatty acidsa   -CH3 1.05 17.37 
cis double bond 5.34 129.97 -CH3 1.16 19.69 
trans double bond 5.12 124.62 Phospholipidsb   
GPLa   CH-glycerol 5.26 70.47 
phenyl alanine 7.27 128.71 PIM2 anomeric 5.10 101.85 
methoxy sugars 4.67 55.36 PIM6 anomeric 5.01 102.63 
Menaquinoneb   TDMb   
aromatic ring 7.74 133.64 CHCO 2.47 52.81 
double bond 5.05 118.94 Cyclopropyl CH2 -.33, 
0.58 10.73 
 
a,b,c Chemical shifts were inferred from 2D-HSQC spectra of  M. smegmatis, M. bovis or 
M. ulcerans respectively. Subtle variations in these chemical shifts can be observed 
between species due to minor structural details. 
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Figure 2.2 Effect of the Composition of Growth Media on the Lipid Profile of M. 
smegmatis 
 
Insert (a) is an expanded window of the area where the signals of different triacyl 
glycerols and glycerol phospholipids are usually detected. Signals of TAG and 
phosphatidyl inositol, indicated by arrows, were recorded at lower intensity in the 
absence of glycerol from the growth media (lower spectrum). Insert (b) is an expanded 
window of the area where the anomeric signals of acylated hexoses are usually recorded. 
These signals were recorded at lower intensity in the absence of dextrose in the media 
(upper spectrum). The anomeric signal of acylated trehalose is indicated by an arrow. 
 
 
 
44
  
 
Figure 2.3 Effect of the Use of Different Growth Media on the Lipid Profile of M. bovis 
BCG 
 
M. bovis BCG cells were harvested and extracted from either 13C-labeled 20mls culture, 
(a), or the lawn of one 13C-labeled 7H11 agar plate, (b). Signals of mycoside B were 
detected at higher intensity in the lipid profile of cells grown on solid media (biomarkers 
of mycoside B are enclosed in dashed-line circles). However, mycobactins were detected 
at higher intensity in the lipid profile of cells grown in liquid media (biomarkers of 
mycobactins are enclosed in solid-line circles). Effect of using different growth media in 
the lipid profile of M. avium is shown in Figure A.2. 
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mycobactins seemed to be of less abundance in cells grown on solid media. These  
differences can be either due to a real metabolic shift as a result of a change in the growth 
environment of the bacteria or due to shedding off some surface lipids in the liquid 
growth media with the continuous shaking and the addition of a surfactant such as 
Tween-80. 
 
    Cells have also been extracted at different growth stages including early exponential 
phase, mid exponential phase and stationary growth phase. The rapid cell division and  
turnover of metabolites in the exponential phase was translated to relatively low signal 
intensities in the lipid profiles of cells growing at optical density of 0.3- 0.4 (Figures 
2.4a, A3). Cells harvested at later stages of growth at optical density of ≥ 0.7 
demonstrated more diversity and intensity of lipid signals especially in the areas where 
glycolipids signals are usually detected (Figures 2.4b, A4). However, throughout the 
different stages of growth, stability in the relative abundance of glycerolphospholipids 
can be observed. This class of lipids is indispensable for the integrity of the cell 
membrane of living cell and so they may be used as an indicator of the overall spectral 
quality or as an additional internal standard when two sets of spectra are being compared.  
 
      In principle, supplementing the growth media with specific13C-labeled lipid 
precursors can achieve some selective labeling of certain group of lipids.  For example, 
adding 13C2-sodium acetate in the growth media of the cells resulted in selective labeling 
of straight chain fatty acids and significant reduction in the intensity of glycolipids 
signals and signals pertaining to polyketide lipids such as PDIM. The result was a        
2D-HSQC spectrum that was representative mainly of straight chain fatty acid 
substituents of major cell wall lipids (Figures 2.5, A.5). 
 
 
2.3.3 Effect of Initial Culture Volume, Solvent and Duration of Extraction 
 
     The choice of the extraction solvent to be used depends mainly on the pre-determined 
target of the lipid profiling. In certain cases, it may be desired to profile a specific sub 
population like apolar lipids, acetone soluble lipids thus the extraction solvent will be 
chosen accordingly. For total lipid analysis, a 2:1 mixture of chloroform-d1 and methanol-
d4 is regarded as a first choice due to  the existence of validated well-respected lipid 
extraction protocols by both Folch191 and Bligh and Dyer192 that depend on the use of 
chloroform:methanol mixtures. 
 
     Cells harvested from 20 and 50 milliliters cultures and extracted with 2:1 mixture of 
CDCl3:CD3OD to a final volume of 500-600µl produced good quality 2D-HSQC spectra 
using 5mm trpfg probe (Figure A.6). On the other hand, cells harvested from smaller 10 
milliliters culture (50mg) required the use of 3mm NMR probe to accommodate smaller 
sample volumes of about 150µl to produce a 2D-HSQC spectrum of comparable quality 
and in reasonable acquisition time (Figure A.7). 
 
     Extraction with CDCl3:CD3OD for 20 minutes was sufficient to produce a good 
quality lipid profile of the major cellular lipids. Longer extraction time of 40, 90 and 120 
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Figure 2.4 Lipid Profile of M. bovis BCG Harvested at Different Growth Stages 
 
M. bovis BCG cells were harvested and extracted at different stages of growth; at 
O.Dλ600=0.4, (a), and O.Dλ600=0.72, (b). Lipid signals were generally reported at higher 
intensity in cells harvested at later stages of growth. The two spectra were normalized in 
their intensities to the intensity of menaquinones signals, indicated by the small arrows. 
Lipid profiles of M. bovis BCG cells harvested at other optical densities are shown in 
Figures A.3, A.4. 
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Figure 2.5 Effect of Acetate Labeling on the Lipid Profile of M. marinum 
 
Cells were grown in Middlebrook 7H9 where 0.2% 13C2-sodium acetate have been added 
as a 13C-source, (a), or 13C6-dextrose and 13C3-glycerol were used as 13C-source, (b). 
Acetate labeling resulted in selective labeling of straight chain fatty acids as indicated by 
the presence of fatty acids signals at comparable intensity in the two spectra 
(representative signals for straight chain fatty acids are indicated by arrows). Another 
example for the effect of acetate labeling is shown in Figure A.5. 
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minutes offered better representation of lipids of lower abundance with no substantial 
improvement observed for extraction longer than 90 minutes (Figure A.8). In all four 
cases, the lipid profile produced after re-extraction of the pellet was of poor quality and 
only displayed signals of some fatty acids and some membrane phospholipids (Figure 
2.6).    
 
     Extraction with acetone-d6, produced good quality spectra but with a slight bias 
towards non polar lipids and against glycolipids, especially phospholipids (Figures 2.7, 
A.9). Other solvents with lower polarity such as benzene and petroleum ether failed to 
produce a reasonable quality spectrum when used to extract the D2O washed cell pellets. 
In fact, re-extraction of the cell pellet remaining after extraction with benzene-d6 
produced a lipid profile where signal intensities were comparable to other profiles 
obtained with a single step chloroform: methanol extraction (Figure A.10). Due to its 
low dielectric constant, benzene-d6 as a solvent failed to solubilize the relatively polar 
cell wall glycolipids that are included within an organized mycolic acids layer in the 
outer membrane.  
 
 
2.3.4 The Use of DMSO as an Internal Standard  
 
     Dimethyl sulfoxide DMSO was chosen here as an internal standard for a number of 
reasons. i) It is miscible with most organic solvent. ii) It is easy to measure due to its 
physical stability as a non volatile liquid. iii) It produces a single discrete signal in the 
2D-HSQC spectrum which does not overlap with other signals in the lipid profile. iv) It is 
chemically stable which means that it does not interact with cellular lipids under the mild 
conditions of extraction and NMR acquisition. In a series of calibrating 1H-13C 2D-HSQC 
spectral evaluation, NMR spectrometer was able to produce a linear response to different 
concentrations of DMSO between one and 25mM that were detected in 1:1 solution of 
CD3OD and CDCl3 (Figure 2.8). Similar linearity in response was obtained when three 
concentration of DMSO at 4mM, 8mM and 16mM were used to reference the lipid pool 
of M. smegmatis. From these concentrations, 8mM concentration (0.025µl of DMSO per 
10mgs of cell pellet) was chosen to provide a reference signal of reasonable integration 
value and without overlapping with other signals in the spectrum. 
 
 
2.3.5 Reproducibility of the Lipid Profiles 
 
      Four cell cultures of M. smegmatis grown under the same growth conditions were 
used to investigate the reproducibility of the procedures. The integral values of three 
biomarker signals for PIMs, TAGs and unsaturated fatty acids (unFA) were collected as 
indicators for the reproducibility of the results.  With the use of a standard extraction and 
NMR acquisition protocols and prior to any adjustment, the standard deviations for the 
three sets of data collected for PIMs, TAGs and unFAs were reported at 17.1%, 17.2% 
and 15.2% respectively (Figure 2.9). When these values were adjusted by normalization 
to the peak intensity of the internal standard DMSO, the values for standard deviation 
were improved to 11.3%, 14.7% and 11.4% respectively. Further improvement to10.6%, 
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Figure 2.6 2D-HSQC Spectrum Produced by Repeated Extraction of the Cell Pellet 
 
The cell pellet remaining after extraction of M. smegmatis cells by 2:1 mixture of 
CDCl3:CD3OD was re-extracted with the same solvent mixture in 3:1 ratio as used 
before. Only signals of straight chain fatty acids were observed in the lipid profile of this 
extract. The 2D-HSQC spectrum shown above was obtained after 10 transients and 256 
increments.  
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Figure 2.7 Effect of Using Acetone-d6 as the Extracting Solvent 
 
M. smegmatis cells were extracted with either acetone-d6, (a), or a 2:1 mixture of 
CDCl3:CD3OD, (b). Signals of GPL were reported at higher intensity in the acetone 
extract (biomarker signals of GPL are enclosed in solid squares). Also highlighted, is the 
loss of signals indicatives of cellular PIMs from the acetone extract (biomarker signals of 
PIMs are enclosed in solid ovals). 
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Figure 2.8 Calibrating Curve of Different Concentrations of DMSO  
 
The integral volumes of the DMSO signals in a series of dilutions in 1:1 mixture of 
CDCl3:CD3OD are plotted as diamond (R2 value=0.996). Also plotted on the curve are 
integral volumes of DMSO peak obtained through the addition of 8mM DMSO to the 
lipid extract of M. bovis BCG, (solid triangles) or M. smegmatis, (squares). 
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Figure 2.9 Assessment of the Reproducibility of Data Obtained from 2D-HSQC Lipid 
Profiles 
 
Data are presented as integral volumes of lipid biomarker peaks, (a), or integral volumes 
normalized to the DMSO peak, (b), or normalized integral volumes divided by total cell 
number, (c). Biomarker signals used were δ1H=5.26, δ13C=70.47 ppm for PIMs, 
δ1H=5.30, δ13C=69.31 ppm for TAG and δ1H=5.12, δ13C=124.62 ppm for unFA. 
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12.9% and 8.77% was achieved when the DMSO-normalized intensities were referenced 
to the total number of cells used for extraction (Figure 2.9c). 
 
 
2.3.6 Lipid Fractionation through Solvent Partition 
 
     Separation of the polar and apolar lipids can be easily achieved through a simple 
modification in the extraction method. When water is released from cells during 
extraction with 2:1 CDCl3:CD3OD, the relative ratios of chloroform to methanol to water 
in the solvent mixture result in partitioning of the sample into two phases. When the two 
phases are separated the most lipophilic lipids are concentrated in the lower chloroformic 
phase while polar lipids migrate to the upper methanolic/aqueous phase. The result of this 
separation was the elimination of the most abundant lipids (namely TAG and acylated 
PIMs) in one pool leaving most glycolipids in a separate more polar pool. This resulted in 
the appearance of multiple signals of less abundant lipids in the HSQC spectrum of the 
methanolic phase, while a better resolution of some overlapping signals was also 
achieved. 
   
     As an example, Figure 2.10 shows the effect of solvent partition on the representation 
of M. bovis BCG lipid pool.  Signals of mycoside B were detected exclusively in the 
apolar lipid spectrum while mycobactin signals were observed in the polar lipid spectrum 
only. Signals for the glycerol containing phospholipids that were overlapping in the total 
lipid pool became more abundant and better presented in the polar lipid pool when the 
abundant TAG and PIMs were removed into the more lipophilic phase. In other species 
that have different lipid compositions, cellular lipids were effectively fractioned as well.  
Glycopeptidolipids GPL of M. avium were only detected in the non polar solvent while 
other lipooligosaccharides remained in the polar methanolic phase (Figure 2.11). Other 
examples of the effect of solvent portioning are demonstrated in Figures A.11 and 
Figure A.12. 
 
 
2.3.7 Mycolic Acid Analysis  
 
     Upon extraction of mycolic acids, we were able to detect all classes of mycolic acids 
in the 2D-HSQC mycolic acid profiles (Figure 2.12). Non overlapping biomarker signals 
were identified for each unique class of mycolic acids including different signals for cis 
and trans configuration of the cycloprapane rings and double bonds substitution. These 
discrete biomarker signals are summarized in Table 2.2. Among these signals, two 
signals can be used to represent the total mycolic acid pool. These are the α-CH at 
δ1H=2.38, δ13C=51.61 ppm and the β-hydroxy CH at δ1H=3.65, δ13C=72.15 ppm. The 
two signals are present in all types of mycolic acids thus they can be used as a way to 
estimate the total mycolic acid pool. The relative contribution of a specific type of 
mycolic acid can be measured by referencing the intensity of each biomarker signal to 
any of these two common signals. Also, an insight to the average chain length of the 
mycolates can be gained through measuring the intensity of the alkyl chain CH2 peak and 
referencing it to either the α-CHCO or the β-CHOH signals. 
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Figure 2.10 Fractionation of the Lipid Extract of M. bovis BCG 
 
1H-13C HSQC spectra generated from M. bovis BCG grown in 13C-labeled 7H9, (a), total 
lipid, (b), apolar lipids and (c), polar lipids. Expanded views showing detail of the 
biomarkers for mycobactins and mycoside B (bottom inserts, δH 6.68-7.28, δC 113-132.3 
ppm) and glycerol containing phospholipids (upper inserts, δH 5.0-5.44, δC 67-78.8 ppm) 
have been shown in these spectra as examples of how lipids can be separated through 
simple fractionation. Only mycoside B is present in the apolar lipid spectrum while 
mycobactin signals are observed in the polar spectrum. The glycerol containing 
phospholipids signals are overlapping in the total lipid pool, (a). However, when the 
abundant TAG and PIMs are removed into the apolar solvent, less abundant species were 
better presented in the polar lipid spectrum.  
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Figure 2.11 Fractionation of the Lipid Extract of M. avium 
 
2D-HSQC profiles of the lipid extract from M. avium, total lipids, (a), nonpolar lipids, (b) 
and polar lipids, (c).  For demonstrating lipid migration between solvent phases, areas 
that represent certain lipids are enclosed within dashed boxes. From the upper most part 
and going downward, first TDM is shown to migrate completely to the non polar solvent 
phase as indicated by its cyclopropyl ring signals. Second, signals for the peptide core of 
GPL disappeared from the polar extract due to migration to the chloroformic phase. The 
third area shows the partitioning of glycolipids between the non polar and polar phase as 
indicated from the sugar anomeric signals. Finally, signals of the phenylalanine residues 
of GPL are detected exclusively in the non polar solvent phase upon fractionation. 
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Figure 2.12 2D-HSQC Profile of Mycolic Acids Isolated from M. bovis BCG 
 
1H-13C HSQC spectrum of mycolic acids extracted from M. bovis BCG as described in 
text (section 2.2.3). Examples for signals common to all mycolic acid are shown by 
arrows (a, βCH-OH and b, α CH-COOH). Signals indicative to specific classes of 
mycolic acids are circled in dashed lines. 
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Table 2.2 Chemical Shift Values of Major Mycolic Acid Biomarkers 
 
Description δ
1H 
ppm
δ13C 
ppm Description 
δ1H 
ppm 
δ13C 
ppm 
Total mycolates   Cyclopropyl ring   
CH2CO 2.38 51.61 Cis CH2 ring -0.33 10.89 
CH-OH 3.65 72.15  0.58 10.89 
Keto Mycolate   Cis  CH 0.65 15.80 
CH2CO 2.56 46.49 Trans  CH2 0.13 10.43 
Methoxy mycolate   Double bond   
OCH3 3.36 57.23 Cis  CH=CH 5.35 129.87 
CHOH 3.56 62.36 Trans CH=CH 5.12 124.45 
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2.4 Discussion 
 
     The chemical diversity displayed by the lipid content of the mycobacterial cells 
represents a great challenge for its comprehensive analysis.216,236 Previous methods 
developed for this process used different techniques and each has its own merits and 
weaknesses.  The classical 2D-TLC method is favored by many researchers when the 
purpose is to track a specific cell wall lipid due to the simplicity of the procedures and the 
lack of requirement for special analytical instruments.136,200,237 When a specific molecule 
is being tracked, a single solvent system can be used and an optimized detection strategy 
(most often radiolabeling) can be employed to improve the sensitivity towards this 
specific molecule.10 The recent MS and LC/MS methods represent great opportunities to 
researchers but they ideally require significant sample manipulation to reduce ion 
suppression or improve HPLC resolution for reasonable data interpretation.215,216 These 
methods confer high sensitivity that allows the detection of minor metabolites that are 
hard to detect by other techniques. On the other hand, MS-based methods are inherently 
biased to polar lipids that can easily ionize under MS acquisition conditions. 
 
     It is crucial in the development of any global analytical technique to guarantee the 
representation of all components of the cellular lipid pool in their respective cellular 
abundance while maintaining enough flexibility to enrich any specific subpopulation if 
desired. In order to achieve this goal it is important to i) optimize extraction and 
acquisition condition for comprehensive analysis of the total lipid pool, ii) develop a 
standard protocol with several measures that insure the reproducibility of lipid profiling 
techniques, iii) investigate the possibility of enriching and targeting specific lipid 
subgroups and iv) provide a clear plan for maximum validation and utilization of the 
acquired data with an easy to apply analytical and statistical models. 
 
 
2.4.1 A Summary of a Standard Protocol for Comprehensive Analysis 
 
     A standard protocol was developed for lipid analysis as discussed in section 2.3.1.  
This basic protocol uses a 2:1 mixture of CDCl3:CD3OD to extract pre-washed cell pellet 
in 3:1 volume per weight ratio. The lipid profiling protocol was found to be reproducible 
when growth conditions, the type of solvent, initial culture volumes, duration and 
temperature of extraction and NMR acquisitions parameters are held constant. A 
universal enrichment of the 13C-content of the cellular lipids was obtained after 
inoculating unlabeled cells in a growth media containing 13C6-dextrose and 13C3-glycerol 
as the main carbon source.  About 20mls of 13C-enriched culture in the middle of its 
exponential growth was required for developing a high quality spectrum using 5mm 
NMR probe. We were also able to use 10mls of culture to obtain a high quality spectrum 
using 3mm probe. It is feasible that by the use of more sensitive NMR-sample probes 
such as the cryogenic probe, the initial culture volume required for a good profile can be 
further reduced.  Such advancement in NMR acquisition and future refining of the 
extraction protocol can allow for the future use of NMR-based method in some in vivo 
settings.  
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2.4.2 Amenability of the Protocol for Both Comprehensive and Targeted Analysis 
 
     Although the procedure discussed here focuses mainly on the analysis of the overall 
free cell wall lipids populations, the method can be easily modified to target a specific 
lipid population.  For such purpose, the global 13C-enrichement strategy using            
13C6-dextrose and 13C3-glycerol can be replaced by a biosynthetically-guided approach 
that uses specific13C-labeled precursors in order to enrich signals from certain lipid 
population. Moreover, subpopulation of apolar lipids, acetone soluble lipids, 
lipooligosaccharides, covalently bound mycolic acids or others can be specifically 
targeted by slight modification of the extraction procedures either by switching to a 
different extraction solvent or by introducing additional steps prior to extraction (e.g. 
alkaline hydrolysis followed by extraction in case of mycolic acids).   
 
     The fractionation of the total lipid pool into smaller better resolved sub population 
pools can also be achieved through modification of the extraction methods. Some 
example methods include successive extraction of cells with deuterated solvents of 
increasing polarity, use of scavenger resins to pull down and fractionate anionic lipids 
and cationic lipids,176,238 and the use of solvent partitions to remove very abundant signals 
or to separate the polar and apolar lipid pools. The latter strategy was employed here with 
considerable success.   
 
 
2.4.3 Biomarker Assignment through Literature Source and Isolation of Standards 
 
     Due to the complexity of the spectra produced by this method and the incomplete 
spectral assignments in the literature, it is important to have a set of standards and 
analyze them under the same conditions as the lipid profile in order to use for effective 
biomarker assignment. For assigning signals in M. tuberculosis lipid profiles, some 
molecules may have low abundance in M. tuberculosis that is not sufficient to obtain 
enough samples to be used as a lipid standard. In these cases, structurally similar 
molecules (i.e. of the same lipid class) can be isolated from other species where their 
cellular levels are significantly higher. If necessary, 3D HCCH-TOCSY and 3D HCCH-
COSY can then be used to confirm assignment of biomarker signals in the total lipid 
profile. This is especially useful for confirming the chemical shifts of any signals that 
may vary slightly between similar molecules isolated from different species. Such 
variations in the chemical shifts are direct results of subtle differences in structural 
composition or substitution.  After biomarkers have been assigned in the total lipid 
profile, spectral sets can be compared and the relative amounts of cellular lipids can be 
inferred by processing the data using software such as Felix or NMR Pipe. 
 
 
2.5 Conclusion 
 
     In conclusion, a simple method to globally analyze mycobacterial cell wall lipids was 
developed. While this method does not have the fine sensitivity of MS-based lipidomics 
approaches, it has the advantage of being suitable to analyze lipid species regardless of 
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their polarity or ability to ionize and allows the simultaneous analysis of a broader range 
of lipids. NMR is particularly well suited for the analysis of mycobacterial lipid pool 
since most of these lipids have relatively high abundance as structural components of the 
cell wall. The lipid profiles produced by this method seem to offer a comprehensive 
representation of all major classes of lipids that have been reported in the literature. The 
rapid nature of this method, the simple procedures and the small sample size required 
make it a new candidate strategy for the definition of target molecules involved in 
virulence. The method requires only the availability of a standard high field NMR 
spectrometer which can be found in most academic settings. This common access can 
encourage a relatively wide use of this method by the mycobacteriology research 
community. 
 
     Potential application of this method can include several areas of mycobacteriology 
research that still represent serious challenges.  Discovery of new genes that are involved 
in the cell wall biosynthesis can be achieved through such simultaneous analysis of cell 
wall lipids to pinpoint changes in the lipid profile as a result of gene mutation. Other 
application areas include studying inter and intra species variation, investigating new 
drugs mode of action and detecting cellular adaptation to drug treatment and other 
environmental stress conditions.  
 
     The methodology also has the potential to be extended to include other bacterial 
pathogens as long as they can be cultured in the laboratory in well defined growth 
medium. Most members of the actinomycetal line have chemotype IV cell walls that are 
rich in mycolic acids and other glycolipids. Actinomycetes include several pathogenic 
species as well as other species that produce unique and clinically relevant cell 
metabolites such as aminoglycosides produced by Streptomyces sp.239 Similar methods 
can be developed for targeted analysis of such metabolites by employing the right 
enrichment and extraction strategies. 
 
 
 
 
 
CHAPTER 3. USE OF 2D-HSQC NMR FOR ANALYSIS OF MYCOBACTERIA 
CELL WALL2 
 
 
3.1 Introduction 
 
 
3.1.1 Mycobacteria Human Pathogens 
 
     Mycobacteria species are mainly saprophytic but some are serious human pathogens 
and are implicated with devastating diseases. One of the mycobacterial diseases, TB, is 
caused by M. tuberculosis and claims 1.7 million lives every year while nine million new 
cases are reported.12 The devastation of TB is most observed in areas of sub-Saharan 
Africa and the densely populated parts of East Asia where the epidemic of HIV is most 
prevalent and less successfully controlled.12,29 The second most common mycobacterial 
diseas, leprosy, is caused by M. leprae with 250,000 reported cases.37 Both M. 
tuberculosis and M. leprae are intracellular pathogens that can survive and replicate 
inside human cells including macrophages, peripheral neurons and endothelial cells.  
 
     The third most common mycobacterial infection is that of Buruli ulcer which is 
endemic to some tropical areas of the world.241,242 The causative agent for Buruli ulcer, 
M. ulcerans, is an extracellular pathogen that mainly resides in the skin and connective 
tissue of the limbs.243,244 Unlike M. tuberculosis and M. leprae, in the laboratory M. 
ulcerans can only grow at temperature not higher than 32°C which makes it unable to 
cause human systemic infections.26,245 M. ulcerans infects tens of thousands of people in 
tropical regions with most prevalence in Ghana, Benin and Cote d’Ivoir in Africa, 
Malaysia and Sri Lanka in Asia and Mexico and Peru in South America and few reported 
cases in Japan, China and Australia.14 Another Mycobacteria pathogen M. marinum 
causes granulomatous cutaneous human disease in the extremities (swimmer granuloma) 
and systemic diseases in fish and frogs.43,246,247 This pathological spectrum is consistent 
with the inability of M marinum to grow at temperatures over 33°C and its common 
existence in environmental water. 
 
     Other human diseases can be caused by an increasing number of environmental non 
tuberculosis Mycobacteria (NTM). The most common infections are those by M. avium 
complex, or MAC, which includes M. avium subspecies avium, silvaticum and 
paratuberculosis and M. intracellulare. MAC infections are responsible for more than 
half the NTM infections and they are the most common opportunistic infections reported 
in HIV/AIDS patients.15,226,227,248 Other NTM include the photochromogenic M. marinum 
and M. kansasii, the scotochromogenic M. gordanae and M. scrofulacelum, and other fast 
growing species such as M. fortutium, M. abscessus and M. Chelonae.15,16,249 These 
                                                 
2 Section 3.3.4 is adapted with permission. Mahrous, E.A., Lee, R.E. & Lee, R.E. A rapid 
approach to lipid profiling of mycobacteria using 2D HSQC NMR maps. J Lipid Res 49, 
455-63 (2008).240 
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species can cause pulmonary TB-like disease and sometimes more severe disseminated 
systemic diseases especially in immunocompromised individuals.16,248 
 
 
3.1.2 Mycobacteria Animal Pathogens 
 
     Other Mycobactyeria are serious animal pathogens with direct economic impact. 
Cattle can be infected with M. bovis which causes cow tuberculosis, a disease with 
similar symptoms to the human TB. Another mycobacterial disease affecting cattle is 
partuberculosis (also named John’s disease) which is caused by M. avium subsp 
paratuberculosis and is characterized by severe diarrhea and granumlomateous enteritis. 
Other live stocks can be infected by different Mycobacteria pathogens such as M 
scrofulaceum and M. xenopi.250,39 M. lepraemurium is another animal pathogens that 
infects mainly cats and rats and causes a disease with symptoms similar to human 
leprosy.250 On the other hand, cold blooded animals have more susceptibility to certain 
Mycobacteria that include M. marinum, M. liflandii, M. pseudoshittsii, M. xenopi and M. 
avium subsp intercellularae.5 
 
 
3.1.3 Old Classification of Mycobacteria  
 
      Mycobacteria species that we recognize today live in a wide range of environments 
with different growth characteristics, infectivity and pathogencity. The early 
classification of Mycobacteria which was based on microbiological features like colony 
morophology and growth characteristics have resulted in long debates between 
researchers. Another result from the use of such classification was some literature 
confusion especially in the assignment of newly discovered organism as a distinct species 
or a variant of an existing species. Generally, the most accepted classic classification is to 
divide Mycobacteria into two main classes; slow growers and fast growers.1  
 
     This old classification gained credibility because most pathogenic Mycobacteria are 
slow growers while few of the fast growing species are associated with disease 
development. The same classification is still accepted now especially when the results 
from 16S RNA sequencing came largely in agreement with this old classification.11 
Mycobacteria slow growers can be further classified based on their evolutionary 
relationship into multi-member clades. It is of special interest to lipidomic research that 
species included within the same clade were found to share a common mycolic acid 
pattern.1 
 
 
3.1.4 Variability in Cellular Lipid among Mycobacteria 
 
     The variation of the cell wall composition of Mycobacteria (especially mycolic acids) 
has played a significant role in its classification. Distribution of mycolic acids in terms of 
chain length and the types of substitution have been will reported and it provided one of 
the first biochemical bases for the chemotaxonomy of Mycobacteria.88,89,91  Other lipids 
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that were suggested as a basis for biochemical classification of Mycobacteria due to their 
wide variability among different species include menaquinones,172,251 caretenoids,7 fatty 
acids,193 and mycobactins.163,164 The most clinically relevant example of the utilization of 
such variabilties is the serotypying of MAC which depends solely on the nature of the 
glycosidic part attached to a largely conserved lipopeptide core of its GPL. These GPL 
are highly antigenic and they are often located on the bacterial surface in direct contact 
with the host environment. Based on their oligosaccharide, these GPL can elicit different 
immunological reactions that serve as the basis for MAC serotypying.96,155 
 
 
3.1.5 Value of Lipid Profiling of Different Mycobacteria Species  
 
     With the routine use of 16S RNA sequencing as a rapid and accurate method for 
taxonomical classification, Mycobacteria lipid profiling is no longer used for this 
purpose.  However, it can be used to provide valuable information about the participation 
of certain lipids in several cellular processes that include virulence, niche adaptation and 
stringent response. Some evolutionary relationships between species can also be inferred 
from such profiles because cell lipids can be considered as ultimate gene products.  Some 
lipid profiling techniques such as HPLC are still used by CDC as a fast tool for diagnosis 
of TB cases to characterize the causative agent for TB infections to the species level.187 
This chapter discusses the variability in the cell wall metabolites among different 
Mycobacteria and how it corresponds to variations in their growth characteristics, 
pathogenicity and evolutionary relationship. It also further validates the use of NMR as a 
rapid tool for monitoring the cell wall metabolites of Mycobacteria as well as other 
microorganisms. The technique can also provide more comprehensive insights into the 
cell wall composition when combined with the previously developed HR-MAS method 
for monitoring cell wall polysaccharides189 (see section 1.7.2.2). This combination is very 
reasonable as both methods require 13C-enrichement of the cellular metabolites and both 
go through similar steps of sample preparation and data processing.  
 
 
3.2 Materials and Methods 
 
 
3.2.1 Strains and Growth Conditions 
 
     Mycobacterial cells were grown in Middlebrook 7H9 supplemented with 0.2% of 
13C6-dextrose, 0.2% 13C3-glycerol, 0.05% tween and 5% BSA at 36.5°C with continuous 
shaking at 250 rpm. Fast growing species (M. smegmatis ATCC mc2155, M. fortuitum 
ATCC 6841, M. phlei, M. abscessus ATCC 19977) were inoculated at initial optical 
density O.Dλ600=0.005, while slow growing species (M. bovis BCG, M. tuberculosis, M. 
avium ATCC25291) were inoculated at initial ODλ600=0.05. M. ulcerans 1615, M. 
liflandii XL-5 and M. marinum 128 were grown at 31°C without shaking in tissue culture 
flask (see Table 3.1 for a list of the species used). Corynebacterium glutamicum,  
Bacillus subtilis and B. anthracis Sterne (a vaccine strain) were grown in Brain Heart 
Infusion media (BHI) made from 1.75 %BHI, 0.2% 13C6-dextrose,  1% tryptone, 
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Table 3.1 Summary of the Mycobacteria Species Investigated in This Study 
 
Species Growth Temperature°C Pathogenicity  Main Host 
Slow growers    
M. avium 36.5 Opportunistic Human 
M. bovis BCG 36.5 Vaccine strain Human 
M. tuberculosis 36.5 Pulmonary, Systemic Human 
M. liflandii 31 Systemic Frog 
M. marinum 31 Systemic Fish 
M. ulcerans 31 Skin, Connective tissue Human 
Fast growers    
M. abscessus 36.5 Opportunistic Human 
M. fortitum 36.5 Opportunistic Human 
M. phlei 36.5 None None 
M. smegmatis 36.5 None None 
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0.5%NaCl and 0.25% disodium phosphate. Cells were incubated with continuous shaking 
at 250 rpm at 36.5°C. 
 
 
3.2.2 Sample Preparation for HR-MAS 
 
     Cells from 40-50mls culture were harvested by centrifugation at 3700xg for 10 
minutes then washed twice with 5mls of D2O with removal of the aqueous supernatant by 
centrifugation in between. The washed cell pellet was then transferred to a pre-weighed 
micro-centrifuge tube using 1ml of D2O. After centrifugation at 21,000xg for 10 minutes, 
cells were re-suspended in minimal amount of D2O (~200µl). About 40µl of the cell 
suspension was then transferred to an HR-MAS rotor for NMR acquisition.  
 
 
3.2.3 Lipid Extraction  
 
     Total cell lipids were extracted from the previously washed cell pellets after the 
removal of all remaining D2O. A 2:1 mixture of CDCl3: CD3OD was added to the cell 
pellet on basis of the wet pellet weight (3μl per 1mg of cells) and cells were extracted for 
90 minutes at 37°C with continuous shaking at 250 rpm. After extraction, more CD3OD 
(1μl per 1mg of original cell weight) was added to the extraction mixture to obtain a 
single phase solution which was then separated from the cell debris by centrifugation for 
10 minutes at 21,000xg at room temperature. The lipid extract was then transferred to a 
5mm NMR tube for NMR data acquisition. 
 
 
3.2.4 Sterility Testing  
 
     For safety regulation, the organic extract of M. tuberculosis H37Rv was tested for 
sterility. The lipid extract was air dried in a biosafety level-3 cabinet then re-suspended in 
one milliliter of sterile Middlebrook 7H9. 100μl of the cell suspension was inoculated to 
Middlebrook 7H11 agar plates. No growth was observed after incubation at 37°C for six 
weeks.   
 
 
3.2.5 Isolation of PGL from M. liflandii 
 
     M. liflandii cells were grown to stationary phase in Middlebrook 7H9, harvested by 
centrifugation and subsequently extracted with ethanol. The ethanolic extract was dried in 
vacuo. The dried residue (80mg) was re-suspended in CHCl3 and applied to a Biotage 
SP1 flash chromatography system equipped with a Biotage Si 12+M silica gel column. 
The column was eluted using a CHCl3-to-CHCl3/CH3OD 9:1(v/v) linear gradient. The 
major PGL was detected through TLC analysis using CHCl3/CH3OH (95:5, v/v) as the 
developing system (Rf of PGL=0.7). Lipid spots were visualized using cerric ammonium 
sulfate in 2M sulfuric acid after charring. Fractions containing pure PGL were pooled and 
dried in vacuo. 
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3.2.6 NMR Acquisition  
 
     For solid state NMR, the MAS rotor containing 40 μl of cell suspension was inserted 
at the magic angle in 5mm GHx nanoprobe. The 2D-HSQC sequences were recorded 
using Varian Inova 500MHz spectrometer at 24°C degrees with continuous spinning at 
2000Hz.  The 2D-HSQC spectra were acquired for 8 transients and 256 increments. For 
liquid profiling, the 2D-HSQC experiments were recorded using a triple resonance trpfg 
probe for 10 transient and 256 increments. NMR data were processed using either VNMR 
or Felix-NMR software.   
 
 
3.3 Results and Discussion 
 
 
3.3.1 Characteristic Features of Some Species 
 
      The use of NMR methods, both solid state and liquid NMR, can provide a rapid tool 
to gain insights to the structural features of the cell wall polysaccharides and lipid 
components respectively. Generally, No significant difference was observed in the AG 
signals between the ten species tested (See Appendix B, Figures B.1-B.10). This 
observation is consistent with the finding of Daffe at al who concluded through 
degradative analysis and the use of GC/MS that AG structure is well conserved among 
Mycobacteria.81 Some quantitative and qualitative differences were reported in LAM 
signals. The relative abundance of LAM signals was significantly higher in some species 
such as M. bovis and M. ulcerans as opposed to other species like M. smegmatis252 
(Figure 3.1a-e). Other reported intra-species variabilities were related to the type of 
capping of the terminal arabinan chains in LAM which follows one of three patterns; 
mannose capping in manLAM, phospho inositol capping in PiLAM and no terminating 
caps as in araLAM. Characteristic signals of manLAM can be detected at δ1H=3.59/ 3.69, 
δ13C=68.13 ppm as in the case of M. bovis BCG.189 While those of PiLAM are detected 
at δ1H=3.88/ 4.12, δ13C=66.20 ppm as in the case of M. smegmatis253 (Figure 3.1f-j). 
 
     In liquid NMR, signature lipids of different species can be readily detected in their 
corresponding lipid profiles.  Among the ten species investigated here, three can be easily 
separated out (M. avium, M. smegmatis and M. abscessus) by the dominance of GPL 
signals in their lipid profiles at δ1H=7.27, δ13C=128.71 and δ1H=4.31, δ13C=49.45 ppm 
(Figure B.11, Figure B.12 and Figure B.13).  M. avium is the only slow growing species 
in this group and it produces a significant amount of cyclopropyl mycolates as indicated 
by the two signals at δ1H=-0.33/0.58, δ13C=10.73 ppm (Figure B.11). M. smegmatis, on 
the other hand, lacks those signals as well as signals of the methyl branched fatty acids 
that can be easily detected in M. abscessus (Figure B.12 and B.13). 
 
     Among other Mycobacteria used in this study, three species grow at significantly 
lower temperature namely M. marinum, M. liflandii and M. ulcerans.  The presence of 
phenol phthiocerol in very high abundance is a major characteristic of these three species 
as indicated by its characteristic aromatic signals at δ1H=6.98, δ13C=129.47 and δ1H=6.7,  
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Figure 3.1 Interspecies Variabilities in the Cell Wall LAM as Observed in the HR-MAS 
Spectra of Different Mycobacteria 
 
Partial windows of the HR-MAS 2D-HSQC spectra of different Mycobacteria.  
Upper panel: LAM signals detected at (δ1H=4.81, δ13C=99.70), (δ1H=5.02, δ13C=98.08) 
and (δ1H=5.05, δ13C=98.13 ppm) and circled in black dashed lines are almost absent 
from the fast growing species M. abscessus, (a), and M. smegmatis, (b). The same signals 
are detected with high intensity in M. bovis BCG, (c), M. tuberculosis H37Ra, (d), and M. 
ulcerans, (e).  
Lower panel: Variation in the type of substitution in LAM as detected by HR-MAS cell 
profiles. Signals indicative of phosphoinositol capping were detected in both M. 
abscessus, (f), and M. smegmatis, (g), at δ1H=3.88/4.12, δ13C=66.20 ppm as circled in 
red. Signals indicative of mannose capping were detected at δ1H=3.59/ 3.69, δ13C= 68.13 
ppm in M. bovis BCG, (h), M. tuberculosis H37Ra, (i), and M. ulcerans, (j), as circled in 
red. 
 
 
68
δ13C=115.01 (Figure B.14). M. ulcerans can be further characterized by the low 
abundance of most major glycolipids and triacyl glycerols (Figure B.15). In fact, signals 
for TAG were not detected in the lipid profile of M. ulcerans using this method. 
Meanwhile, the lipid profiles of M. liflandii and M. marinum displayed some degree of 
similarity. However, M. marinum can be distinguished by a more complex profile which 
is significantly rich in glycolipids and carotenoids (Figure B.16 and Figure B.17). 
 
     M. bovis BCG and M. tuberculosis H37Rv have very similar lipid profiles but M. bovis 
BCG can be distinguished by the presence of the two aromatic signals of its phenolic 
glycolipid (mycoside B) at δ1H=7.13, δ13C=129.39 and δ1H=7.00, δ13C=116.52 and the 
relatively low abundance of methyl branched fatty acids and PDIM as inferred from the 
low intensity of methyl groups signals at δ1H=1.16, δ13C=19.69, δ1H=1.05, δ13C=17.37 
and δ1H=0.99, δ13C=18.11 (Figure B.18). On the contrary, M. tuberculosis produces 
significantly higher amounts of PDIM and lower amounts of acylated glycerols (Figure 
B.19).  
 
     The saprophytic M. phlei is easily characterized by the production of large amount of 
trehalose phleiates,63 compounds that are easily detected through the presence of multiple 
olefinic signals in the range between 5.00 and 5.60 ppm (Figure B.20). M. fortitum, a fast 
grower, produces a lipid profiles that displays a lack of all signals of cyclopropyl 
mycolates, GPLs and PGLs. It is characterized, however, by the presence of a form of 
acylted trehalose previously designated mycoside F.118 This lipid molecule is represented 
in the lipid profile by a cluster of methyl groups at δ1H=0.7-1.0 ppm and δ13 C=15-22 
ppm (Figure B.21).  
 
 
3.3.2 Comparison between Slow Growers and Fast Growers  
 
     Fast growing species included in this discussion, M. smegmatis, M. phlei, M. fortuitum 
and M. abscessus, have an average doubling time of about 2-4 hours. The slow growing 
Mycobacteria investigated here include M. bovis, M. tuberculosis and M. avium and have 
doubling time of 12 hours or longer. We limited our comparison to these two groups 
because both can grow in the same media and under the same growth conditions. As 
expected, the HR-MAS profiles showed similar AG structural characteristics in both 
groups but variations were observed in LAM and lipids signals. LAM signals at 1H=4.81, 
δ13C=99.70, δ1H=5.02, δ13C=98.08 and δ1H=5.05, δ13C=98.13 ppm189 were detected at 
higher intensity in M. tuberculosis H37Ra and M. bovis BCG and at lower intensity in M. 
abscessus , M. fortitum , M. phlei and M. smegmatis (Figures 3.2a, B.1, B.4, B.7, B.8). 
 
     Also in all HR-MAS spectra of the fast growing species, signals for TAG at δ1H=5.13, 
δ13C=69.00, δ1H=4.19/ 3.99, δ13C=62.01 ppm were easily detected which were absent 
from the spectra of slow growing species (Figure 3.2b). This observation was further 
confirmed in the corresponding lipid profiles as fast growing species clearly produced 
larger amounts of TAG and fatty acids as indicated from the integral values of TAG 
peaks in their lipid profiles (Figure 3.2c). On the contrary, polyketides-based lipids such 
as PGL and PDIM were detected at higher intensity in the slow growers (Figure 3.2d). 
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Figure 3.2 Comparison between the HR-MAS and Lipid Profiles of Some Fast Growing 
and Slow Growing Mycobacteria 
 
Panel (a), differences were observed in the intensity of LAM signals’ most notably in the 
intensity of the terminal α-DManp signal at δ1H=4.81, δ13C=99.70, 2-α-D-Manp  at 
δ1H=5.02, δ13C=98.08 and 2,6-α-D-Manp at δ1H=5.05, δ13C=98.13 ppm in the HR-MAS 
whole cell profile of M. abscessus, M. smegamatis, M. bovis BCG and M. tuberculosos.  
Panels (b) and (c), variabilities in the amount of TAG produced by fast growers and slow 
growers as indicated in both the HR-MAS profile, (b), and the total lipid profile, (c). 
Signals of CH of glycerol at δ1H=5.13, δ13C=69.00 ppm, and CH2 at signals δ1H= 4.19/ 
3.99, δ13C=62.01 ppm are detected in HR-MAS profiles of only M. abscessus and M. 
smegmatis. Similar results were observed in the lipid profiles where TAG signals were 
observed with higher intensity in the fast growing species. The lipid profile of M. bovis 
BCG show moderate levels of TAG that could not be detected in the HR-MAS probably 
due to short T2 relaxation. Panel (d), signals of the methyl groups indicative of methyl 
branched lipids such as phthienoic and mycocerosic acids were detected at high intensity 
in the lipid profiles of slow growers at δ1H=1.05, δ13C=17.37 and δ1H=1.16, δ13C=19.69 
ppm. Signals of such methyl groups can be seen at low levels in M. abscessus while they 
were completely absent from the lipid profile of M. smegmatis. Panel (e), signals of 
cyclopropyl mycolates were detected exclusively in the lipid profiles of slow growers at 
δ1H=-0.33/ 0.58, δ13C=10.73 and δ1H=0.65, δ13C=15.80 ppm. 
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Although both groups displayed signals indicative of trehalose dimycolates at1H=2.47, 
δ13C=52.81 and δ1H=4.44/4.24, δ13C=98.08 ppm, signals of cyclopropyl mycolates were 
absent from the lipid profiles of most fast growers (Figure 3.2e). However, these signals 
were observed with low abundance in M. phlei. 
 
    It is worth mentioning that the line that divides Mycobacteria into slow and fast 
growers overlaps to great extent with the line that divides them into pathogens and non 
pathogens. Although some of these previous observations are best looked at in the light 
of variable growth rates, others may be better understood in the context of virulence and 
pathogenicity. For example, the disparity in the levels of the structurally simple TAG and 
the complex polyketides between the two groups can be explained by differences in the 
metabolic rates of the bacteria and the biosynthetic energy burden associated with these 
lipids. Other observations such as the abundance of cyclopropyl mycolates and the 
presence of mannose capped LAM seem to be in better agreement with the pathogenicity 
and virulence argument. As a supporting evidence, the two totally non pathogenic species 
investigated in this study (M. smegmatis and M. phlei ) both are fast growers and both are 
devoid of most of immunogenic cell wall components previously identified in 
Mycobacteria e.g. manLAM, PDIM and PGL. Other pathogenic Mycobacteria that were 
not included in this comparison like M. ulcerans and M. marinum produce one or more of 
these molecules and will be discussed in the following section.    
 
     
3.3.3 Comparison between Intracellular and Extracellular Pathogens 
 
     M. ulcerans is one of the few Mycobacteria that can be detected in the extracellular 
space in the infected host tissue (in this case human skin and connective tissues).243,244 In 
order to limit the participation of multiple factors in this comparison, M. ulcerans was 
compared only to M. marinum an intracellular human and fish pathogen25,26 that was 
grown under the same laboratory conditions for the purpose of this study. Moreover, M. 
marinum is closely related to M. ulcerans taxonomically and is thought to be the 
evolutionary ancestor of M. ulcerans. Based on their HR-MAS spectra, M. ulcerans and 
M. marinum share a similar AG structure but some differences were observed in LAM 
signals. Most of the LAM signals were detected at higher intensity in M. ulcerans as 
opposed to most Mycobacteria. These high levels can be observed in the signals of 6-α-
Manp at1H=4.81, δ13C=99.70 and that of the terminal D-α-Manp at δ1H=4.93, 
δ13C=102.19 ppm while AG signals in both species were recorded at comparable 
intensity (Figure 3.3a,b). Also evidence from the HR-MAS suggests more frequent 
mannose capping of LAM in the case of M. ulcerans as indicated by both the abundance 
of the t-α-Manp as mentioned above and the high intensity of the mannose capped 
arabinan CH2 signals recorded at δ1H=3.59/ 3.69, δ13C=68.13 ppm (Figure 3.3a,b).   
 
     More stark differences can be observed between the two species by examining their 
lipid profiles. While M. marinum exhibits a lipid profile with some similarities to that of 
other pathogenic species like M. bovis and M. tuberculosis that display a wide variety of 
glycolipids and lipooligosaccharides, the lipid profile of M. ulcerans contains only 
signals of PIMs and trehalose dimycolate in the carbohydrate region (Figure 3.3c,d).  
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Figure 3.3 Comparison between the Extracellular M. ulcerans and the Intracellular M 
marinum 
 
HR-MAS profiles of M. ulcerans, (a), and M. marinum, (b). The two profiles indicate the 
presence of manLAM in both species (signals at δ1H=3.59/ 3.69, δ13C=68.13 ppm are 
circled in red in the upper insert). However, substantial difference can be observed 
between the levels of manLAM detected in each case. Higher levels were detected in M. 
ulcerans as shown by the intensity of the LAM signals in the lower inserts. Also in the 
same insert the anomeric signal of trehalose base molecules can be detected at higher 
levels in the HR-MAS spectrum M. marinum (the anomeric signal of trehalose is circled 
in blue in both spectra). 
The lipid profile of M. ulcerans, (c), is strikingly different from that of M. marinum, (d), 
in the relative amounts of PDIM and glycolipids produced. M. ulcerans lipid pool shows 
limited variety of glycolipids signals when compared to that of M. marinum (the 
glycolipid region is circled in the two lipid profiles). The aromatic signals for phenol 
phthiocerol and its glycosylated derivative (mycoside G) are highlighted in a rectangular 
box in the lipid profile of M. ulcerans and M. marinum respectively. These signals are 
shifted downfield in the lipid profile of M. marinum due to glycosylation. Also in the two 
spectra, the location of TAG biomarker signals is indicated by a black arrow. This signal 
was not detected in the lipid profile of M. ulcerans.  
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Figure 3.3 (Continued) 
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Under the growth conditions used, M. ulcerans produced unusually high amounts of 
lipophilic waxes that include PDIM, phthiocerol, phthidiolone and their aromatic 
derivatives. Meanwhile, signals for TAG were not detected in M. ulcerans based on the 
detection limit of this method. In addition, signals characteristic of M. ulcerans secreted 
toxin (mycolactone) were recorded only after long acquisition time at δ1H=5.04, 
δ13C=131.21 and δ1H=4.90, δ13C=76.3 ppm. 
 
 
3.3.4 Evidence of Evolutionary Relationship between M. liflandii and M. marinum 
 
     M. liflandii is a frog pathogen that was first isolated in 2004 from infected laboratory 
frogs Xenopus tropicalis and X. laevis as reported by Trott et al. 254,255 At that time, it was 
suggested that M. liflandii was closely related to either M. marinum or M. ulcerans.254 
When the lipid profile of this species was compared with the profiles of other 
Mycobacteria (M. tuberculosis, M. smegmatis, M. ulcerans, and M. marinum), indeed, the 
similarity between the M. liflandii lipid profile and those of M. ulcerans and M. marinum 
was evident by the production of abundant PDIM, mycolatone and phenolic glycolipids. 
In fact, M. liflandii lipid profile represented an intermediate lipid expression between M. 
marinum, which produces abundant glycolipids and carotenoids, and M. ulcerans, which 
lacks most of these molecules (Figure 3.4a-c). This observation was validated recently 
through in-depth genomic study of several mycolactone-producing strains.256 That study 
suggested a recent reductive evolution of M. ulcerans from M. marinum, whereas other 
mycolactone-producing strains like M. liflandii were identified as an earlier divergence 
during this evolutionary process.257,258  
 
     From this study, it was also revealed that M. liflandii produces significant amounts of 
PGL, a class of lipids closely related to phthiocerol dimycocerosates, which are produced 
by few pathogenic mycobacterial strains.259-261 Signals attributed to PGL from M. 
liflandii were found to superimpose with signals corresponding to PGL in the M. 
marinum spectrum.262 This observation was confirmed by the subsequent isolation and 
structural characterization of this molecule which was found to be phenolphthiodiolone 
glycosylated with 3-O-methyl-rhamnose at the phenolic hydroxyl (Figure 3.4d). This 
supports our previous observation about the evolutionary relationship between the three 
species. On one hand, M. liflandii has a limited lipid metabolome like that of M. ulcerans 
and on the other it still can produce PGL while M. ulcerans can not. 
 
 
3.3.5 Different Lipid Profiles for Different Laboratory Strains and Clinical Isolates 
 
     Different laboratory strains of M. tuberculosis are traditionally used in TB research 
either for drug susceptibility testing or other microbiological and biochemical research. In 
this experiment, the avirulent M. tuberculosis H37Ra and some virulent laboratory strains 
of H37Rv, Erdman’s, the highly virulent HN878 strain and the highly transmittable 
CDC1551 strain were used. Comparison between these strains were limited only to their 
lipid profiles as it is not possible to obtain an HR-MAS profile of such virulent strains 
due to biosafety concerns. Some subtle differences, most of them are quantitative in  
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Figure 3.4 Lipidomics Characterization of M. liflandii 
 
a-C, 1H-13C HSQC spectra (δ1H,0.6-7.6 ppm, δ13C14-136 ppm) of total lipid extract from 
M. liflandii, (a), M. marinum, (b), and M. ulcerans, (c). M. liflandii is thought to represent 
an intermediate stage in the reductive evolution of M. ulcerans from M. marinum 
progenitor which is reflected in these lipid profiles by comparing the diversity of the 
glycolipid pools of the three species. (d), 1H-13C HSQC spectrum of the major PGL 
purified from M. liflandii total lipid extract. 
 
 
76
nature, were observable between different strains (Figures B.22-B.26). For example, 
when compared to M. tuberculosis H37Rv, Erdman’s strain seemed to produce higher 
levels of methyl-branched fatty acids while H37Ra produced significantly lower amounts. 
The validation of these observations is beyond the scope of this study and without prior 
reports of similar results they could not be further verified.  
 
     However, our observations on strains from well characterized lineage such as HN878 
strain which belongs to the W-Beijing lineage can be easily verified. In the lipid profile 
of HN878, both qualitative and quantitative differences were observed. As an example of 
the first, the production of PGL was detected in HN878 lipid profile by the presence of its 
two aromatic signals at δ1H=7.02, 13C=17.6 and δ1H=7.18, 13C=129.7 ppm and its CH2 
benzylic protons at δ1H=2.58, δ13C=46.8 ppm (Figure B.25). As an example of the 
quantitative differences, we reported the production of unusually high levels of 
triglycerides as indicated by the high intensity of the signal of C-2 glycerol at δ1H=5.30 , 
δ13C=69.32 which comes in agreement with recently published data that characterized the 
general features of the W-Beijing lineage.263 
 
 
3.3.6 Lipid Profiles of Other Bacteria: Corynebacterium and Bacillus 
 
     Corynebacteria are mycolic acid producing actinomycetes and they share a similar cell 
wall structure with Mycobacteria that contains polysaccharides complexes like mAG and 
LAM as well as free lipids such as acylated trehalose and acylated glucose.264 The HR-
MAS of C. glutamicum showed a similar AG and LAM structures to that observed in 
most Mycobacteria species except for the apparent absence of the 3,5-α-Araf anomeric 
signal which is usually reported at δ1H=5.07, δ13C=107.38 as it is the case of M. bovis 
BCG (Figure 3.5a,b). Instead, two other anomeric signals were detected in C. 
glutamicum spectrum at δ1H=5.08, δ13C=109.25 and at δ1H=5.01, δ13C=105.74 ppm. 
This shift indicates a significant variation in the branching patterns of the AG 
macromolecule between Mycobacteria and Corynebacteria. There was no literature report 
of such observation to the best of our knowledge. Upon analysis of cell total lipids, the 
lipid profile of C. glutamicum displayed similar general features to that of Mycobaceria. 
Abundant glycolipids, phospholipids, mycobactins and limited amount of triacyl 
glycerols were easily detected (Figure 3.6). 
      
     The second step was to utilize the method for the analysis of completely unrelated 
species. Two Gram positive species were chosen; B. anthracis Sterne, a vaccine strain of 
the pathogenic B. anthracis, and B. subtilis, a soil bacteria. Both species displayed a lipid 
profiles that was different to a large degree from that of Mycobacteria and 
Corynebacteria. The only reported similarities were in the fatty acid and some 
phospholipids signals which are present in all bacterial plasma membranes. A distinct 
feature observed in these two profiles was the presence of two anomeric proton signals at 
δ1H=4.39, δ13C=102.9 and 1H=4.32, 13C=103.42 (Figure 3.7). These signals are likely to 
be related to the mitogenic glycerolphosphoglycolipids isolated by Fischer et al in 
1978265 and later confirmed in its structure and mitogenicity by Li, Y and colleagues.266 
On comparison between the two species, B. anthracis lipid profile was rich with signals  
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Figure 3.5 Comparison between the HR-MAS Profile of C. glutamicum and M. bovis 
BCG 
 
HR-MAS profiles of C. glutamicum, (a), and M. bovis BCG, (b). Differences can be 
observed in the AG structure of C. glutamicum with the appearance of two distinct 
signals at δ1H=5.08, δ13C=109.25 and δ1H=5.01, δ13C=105.74 ppm (signals are circled in 
the blow-up inserts). The anomeric signal for 3,5-α-Araf  detected at δ1H=5.06, 
δ13C=107.04 ppm in the HR-MAS of M. bovis BCG was absent from the HR-MAS 
spectrum of C. glutamicum as indicated in the inserts by the black arrow. 
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Figure 3.6 2D-HSQC Lipid Profile of C. glutamicum 
  
 
 
 
 
 
Figure 3.7 2D-HSQC Lipid Profile of Bacillus Species 
 
 
2D-HSQC lipid profile of B. anthracis (Sterne), (a), and B. subtilis, (b). The arrows 
indicate the position of the two anomeric signals of Bacillus mitogenic glycerol 
phosphoglycolipid at δ1H=4.39,13C=102.9 and δ1H=4.32,13C=103.42 ppm. 
 
 
79
for long aliphatic chains, sugar residues and unsaturated substructures, while that of B. subtilis 
displayed smaller number of signals especially in the sugar residue regions and very weak signals 
in the oleifenic region (Figure 3.7). 
 
 
3.4. Conclusion 
 
 
3 4.1 NMR-Based Approach for Comprehensive Cell Wall Analysis 
 
     A combination approach of HR-MAS monitoring of cell wall polysaccharides (mainly 
AG and LAM) and 2D-HSQC lipid profiling was developed. Such approach can provide 
researchers with valuable insights to the structural features of the mycobacterial cell wall 
in relatively short time and with reasonable degree of confidence in data interpretation. 
Based on the examples discussed in this chapter and in the previous chapter, a cell culture 
of 30-40 milliliters enriched with 13C-dextrose and/or glycerol can be used to produce 
comprehensive reproducible profiles for both cell lipids and polysaccharides. Sample 
preparation protocols for both techniques follow the same set of procedures for the most 
part and human effort designated for this purpose can be greatly reduced as a result. The 
two techniques combined require the use of a single high field NMR spectrometer with 
interchangeable sample probes to accommodate both solid (HR-MAS) and liquid sample 
(lipid profile).  
 
     This combination in itself can also serve the purpose of a self control. For example, 
when certain gene mutation is being sought to affect cell wall lipid biosynthesis, lipid 
extract from the mutant strains can be analyzed by 2D-HSQC NMR for that purpose. 
Meanwhile, the same cells that were extracted can be used to generate an HR-MAS 
profile to confirm the integrity of other cell wall components such as AG and LAM. Such 
approach provides solidity of the interpreted data and can also help identify some 
important cellular process like adaptation to gene mutation and possible metabolic 
coupling. 
 
   
3.4.2 Species Differentiation Using NMR Metabolic Profiling 
 
     Mycobacteria species and strains can be differentiated by a wide array of methods 
with very high sensitivity. The purpose of this study was not to offer an alternative to 
such techniques. However, several goals have been achieved from such study including; 
i) demonstrating the utility of this combined approach across different number of 
Mycobacteria that are representatives of different clades, ii) validating the utility of the 
technique by its capability to detect both qualitative and quantitative differences between 
multiple species, iii) starting a database of standardized referenced lipid profiles of 
several Mycobacteria species and strains that can later be used as base line references, iv) 
providing information that can help in the assignment of biomarkers signals for some 
lipid molecules by choosing the most suitable lipid profiles where these signals can be 
observed in high abundance and with optimal resolvability, v) exploring the possibility of 
application of these method to characterize the main features of the cell wall 
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compositions of newly isolated species and vi) pinpointing to differences that exist 
between different laboratory strains and clinical isolates. Such differences must be taken 
into consideration when comparing and using research data obtained through the use of 
different laboratory strains. 
 
 
3.4.3 Applicability to Other Bacterial Species 
 
     Like Mycobacteria, all actinomycetal line (Mycobacteria, Corynbacteria, Nocardia 
and Rhodococci) have a chemotype IV cell wall and possess a complex cell wall structure 
rich in lipids especially mycolic acids.  The combined NMR approach discussed above 
can be helpful in studying a large array of these species as long as they can be maintained 
in the laboratory in a well-defined growth media that uses glycerol and/or dextrose as the 
primary carbon source. As a demonstrative example, C. glutamicum was grown in BHI 
media where 13C6-dextrose was added as the primary carbon source. This isotope 
enrichment strategy was successful in providing high quality HR-MAS and lipid profiles 
as outlined in section 3.3.7. Outside the actinomycetals line, all eubacteria share a similar 
phospholipids bilayer plasma membrane and through lipid profiling, components of these 
membranes can be investigated and compared with relative ease. This concept was used 
here to compare between two Bacillus species. Such results also underscore the 
applicability of such methodology to a wide spectrum of species and in diverse research 
fields. 
CHAPTER 4. METABOLOMIC STUDIES OF MYCOBACTERIA ADAPTATION 
TO STRESS CONDITIONS 
 
 
4.1 Introduction 
 
     Since the introduction of streptomycin as the first treatment for TB in the 1940s, we 
have made a significant progress that is undeniable.  The great white plague that 
devastated Europe is now a curable disease. However, this curable disease is reported in 
nine million cases every year and is claiming close to two million lives annually.12 For a 
certain period of time we were very optimistic of our capability to reduce TB to “a minor 
aliment to man” as Waksman once announced in his 1960s book “The Conquest of 
Tuberculosis.”267 This optimistic prediction seems so far from reality now like never 
before. We now live in a world where one third of the population harbor the tubercle 
bacilli in their bodies and where there is a serious concern in our ability to treat highly 
drug resistant forms of the disease. 
 
     Our failure to eradicate TB is caused by the success of the tubercle bacilli to tolerate 
anti-TB chemotherapy and develop resistance. Unlike most other bacterial infections that 
can be treated with a single antibiotic, monotherapy has not been reliable as an anti-TB 
treatment.  Currently, any effective anti-TB regimen is based on the use of combination 
therapy to deter the rise of resistance.34 However, one of our major health concerns now 
is the global spread of MDR-TB.  Although MDR-TB is currently treatable through a two 
years regimen that includes several second line anti-TB drugs, it is hard for TB patients to 
adhere to such lengthy and often not well tolerated course. As a result of our failure to 
control MDR-TB, we were confronted with XDR-TB, a form of the disease that resists 
treatment with rifampin and INH in addition to key second line drugs (a fluroquinolone 
and at least one of the injectable aminoglycosides).36,268 XDR-TB is associated with very 
high mortality rates and is currently untreatable by available anti-TB chemotherapy.36 
 
     The tolerance of M. tuberculosis to most antibacterial chemotherapy and the rapid rise 
of resistance against the few useful anti-TB drugs can be partially explained by the 
unique characteristics of the tubercle bacilli and the pathological features of TB itself. M. 
tuberculosis cell wall displays unique complexity which includes an outer lipid 
membrane of mycolic acids that works as an efficient permeability barrier against the 
entry of most chemotherapeutic agents. Inside their host, the infecting bacilli exist in 
different metabolic states including actively dividing and latent bacilli.217,218 While 
actively growing bacteria are susceptible to commonly used anti-TB drugs, latent bacilli 
are much harder to kill due to their slow metabolic rates and limited replication.52 In 
addition, these latent bacilli are enclosed inside the TB-granuloma, a hypoxic locus that 
receives limited blood supply. To constantly deliver anti-TB drugs at their inhibitory 
concentration inside the TB-granuloma, anti-TB drug dosage and administration have to 
be carefully monitored. Failure to maintain proper concentration of the drug inside the 
granuloma enriches the latent population with naturally occurring resistant mutants. 
When a patient prematurely terminates his TB treatment course due to a temporary relief 
of symptoms, the latent bacteria can remerge causing a recurrence of the disease. The 
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pursuit of novel chemotherapeutic agents that target the latent bacilli is now a top priority 
in the TB research community.198,269,270 Such development when it happens will be a 
major breakthrough as it should shorten the treatment course and limit the incidence of 
resistance. In order to develop such drugs, we need to identify the intrinsic factors that 
contribute to Mycobacteria latency and hence the persistence of the tubercle bacilli. 
 
     Several laboratory models have been developed to study the metabolic states of the 
different bacterial population during latency.  The most common animal models include 
the murine, Guinea pigs, rabbits and non human primates.52 Although the murine model 
is the most widely used in research, it carries the least similarities to the pathological 
features of the human disease.52 On the other hand, non human primate models develop 
lung tuberculosis that is very similar to human TB but their use in routine research is 
limited by their high cost.271,272 In vitro latency models that try to mimic the growth 
conditions of the latent bacilli have also been developed. The most common is that 
developed by Wayne in 1996 which uses sealed culture with limited aeration to drive the 
bacterial to a state of dormancy through gradual oxygen depletion.273,274 Bacilli grown 
under these conditions pass through two phases of non replicating growth where cells 
prepare for and then enter a microaerophilic metabolic phase.274 To adapt to these 
hypoxic conditions, several genes are either down regulated or up-regulated to transfer 
the cells to a state of low energy requirement. Lower expression of type-I NADH 
dehydrogenase and most subunits of ATP synthase have been reported,275,276 while 
isocitrate lyase,277 triglyceride synthases,278 and nitrate reductases275 are among genes 
that have been found to be upregulated. 
 
     Other in vitro models are designed to test the persistence of Mycobacteria in case of 
nutrient starvation. M. tuberculosis has the ability to survive and replicate inside human 
macrophages and within the granuloma structure in an environment with a limited supply 
of nutrients.  In these models, a population of persistent drug tolerant bacilli can be 
developed which can be used to validate the ability of drugs to kill persistent bacilli.220 
The response of Mycobacteria under nutrient starvation includes down regulation in the 
biosynthesis of most cell metabolites with up-regulation in the transcription of genes 
involved in RNA synthesis and modification.279,280 Cells maintained under these nutrient 
starvation conditions show significant stress resistance, higher stability in their mRNA 
and low susceptibility to common anti-TB drugs such as rifampin and INH.279,281 
 
     Inside the macrophage, not only does M. tuberculosis have to survive in limited 
nutrient supply but it also has to endure abundance of reactive oxygen species and 
nitrogen intermediates in an environment of low pH.57,241,282 In the laboratory, the 
response of Mycobacteria to stress condition (stringent response) can be induced by 
starvation as well as by exposure to acids or UV lights.280 Evidence suggested that 
significant number of genes that are up-regulated under laboratory stress conditions were 
also identified in separate studies as essential for mycobacterial in vivo survival.52,217,277 
These findings validate the use of in vitro models to identify genes and metabolic 
products that are essential for Mycobacteria infectivity.  
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     This report investigates the changes of the mycobacterial metabolome under several 
stress conditions mainly low oxygen, limited supply of nutrients and total starvation in 
phosphate buffer saline (PBS).  M. bovis BCG, a vaccine strain for TB, is used here as a 
surrogate for M. tuberculosis. This use is common due to the availability of a complete 
genome sequences and the reported similarity between the two species. 
 
 
4.2 Materials and Methods 
 
 
4.2.1 Strains and Growth Conditions 
 
     Mycobacteria bovis BCG was inoculated at an initial O.Dλ600 of 0.05 in Middlebrook 
7H9 growth media supplemented with ADG and 0.05% Tween 80. For 13C-enrichement 
the dextrose and glycerol in the ADG supplement were replaced by 13C6-dextrose and 
13C3-Glycerol respectively (Cambridge Isotope Lab. MA). For low nutrients conditions, 
the concentration of glucose and glycerols were reduced to 0.02% instead of the normal 
0.2% concentration obtained using the ADG supplement while all other growth 
conditions were maintained unchanged. All bacterial cultures were incubated at 37°C 
with continuous shaking at 250 rpm.  
 
 
4.2.2 Starvation Model 
 
     Forty milliliters of M. bovis BCG grown in 13C-enriched Middlebrook 7H9 to the mid 
exponential phase (O.Dλ600=0.6) were harvested by centrifugation then washed twice with 
10mls of PBS. After washing, cells were left to starve in 40mls of PBS without shaking at 
37°C for previously determined time periods. For reactivation of the starved cells, cells 
were harvested by centrifugation at 3700xg. The cell pellet was then washed twice with 
10mls of plain 7H9 then re-suspended in 13C-enriched 7H9. Viable count of the starved 
and reactivated cells was determined by plating dilutions of the cell culture on 
Middlebrook 7H11 agar plates and the number of colonies was counted after 4 weeks 
incubation period at 37°C. 
 
 
4.2.3 Low Oxygen Model 
 
     200mls of Middlebrook 7H9 supplemented with 13C3-glycerol and 13C6-dextrose were 
inoculated with M. bovis BCG to an O.Dλ600 of 0.005 in round bottom glass flasks with 
300ml total capacity. The culture flasks were sealed with silicon rubber caps and were 
incubated at 37°C with slow stirring at 100 rpm. At different time points, the optical 
density of the bacterial culture was measured and cells were subsequently harvested.  
Methylene blue was used as a redox indicator to monitor oxygen level at 15µM 
concentration. For reactivation, the bacterial cultures were transferred to new flask with 
5X head space with continuous shaking at 250 rpm at 37°C. 
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4.2.4 Sample Preparation for HR-MAS 
 
     Cells were harvested by centrifugation at 3700xg for 10 minutes. The cell pellet was 
washed twice with 5mls of D2O. The supernatant washing liquid was removed in between 
by centrifugation at 3700xg for 10 minutes. The washed pellet was then re-suspended in a 
minimal volume of D2O and 40 µl of the cell suspension was transferred to an NMR-
MAS rotor.  
 
 
4.2.5 Lipid Extraction 
 
     The bulk of the previously washed cell pellet was transferred to a pre-weighed micro-
centrifuge tube using one ml of D2O. After removal of D2O by centrifugation, cells were 
re-suspended (3µl per 1µg wet cell weight) in 2:1 mixture of CDCl3:CD3OD to which 
DMSO was added as an internal standard (0.0025 μl per every milligram of cells). Lipids 
were extracted by continuous shaking for 90 minutes at 37°C degrees. After extraction, 
additional volume of CD3OD was added (1µl per 1mg of original cell weight) to achieve 
a single phase solution. The final lipid extract was removed by centrifugation for 10 
minutes at 21,000xg then transferred to 5mm NMR tube.  
 
     For mycolic acid saponification, two milliliters of 1M methanolic KOH were added to 
the delipidated cells in glass screw cap tubes. Saponification process was continued for 
16 hours with continuous stirring. After saponification the solution was cooled down and 
then neutralized with concentrated HCl to pH=4. Free mycolic acids were then extracted 
twice with diethyl ether. The combined extract was washed with deionized water and 
then dried with rota-evaporator under vacuum at 40°C. For NMR acquisition, dried 
mycolic acids were dissolved in 1:1 CD3OD:CDCl3. 
 
 
4.2.6 NMR Acquisition and Data Processing 
 
     2D-HSQC lipid profiles were obtained using a Varian Inova-500MHz NMR 
spectrometer equipped with a 5mm trpfg probe using 2D-HSQC pulse sequence (nt=10 
ni=256). Samples were individually shimmed, locked and tuned at 24°C and other 
acquisition parameters were optimized for each sample. NMR data was processed using 
Felix–NMR. Specific cross peaks in the 2D-NMR spectrum were integrated and 
normalized to the integration value of the DMSO peak that was used as an internal 
standard. For acquisition of HR-MAS spectra, MAS rotors were inserted at the magic 
angle in a GHx-nanoprobe with continuous spinning at 2 KHz and temperature of 24°C 
degrees. Acquisition parameters were adjusted for individual samples. 2D HSQC pulse 
sequence was applied for 8 transients and 256 increments.  
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4.3 Results 
 
 
4.3.1 Effect of Low Nutrients 
 
     Cells grown in Middlebrook 7H9 with 0.02% only of dextrose and glycerol showed 
normal growth curve compared to that of cells grown with 0.2% glucose and glycerol. 
However, when the O.D. reached a value of 0.4-0.6, the growth of cells grown in low 
nutrient supply halted. The lipid profile of these partially starved cells looked overall less 
crowded than that of cells grown under normal growth conditions. The quality of the 
spectra was first assessed by referring to the signals of cell membrane phospholipids 
which fell in the normal range observed in control experiments. Upon comparison of 
these lipid profiles, lower intensities of signals of major acylated trehalose and triacyl 
glycerols were observed. There was also a significant reduction in the levels of 
unsaturated fatty acids and PIM6 when compared to the levels recorded in normally 
grown cells that have been harvested at different O.D. (Figure 4.1).  
 
     Upon examining the HR-MAS spectra for changes in the mAG complex, no such 
changes were readily detectable (Figure 4.2). However, signals corresponding to the cell 
wall glucan were detected at a relatively low intensity when compared to cells grown 
under normal growth conditions and harvested at different stages of their growth. LAM 
signals were recorded at significantly lower intensity in the partially starved cells as 
opposed to AG signals which remained at stable levels. Meanwhile, all lipid signals that 
could be detected in the HR-MAS spectrum were either absent (such as unsaturated fatty 
acids signals) or recorded at much lower intensity (Figure 4.2).  
 
 
4.3.2 Effect of Starvation 
 
    Cells starved in PBS were maintained over a period of four weeks. Over this period, 
we observed a drop in the viable count of the starved cells by approximately one 
logarithmic unit (Figure 4.3a). This loss in cell viability was directly detected in the 
cellular lipid profile as one logarithmic unit decrease in the intensity of NMR cross peaks 
previously assigned to cellular phosphoglycerolipids (PL) as shown in Figure 4.3b. 
Other cellular lipids, most notably triacyl glycerols (TAG), were greatly affected by 
prolonged starvation. TAGs are associated with the cell wall lipid pseudomembrane but  
they are mainly  located inside the cytoplasm in large lipid vacuoles. After starvation for 
two days, the TAG pool was depleted from the cells (based on the detection limit of this 
method), while other cellular components remained at their original levels. However, 
after only six hours of transferring the cells to nutrients rich media, TAG levels were 
measured at twice their value and continued to rise after 24 and 48 hours. During that 
time, cells seemed to be preparing for a complete recovery and cell replication was 
halted. After 2-4 days of this peak, the TAG levels were restored back to their normal 
abundance in M. bovis BCG (Figure 4.3c). 
 
     Other cell wall lipids (PDIM, fatty acids, TDM, PIM and AT) of the cell wall 
remained at their original levels for more than two weeks but a significant drop in their  
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Figure 4.1 Effect of Limited Nutrients Supply on the Cellular Lipid Content of M. bovis 
BCG 
 
Cellular lipid contents are expressed as the integration volumes of specific biomarker 
signals for each lipid class; δH=1.23, δC=45.54 ppm for PDIM, δH=5.30, δC=69.31 ppm 
for TAG, δH=5.26, δC=70.74 ppm for PL, δH=5.10, δC=101.85 ppm for PIM2, δH=5.01 
δC=102.63 ppm for PIM6, δH=5.34, δC=129.97 ppm for unFA, δH=0.67, δC=15.76 ppm 
for TDM and δH=5.13, δC=93.65 ppm for ATs. All integral values were normalized to 
that of DMSO which was used as an internal standard. 
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Figure 4.2 Effect of Limited Nutrients Supply on the Cell Wall AG and LAM of M. 
bovis BCG 
 
HR-MAS 2D-HSQC spectra of M. bovis BCG cells which were grown at normal 
conditions and harvested at O.Dλ600 of 0.3, (a), grown in limited nutrient supply and 
harvested at O.Dλ600=0.45, (b), or grown under normal conditions and harvested at 
O.Dλ600=0.6, (c). In general, HSQC signals for cellular lipids and glucans were recorded 
at lower intensities in the HR-MAS spectrum of the partially starved cells as seen in (b). 
Shown in the bottom inserts is the variation in the abundance of LAM between the three 
spectra as indicated by arrows. At the same time, AG signals are recorded at comparable 
intensities in the three spectra (the anomeric signal of 6-β-Galf is highlighted in the three 
spectra inside small ovals). 
88 
 
   
     
 
89 
 
Figure 4.3 Effect of Prolonged Starvation in PBS on the Cell Wall Lipids of M. bovis 
BCG 
 
A drop in the viable count of the starved cells can be observed after one week, (a), a 
parallel drop is also observed in cellular PL (solid diamond in b) and a less significant 
drop is observed in PIM2 and PIM6 content (solid square and solid triangles in b). Levels 
of other cell wall lipids were monitored during PBS starvation and subsequent 
resuscitation, (c). All cell lipids are represented as normalized integral volumes of their 
corresponding biomarker signals as described under Figure 4.1. Ratios of different 
mycolic acid classes as compared to the total mycolate pool during starvation are plotted 
in (d).  The relative ratios of mycolic acids were obtained as the integral value for each 
biomarker signal as described in Table 2.2 divided by the value of the β-CHOH signal at 
δH=3.65, δC=72.15ppm. 
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concentration was observed after four weeks of starvation (Figure 4.3c). At the same 
point a further drop was observed in the viable count of the starved cells. Upon 
transferring the starved cells to nutrient rich growth media, the cellular level of these 
molecules remained relatively stable for the first 24-48 hours. During the same period, 
the viable cell count remained constant while the concentration of TAG increased 
drastically. Levels detected for most cellular lipids were not restored back to their normal 
values till after four days of reactivation (Figure 4.3c). At which point it is expected that 
the bacterial population has completely shifted to a logarithmic growth phase. 
 
     In the HR-MAS profile of the starved cells, minimal changes were observed in the AG 
and LAM pool but there was a fast depletion of the outer cellular glucans as indicated by 
the gradual loss of the intensity of the glucan signals in the 2D-HSQC spectrum. Glucan 
signals were reported at significantly lower intensities after one week of starvation and 
almost disappeared after four weeks. This observation was rapidly reversed upon 
transferring the starved cells to a nutrient-rich media for less than 24 hours (Figure 4.4). 
The integrity detected in the cell wall mAG complex upon starvation was further 
confirmed by the stability observed in the covalently bound mycolic acid pool (Figure 
4.3d). This suggests that even with prolonged starvation periods, Mycobacteria can 
preserve the integrity of its structural cell wall components with no adjustments in the 
substitution pattern of the covalently bound mycolic acids.  
 
 
4.3.3 Effect of Gradual Oxygen Depletion 
 
     In our low oxygen model, M. bovis BCG cells exhibited a very slow growth when 
compared to cells grown under normal growth conditions (Figure 4.5a). Aerobic 
conditions were sustained in this model for the first seven days as indicated from the 
color stability of the redox indicator methylene blue. At the end of this period, the optical 
density of the cells reached 0.3 which was comparable to that reached by cells grown 
under normal growth condition for the same period. However, when oxygen levels started 
declining, the rate of cellular growth slowed down significantly. An increase in the 
optical density to a plateau level of O.Dλ600=0.56 was achieved after 28 days of 
inoculation and after fading of the redox indicator color. This slow growth is indicative of 
an effective adaptation of the cells to low oxygen conditions. It has been previously 
reported that the success of the transfer of Mycobacteria to anaerobosis depends on the 
length of such transition periods. 
 
     During this slow process, some gross changes in cell density and texture were 
observed in the actively adapting cells that may indicate cell wall reorganization. For 
example, a gradual decrease in the cell density which reached its maximum at 28 days 
was observed. In parallel to this gross morphological change, there was a significant rise 
in the levels of TAG that also reached its peak at 28 days and started to decline 
afterwards (Figure 4.5c). Upon exposure of the cells to normal oxygen levels, normal 
cell density as well as TAG levels were partially restored after 6 hours. A complete 
restoration of cell texture and TAG levels was detected after 4-7 days (Figure 4.5c). 
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Figure 4.4 Effect of Prolonged Starvation in PBS on the Cell Wall Polysaccharides of M. 
bovis BCG 
 
HR-MAS 2D-HSQC spectra of M. bovis BCG grown under normal growth conditions 
and harvested at O.Dλ600=0.6, (a), M. bovis BCG starved in PBS for four weeks starting 
with the same optical density, (b), and M. bovis BCG that has been resuscitated for four 
days after four weeks of starvation in PBS, (c). Circled in the three spectra are signals 
indicative of the cell wall glucan which were greatly reduced in their intensity upon 
starvation as seen in (b). 
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Figure 4.5 Effect of Gradual Oxygen Depletion on the Cell Wall Lipids of M. bovis BCG 
 
M. bovis BCG cells grown under low oxygen condition exhibited a very slow growth rate 
as indicated by their O.D. measurement (solid square in a) when compared with cells 
grown under normal growth conditions (solid circles in a). The arrow indicates the time 
point at which the color of the redox indicator methylene blue started to fade. During the 
oxygen depletion process, cellular levels of membrane phospholipids remained 
essentially constant, (b).  In panel (c), levels of other cellular lipids are reported during 
oxygen depletion and after resuscitation. The relative abundance of TAG, PIM2, PDIM, 
AT and fatty acids are plotted as the integral values of their corresponding biomarker 
signals normalized to that of DMSO. 
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     As expected, there was a remarkable stability in the levels of cellular phospholipids 
which levels remained unaffected during low oxygen conditions and also during 
reactivation by exposure to oxygen (Figure 4.5b). This stability indicates successful 
transformation to anaerbosis as any loss of cell viability will be detected by a loss of PL 
signal intensity.  
 
     In the HR-MAS spectrum, signals of TAG (which are usually recorded at low 
intensity in M. bovis BCG) were recorded at unusually high intensity indicating the 
presence of an overwhelming amount of these lipids. Despite that, signals of glucan and 
AG were easily detected at their normal levels (Figure 4.6). It is to be noted however, 
that a significant shift in the LAM signals was observed. Cells grown under low oxygen 
condition for four weeks showed very low intensity of signals indicative of 2-α-Manp and 
higher intensities of those indicative of 2,6-α-Manp.  As shown in Figure 4.6, the 
anomeric signals corresponding to 2-α-Manp and 2,6-α-Manp are usually recorded with 
comparable intensities (Figure 4.6a). However, under low oxygen conditions, it appears 
that a larger number of 2,6-α-Manp residues are present in the mannan core indicating 
extensive substitution of the linear mannan chain at the 2-position. Such observation can 
be also supported by relative increase in the intensity of signals of the terminal Manp 
residues as detected at δ1H=4.93, δ13C=102.19 ppm and a parallel decrease in the signals 
for the unsubstituted 6-α-Manp residues (such effect can be seen in the C6 signal of 6-α-
Manp as detected at δ1H=3.70/3.87, δ13C=65.26 ppm). 
 
     In addition, the apparent lower abundance of 2-α-Manp residues (2-α-Manp is located 
in the mannose caps of manLAM) may indicate a lower frequency of mannose capping or 
a shift in the LAM/LM ratios. The physiological outcome from any of these two 
possibilities is likely to be similar. As previously discussed under section 1.4.3.1, both 
uncapped LAM and LM are associated with the induction of a strong pro-inflammatory 
response, while manLAM has some immune-suppressive actions.  As a result, this shift in 
balance towards the production of lower manLAM levels in dormant bacilli is likely to 
induce a corresponding change in the host immune response to the infection. Further 
studies are needed to confirm these findings considering the possibility that the gross 
morphological changes that were observed in the cells may have affected the mobility of 
some of the carbohydrate residues under HR-MAS acquisition conditions. 
 
    Unlike the stability observed in the mycolic acid pool under starvation conditions, 
some significant changes were observed in the relative abundance of mycolic acid 
classes. The most drastic of which was the gradual depletion of keto mycolates which 
completely disappeared after four weeks (based on the detection limit of this 
methodology). This reduction in keto mycolates levels was parallel to an increase in the 
levels of hydroxyl and methoxy mycolates (Figure 4.7). Ketomycolates are one of the 
major mycolic acid groups of M. bovis BCG while hydroxyl and methoxy mycolates are 
normally present at lower levels. It is not clear how this may affect the cell wall 
properties but such shift is a rational adaptation for cells that grow inside the TB 
granuloma as it appears that the bacterial cells may not be able to retain molecules of 
high oxiditative state under low oxygen conditions. 
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Figure 4.6 Effect of Oxygen Depletion on the Cell Wall Polysaccharides of M. bovis 
BCG 
 
HR-MAS 2D-HSQC spectra of M. bovis BCG cells grown under normal conditions, (a), 
grown under low oxygen conditions for four weeks, (b), and resuscitated for one day after 
oxygen depletion, (c). Signals circled in the three spectra are that of TAG which are 
usually detected at low intensity as seen in (a), but their levels reached a peak 
concentration after four weeks of oxygen depletion as shown in (b). Bottom inserts show 
the variability observed in the relative abundance of some of the LAM signals between 
the three spectra. Signals for 2-α-Manp at δH=5.02, δC=98.08 ppm and that of 2,6-α-
Manp at δH=5.05, δC=98.13 ppm are circled in these inserts. In the case of cells that 
were grown under low oxygen for four weeks, the relative ratios of these two mannose 
residues changed towards the dominance of 2,6-α-Manp signals (on the left). Such 
change in the abundance of the 2,6 disubstituted Manp residues was paralleled by a 
decrease in the intensity of the signals of monosubstituted 6-Manp (signal for C6 of 
Manp are indicated by red arrows). To less extent, an increase in the number of terminal 
α-Manp residues can be observed as indicated by black arrows in the bottom insert. 
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Figure 4.7 Effect of Gradual Oxygen Depletion on the Cell Wall Mycolic Acid of M. 
bovis BCG 
 
Relative ratios of different classes of mycolic acids are plotted as the integral volumes for 
their corresponding biomarker signals as described in Table 2.2 divided by the integral 
volume of the β-CHOH signal at δH=3.65, δC=72.15ppm. Shown here are the relative 
abundance of different chemical classes of mycolic acids as monitored during gradual 
oxygen depletion and subsequent resuscitation. Mycolic acids represented here include 
hydroxyl mycolate, ketomycolate, α-unsaturated mycolates, α-cyclopropyl mycolates and 
methoxy mycolates.  
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4.4 Discussion 
 
 
4.4.1 Stability of the Structural Components of the Mycobacteria Cell Wall 
 
     It has been well recognized that Mycobacteria have the ability to survive under harsh 
conditions. Such unique survival ability has led to its persistence as a human pathogen 
since prehistoric times. In this aspect, Mycobacteria complex and unique cell wall can be 
thought to act as the shield it uses to protect itself from the harsh environmental 
conditions it usually encounter. Whether it is inside the human macrophage or enclosed 
in a complex isolated granuloma, the cell wall seems to be one of the most essential 
components of the Mycobacteria survivosome. Hence, the integrity of the cell wall is 
crucial for Mycobacteria infectivity and virulence. This is most notable in the case of AG. 
AG structure is conserved among all Mycobacteria as discussed in the previous chapter 
and as we observed in this study, it also remains unaffected by different stress conditions. 
While these observations pinpoints to the importance of an intact AG for mycobactrial 
survival, it further underscore its value as an important target for the development of new 
drug candidates. From this study, it became obvious also that cellular levels of many 
other structural cell wall components were preserved despite the exposure to prolonged 
stress conditions to maintain an optimal cell wall integrity. In fact, most of the major 
changes identified in this study are related to TAG which are present for the most part 
inside lipid vacuoles in the cytoplasm. In case of starvation, other changes in cell wall 
lipid composition were found to be associated with a parallel loss of viability. 
 
 
4.4.2 Phospholipids as Indicators of Cell Viability 
 
     From this study, we confirmed the use of phospholipids signals as indicator for cell 
viability. During either starvation or hypoxic conditions, the levels of PL lipids that we 
detected in our lipid profiles have always matched the cell viability determined by 
traditional microbiological techniques. This is due to the fact that upon cell death and 
membrane rupture, phospholipids are rapidly hydrolysed and utilized by other cells once 
they are not stacked in an organized lipid membrane bilayer structure. Chemical analysis 
of phospholipids has been used as indicator to the presence of viable bacteria in inorganic 
and organic samples such as water and soil in other studies.283,284 For our purpose, not 
only do these phospholipids serve as an indicator of cell viability, but they can be used 
also to ensure the quality of the lipid profiles obtained through this methodology. In 
comparative analysis that include different experiments, the integration value of these 
molecules can be used as an internal standard to which integration values of other 
biomarker signals can be normalized to. 
 
 
4.4.3 Triacyl Glycerols as Favorite Energy Sources 
 
     One of the interesting results of this study was to elaborate on the role that TAG play 
to enhance Mycobacteria stringent response and survivability. Our results indicate that 
under hypoxic conditions and during exceptionally slow growth, cells have accumulated 
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massive amount of TAG (up to 40 times their normal values). This result is consistent 
with a similar study by Daniel et al who reported overexpression of triglyceride synthases 
upon adaptation of the cells to hypoxic conditions.278 It can be argued that this process 
can be a direct result of either accumulation of TAG due to halted β-oxidation or as a 
measure taken by the cells in preparation for a long process of dormancy. There is more 
evidence however in favor of the second argument. First of all, levels of TAG started 
declining after reaching a peak level despite continued hypoxic conditions. Second, we 
also detected a short term accumulation of TAG in the first hours of transferring the cells 
to fully nutrient growth media in presence of normal oxygen levels. Third, we have 
always observed that any decline of TAG levels from previous status was matched by an 
increase in the levels of other organic molecules which points to the role of TAG as 
biosynthetic precursors. Furthermore, if we look at multicellular organisms as an 
assembly of unicellular ones, the behavior of hibernating animals which store their food 
supply with the first signs of looming winter can be extrapolated to microbial cells 
storing their favorite energy source after receiving signals of expected dormancy. 
 
 
4.4.4 Process of Reactivation Has Optimum Goal 
 
     Regardless of the harsh conditions imposed on the mycobacterial cells, levels of 
different cellular components are always restored to a preset limit upon returning to their 
normal growth conditions. This observation was valid among cells that underwent partial, 
complete nutrient starvation or oxygen depletion. In each case however, there were 
certain temporary changes in the composition of cellular lipid pools especially during the 
first few hours of reactivation. But such temporary changes were short lived and 
restoration of a specific concentration to most organic molecules was achieved within 
two to four days and most likely as a direct result of resumed cell replication. 
 
 
4.5 Conclusion 
 
     In conclusion, we have demonstrated the adaptive response of Mycobacteria to 
laboratory stress conditions that are generally accepted to mimic the in vivo environment 
of latent bacilli. We were able to monitor gradual changes in the cell wall composition by 
2D-HSQC NMR maps using less than 100mgs of cell. This NMR-based approach 
allowed us to provide a comprehensive profile for different components of the cell wall 
lipid pool, cell wall polysaccharides and the covalently bound mycolic acid pools. As a 
result, we were able to detect changes in these pools and relate them to adaptive response 
mounted by Mycobacteria during infection. For example, we have identified the 
accumulation of large amount of TAG during oxygen depletion. Similar observation has 
been reported from bacteria isolated from diseased tissues. Electron micrographs of these 
bacilli indicated the presence of large lipid vacuoles that extend to cover more than 90% 
of the cytoplasmic space.7,63 This apparent agreement in results supports our finding and 
also validates the utility of in vitro oxygen depletion models. Furthermore, we observed 
certain changes in the LAM/LM pool of the bacilli when they were grown in the same 
oxygen depletion model. To the best of our knowledge, such observation has not been 
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reported previously and it is a candidate for further investigation due to the shift in 
balance that it may impose in the Mycobacteria-host immune interaction. 
 
    This study has also validated previous reports of the unique ability of Mycobacteria to 
adapt to a range of harsh environmental conditions. This adaptation process is better 
served when the transition period to such new environment is prolonged. In our low 
oxygen model, we reported a very successful transition to hypoxic conditions due to an 
unusual slow growth rate. We also have noticed that cells that have been partially starved 
in low nutrient media do not suffer any measurable loss of viability upon transfer to PBS 
for an extended time period. Such transition periods are required for cells to adjust its 
metabolome for the harsh environment it expect to encounter.  However, regardless of the 
stress conditions that the bacilli were subjected to, certain structural components (most 
notably AG) remained well preserved during both the stress and the recovery period. This 
underscores the importance of the integrity of AG for cell survivability and should 
encourage scientists to further study AG biosynthesis to identify new targets for anti-TB 
therapy beside the already established  enzyme target (EMB-b) for etahmbutol. 
CHAPTER 5. TWO CASE STUDIES FOR THE USE OF BIOANALYTICAL 
TOOLS IN SCREENING FOR VIRULENCE DETERMINANTS OF 
PATHOGENIC MYCOBACTERIA3 
 
 
     This chapter discusses two specific examples where different spectroscopic techniques 
were used as a tool for targeted lipid analysis. In both cases the targeted lipid molecule is 
an immune-modulator. However, due to differences in their physiochemical properties, 
two different strategies where used for their analysis. 
 
 
5.1 Case Study-I: Screening Various Mycobacteria Species for the Production of 
Mycolactone Toxins 
 
 
5.1.1 Introduction 
 
     Mycolactones are macrolides produced by a small number of Mycobacteria species 
and are associated with potent immune-suppression and cytotoxic properties.286 
Mycolactones were introduced to the scientific community in 1999 with the discovery of 
the first mycolactone from a Malaysian isolate of M. ulcerans.231 Because it was isolated 
as a mixture of two geometric isomers, it has been designated as mycolactone A/B.287 
This was the first report of  macrolide production by a mycobacterium although 
macrolides in general have been isolated from many other organisms most notably 
Streptomyces species.239 Other analogues of mycolactone A/B were later detected in 
different M. ulcerans isolates and other closely related Mycobacteria.254,285,288-290 All 
mycolactones share a totally conserved common macrolide core (a 12-membered lactone 
ring conserved in its chemical substitution and stereochemistry).  This core is esterfied at 
C-5 position to a polyene acidic side chain. Mycolactone molecules identified that far 
show only variability in the length and substitution of their side chains (Figure 5.1 and 
Table 5.1).  
 
     All Mycobacteria producing mycolactone (MPM) contain a large plasmid that encodes 
three large polyketide synthase (PKS) genes responsible for mycolactone biosynthesis 
(mlsA1, mlsA2 and mlsB).291 All three genes belong to the bacterial PKS-type I class 
where the PKS consist of several multi-enzyme modules that work together as a 
molecular assembly line. Every module consists of at least three basic proteins; 
ketosynthase (KS), Acyl transferase (AT) and acyl carrier protein (ACP) and is 
responsible for addition of a specific unit to the growing molecule (Figure 5.2).291 More 
diversity among these building units results from the activity of additional enzymes in 
specific modules. Such enzymes include keto reductase (KR), dehydratase (DH) and 
enoyl reductase (ER).292  
                                                 
3 Parts of this chapter are adapted with permission. Ranger, B.S. et al. Globally 
distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic 
macrolide, mycolactone F. Infect Immun 74, 6037-45 (2006).285 
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Figure 5.1 General Structure of Mycolactones 
 
 
 
 
Table 5.1 Differences in the Structures of Mycolactones Isolated So Far 
 
Side Chain (R) Name Parent Strain  (Host) Location of Isolation Mwt References 
 
A/B M. ulcerans  (human) Malaysia 742 
231,287,293,294 
 
C M. ulcerans  (human) Australia 726 
290,295 
 
D M. ulcerans  (human) China 756 
296 
 
E M. liflandii  (frog) Laboratory colony USA 714 
254,297,298 
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Figure 5.2 Domain and Module Organization of Mycolactone A/B PKS Genes 
 
Within each of the three genes (mlsA1,mlsA2 and mlsB), different domains are 
represented by a colored block. The domain designation is described in the key. White 
blocks represent interdomain regions of 100%identity. The structure of mycolactone has 
also been color-coded to match the module responsible for a particular chain extension. 
Reprinted with permission. Stinear, T.P. et al. Giant plasmid-encoded polyketide 
synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci 
USA 101, 1345-9 (2004).291 
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Similarly, structural variations between mycolactones produced by different MPM are 
attributed to genetic variability in specific modules which translates to addition or 
elimination of a specific structural feature in the growing chain.286,291,292  
 
     The first mycolactone, isolated from M. ulcerans 1615 strain, was found to be a 2:3 
mixture of two double bond isomers hence was the designation mycolactone A/B.287Most 
other mycolactones exist in the form of an equilibrating mixture of two major geometric 
isomers. This isomerization is a result from unrestricted rotation around 4’-5’ double 
bond. For example, mycolactone A/B is a 2:3 mixture of Z-∆4’,5’ and E-∆4’,5’isomers and 
mycloctone C is a 1:1 mixture of two similar Z-∆4’,5’ and E-∆4’,5’ isomers.295 
 
     Due to their structure, mycolactone are readily ionizable molecules that can be easily 
detected by MS as sodium adducts at [Mwt+23] in the positive mode.290 On the other 
hand, the chemical instability of the polyene structure and the possible isomerization due 
to photo-oxidation can result in a mixture of a large number of geometric isomers 
especially in aged samples. This large number of possible isomers can result in multiple 
overlapping signals during NMR acquisition and mar the accurate interpretation of the 
NMR data. Also the relatively low abundance of these molecules (1mg/liter in culture 
grown in T-flask)299 makes MS better suited for their accurate and efficient analysis. 
 
 
5.1.2 Materials and Methods 
 
5.1.2.1 Bacterial culture and growth conditions 
 
     All isolates were grown either on plates of Middlebrook 7H11 agar media 
supplemented with 10% oleic acid-ADG supplement, or in T-flasks  in Middlebrook 7H9 
supplemented with 10% ADG and 0.05% Tween 80. M. ulcerans strains were incubated 
at 32° C. All other isolates were grown at room temperature. 
 
5.1.2.2 Lipid extraction 
 
     Lipids were extracted from M. ulcerans using chloroform:methanol 2:1 (vol/vol) and 
phospholipids were removed by precipitation with ice cold acetone to obtain acetone-
soluble lipids (ASLs). Purified mycolactone was obtained using centripetal silica 
chromatography with a chromatotron after elution with chloroform:methanol:water 
90:10:1 (vol/vol/vol).  
 
5.1.2.3 HPLC analysis 
 
     Methanolic extracts of ASLs were analyzed using Shimadzu LC-20AD analytical 
HPLC with UV detection at 360 nm.  Separation of various mycolactones was obtained 
on a Phenomenex-Luna, C18 250X4.6 mm column at 2ml/min flow rate with 
water/acetonitrile gradient: 55% acetonitrile 3 min; isocratic followed by a 37 min linear 
gradient to100 % acetonitrile.  
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5.1.2.4 MS analysis  
 
     UV active fractions were analyzed offline on an ion trap ESI Bruker-Esquire mass 
spectrometer.  MS analysis conditions: dry temperature of 300°C, gas flow of 5 L/min 
and nebulizer pressure of 15 psi. For preliminary screening, the methanolic extracts of 
ASLs were directly analyzed without chromatographic separation.  
 
5.1.2.5 NMR analysis 
 
     Two milligrams of mycolactone F, purified from M. marinum DL240490 strain, was 
dissolved in acetone-d6 (500µl). 1H NMR and 2D-COSY spectra were recorded on a 
Varian Inova spectrometer at 500MHz.  Chemical shifts were reported in ppm relative to 
the residual acetone peak at 2.09 ppm. 
 
 
5.1.3 Results  
 
5.1.3.1 Screening by MS/MS and detection of mycolactones 
 
     Previously identified mycolactones and co-metabolites share a conserved core 
structure with variation only in the substitution of the side chain. It is very advantageous 
for MS analysis that the fragmentation of mycolactone often results in the formation of a 
lactone core fragment through McLafferty rearrangement (Figure 5.3). This fragment, 
detected at m/z=429, is indicative of the conserved mycolactone core sodium adduct. 
This fact can be used to identify mycolactones directly from cellular lipid extract by 
screening for ions that can produce such fragment. In the case of Mycolactone A/B, upon 
capture and fragmentation of the precursor mycolactone adduct, it produces two main 
ions; that of the core at m/z=429 and the other for the side chain at m/z=359 (Figure 5.3).  
 
     Therefore, MS analysis of ASLs can be a very useful tool in screening for new 
mycolactones.289,290 MS analysis of several M. ulcerans isolates from Africa showed 
precursor ion and fragment peaks consistent with that of mycolactone A/B. However, 
different molecular ion peaks were observed in isolates from China where the dominant 
ions where detected at m/z=779 and 777. Upon fragmentation, these precursor ions 
produced the core fragment at m/z=429.4 and the side chain fragment at m/z=373 and 
371 respectively. This pattern is in agreement with the presence of Mycolactone D.296 
 
     M. ulcerans 842 isolate from South America produced two major mycolactone ions at 
m/z=763 and 737. The later, now identified as mycolactone E, produced a side chain 
fragment ion at m/z=331 while the precursor ion at m/z=763 produces a product ion at 
m/z=357. Similar patterns were observed upon the analysis of ASLs from different M. 
liflandii isolates from two laboratory colonies of Xenopus tropicalis and Xenopus lavis.  
However, no peaks at m/763 were observed. This indicates that while both the South 
America M. ulcerans isolates and the frog pathogen M. liflandii produce similar molecule 
(mycolactone E), there seems to be a limit to the length of the side chain of mycolactones 
produced by the frog pathogen. 
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Figure 5.3 Major Fragmentation Pathways of Mycolactone A/B 
 
MS fragmentation of mycolactone A/B proceed through Mclafferty rearrangement to 
produce two characteristic product ions; that of the core at m/z=429 and the side chain at 
m/z=359. All mycolactone molecules produce the same core fragment while their side 
chain fragments differ in their m/z based on the side chain substitution. Another 
fragmentation pathway produces a product ion at m/z=565.7 is common among all 
mycolactone that have the same side chain substitution between C1’-C-6’.288,296 
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     A newly identified organism (temporarily identified as M. shinshuense. and currently 
as M. ulcerans subsp. shinshuense) was isolated in Japan from a small number of patients 
with cases of skin lesions similar to that of Buruli ulcer.300,301 Direct MS analysis of the 
ASL extract from this isolate identified at least three major mycolactones at m/z=793, 
779 and 777. All three ions where associated with a product ion of the core lactone ring 
upon fragmentation (Figure 5.4a,b). Their side chain product ions where detected as 
expected at m/z=387, 373 and 371 respectively.  A Peak indicative of mycolactone A/B 
at m/z=765 was detected as well. 
 
      Finally, MS analysis for the ASL of M. pseudoshottsii L15 (a pathogen isolated from 
sea striped bass found in the Chesapeake Bay)42 and nine isolates of M. marinum isolated 
from infected fish in the Middle East region revealed a major ion at m/z=723 [M+Na]+. 
Upon fragmentation, this precursor ion produced the conserved core fragment ion at 
m/z=429 suggesting the presence of another mycolactone, later designated as 
mycolactone F (Figure 5.4c,d). Moreover, the fragmentation patterns in all samples were 
identical suggesting that the mycolactones produced by these strains have the same 
chemical structure. In all ten cases, the side chain fragment was detected at m/z=317. 
Other mycolactone characteristic product ions where detected at m/z=635, 565 and 273. 
The complete results of MS screening of the various lipid extract are summarized in 
Table 5.2. 
 
5.1.3.2 HPLC profiles of different mycolactones 
 
     Because of the presence of six conjugated double bond in the side chain of 
mycolactone A/B, it is relatively easy for mycolactone to undergo double bond 
isomerization. It is well known that 1,3,5-hexatriene can undergo double bond 
isomerization at C3-C4 through a biradical transition state as a result of photo-oxidation. 
Similarly, due to the extended conjugation in the mycolactone side chain, unrestricted 
rotation is possible around C4’-C5’ double bond. This free rotation is responsible for the 
existence of mycolactones as equilibrating mixture of double bond isomers. 
  
     Traditional HPLC columns are capable of separating these geometric isomers. But 
once outside the column, each isomer is converted to an equilibrating isomeric mixture of 
specific ratio. For further structural analysis, it is necessary to understand the nature of 
each mycolactone as a mixture of isomers rather than a single molecule. Under the 
condition described in section 5.1.2.3, mycolactone A/B was separated by HPLC to two 
major isomers with comparable concentration at 20.1 and 23.8 minutes (Figure 5.5a). 
Other isomers of the same molecular weight were also detected. In the case of 
mycolactone E and F, the side chain lacks one of the double bonds of mycolactone A/B. 
This results in apparent stability of these two molecules. At room temperature, a 
dominant isomer is detected by HPLC at 23.2 minutes in case of mycolactone E and at 
20.5 min in case of mycolactone F (Figure 5.5d). The production of the same molecule 
(mycolactone F) by multiple strains was also confirmed through the production of similar 
HPLC chromatogram by ten of the strains tested in this study. 
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Figure 5.4 MS Analysis of Different Mycolactone Molecules 
 
MS analysis of the ASL of M. ulcerans subsp. shinshuense showing three major 
mycolactones at m/z=793, 779 and 763, (a). Fragmentation of the m/z=793 precursor ion 
result in the production of the mycolactone core ion at m/z=429.4, (b). MS analysis of the 
ASL of M. pseudoshottsii L15 showing the dominance of a major mycolactone ion at 
m/z=723, (c). Fragmentation of the precursor ion at m/z=723 produces a core ring 
product ion at m/z=429 and a side chain product ion at m/z=317, (d). MS analysis 
conditions were described under section 5.1.2.4. 
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 Table 5.2 Mycolactone Ions Identified in Different Mycobacteria Strains 
 
Strain Origin [M+Na+] Ions  
M. ulcerans 1615 Human Malaysia 765, 747, 749 
M. ulcerans 98-912 Human, China 779, 777 
M. ulcerans 842 Human, S. America 763, 761, 737 
M. ulcerans subsp shinshuense Human, Japan 793, 779, 777 
M. liflandii 128 Frog, ,USA 737, 735 
M. liflandii HW-1 Frog , USA 737, 751, 733 
M. liflandii XL-5 Frog, USA 737, 753, 735 
M. pseudoshottsii L15 Fish, Chesapeake Bay 723, 763, 755, 739 
M. marinum DL240490 Fish, Red Sea 723, 763, 755, 739 
M. marinum SA200695 Fish, Red Sea 723, 755, 739 
M. marinum Hyb270995 Fish, Red Sea 723, 757, 739 
M. marinum DL150991 Fish, Red Sea 723, 757, 755, 739 
M. marinum DL180 Fish, Red sea 723, 755, 739 
M. marinum CFO30494 Fish, Red Sea 723,.757,.755,.739 
M. marinum DL045 Fish, Red sea 723, 739 
M. marinum CC240299 Fish, Red Sea 723, 739, 721 
M. marinum BB170200 Fish, Red Sea 723, 755,.739 
 
Major mycolactone ions are highlighted in bold numbers. 
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Figure 5.5 HPLC Profiles of the ASL Extract from Different Mycobacteria 
 
HPLC chromatogram of the ASL obtained from M. ulcerans 1615, (a). Arrows indicate 
the elution of mycolactone A/B isomers with m/z=765. HPLC profile of ASL from M. 
liflandii XL-5, (b). Arrows indicate the elution of a mycolactone E isomer at m/z=737. 
HPLC profile of ASL from M. ulcerans subsp. shinshuense, (c). Arrows indicate the 
elution of different mycolactone molecules of variable m/z. HPLC chromatogram of the 
ASL of M. marinum DL240490, (d). Arrows indicate the elution of mycolactone 
molecules m/z=723. HPLC and MS analysis conditions were describes in sections 5.1.2.3 
and 5.1.2.4 respectively. 
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    Finally, The HPLC chromatogram of the ASL extract from M. ulcerans subsp. 
shinshuense showed more complexity than all previous cases (Figure 5.5c). In part, this 
is due to the presence of at least three mycolactone analogs as detected by MS analysis 
but double bond isomerization have significant contribution to this complexity as inferred 
from offline MS analysis of the HPLC eluted peaks.  
 
5.1.3.3 Structural determination of mycolactone F 
 
     Although mass spectrometry is an increasingly valuable tool for molecular analysis, 
data from NMR analysis provides a more rigorous method for structural assignments. 
The limited amount of mycolactone produced by mycobacterial species as well as the 
very slow growth rate of MPM has made it extremely difficult to obtain sufficient 
mycolactone for optimal structural analysis. However, the relatively robust growth yield 
of lipids from some M. marinum isolates made it possible to undertake a more thorough 
analysis of mycolactone F structure isolated from M. marinum DL240490 strain.  
 
     To determine the structure of mycolactone F, 1D and 2D NMR experiments were 
performed on purified sample of mycolactone F. As expected, 1H NMR revealed a 
structure very similar to that reported for mycolactones A/B with the characteristic core 
proton signals at C9, C15, C11 and C5 easily identified at 5.16, 5.03, 4.93 and 4.75 ppm 
respectively287 (Figure 5.6). In the region corresponding to the side chain, two 
geometrical isomers were distinguished with an integration ratio of 10:1. Both isomers 
showed five olefinic protons.  For the major isomer, the most downfield proton was that 
of C3’ which appeared as a doublet at 7.39 ppm and was coupled to C2’ proton (doublet 
at 5.91 ppm).  The presence of two singlet peaks at 6.4 and 6.1 ppm suggested the 
presence of methyl substitutions at C4’, C6’ and C8’. This was confirmed by 2D-COSY 
analysis which showed the long range coupling of these olefinic protons to methyl groups 
at 2.06 and 2.03 ppm.  The remaining side chain signals from C10’ to C15’ overlapped 
signals from the mycolactone core in the 1D-1H NMR.  Thus, 2D-COSY was used to 
assign these protons (C9’ to C14’) using the off diagonal 1H-1H correlation peaks (Table 
5.3).  Mycolactone F is the smallest mycolactone identified so far and as with other 
mycolactone variants, the core lactone structure is identical to that of other mycolactones, 
whereas the side chain is unique. 
 
 
5.1.4 Discussion 
 
     The use of MS for the structural analysis and screening for mycolactones is a very 
efficient approach. Unlike most cellular lipids that posses long hydrophobic fatty acid 
chain, mycolactones are polyketide in nature and their substitution pattern contain many 
oxygenated function that make their ionization by soft techniques like ESI more efficient. 
It is also useful that variations in the mycolactone structures are restricted to the side 
chain and that the fragmentation pattern of mycolactone follows simple and often 
predictable pathways. However, for a complete structural assignment, NMR provides the 
necessary tool for structural determination provided that the analyzed sample is of 
enough purity and shows significant chemical stability. 
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Figure 5.6 Structure and 1H-NMR of Mycolactone F 
 
 
 
 
Table 5.3 Proton Chemical Shifts of the Major Isomer of Mycolactone F  
 
Side Chain Core Ring Side Chain Core Ring 
Atom δ1H (ppm) Atom δ1H (ppm) Atom δ1H(ppm)  Atom δ1H(ppm) 
2’ 5.91 (d) 2 2.45, 2.04 16’ 2.03 15 5.03 
3’ 7.39 (d) 3 1.60 17’ 2.06 16 2.39 
5’ 6.46 (s) 4 1.7   17 3.5 
7’ 6.09 (s) 5 4.75   18 1.62, 1.13 
9’ 5.56 (t) 6 2.01   19 3.99 
10’ 2.31 (m) 7 1.92   20 1.13 
11’ 3.99 9 5.16   21 1.00 
12’ 1.12 10 2.51, 2.12   22 1.7 
13’ 3.56 11 4.93   23 1.03 
14’ 1.03 12 2.09   24 1.69 
15’ 1.06 13 2.14     
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     It was possible to determine that all ten fish pathogen tested here produced the same 
molecule through analysis of both MS/MS and HPLC analysis. The production of the 
same product ions upon fragmentation of the precursor ion at m/z=723 indicated that the 
side chain of all these molecules are the same. On the other hand, consistency in the 
HPLC profiles of the equilibrating double bond mixtures further confirmed this 
observation. However in both cases, differences in the stereochemistry between these 
mycolactone F molecules can not be ruled out. Recently, the structure of mycolactone F 
was confirmed through chemical synthesis and its absolute stereochemistry has been 
assigned.302 
 
     The structure of mycolactone D has been proposed by Hong et al through a detailed 
examination of all the product ions it produced upon its fragmentation in MS/MS 
mode.296 The presence of a C2’ methyl in mycolactone D (m/z=779) was suggested based 
on the apparent mass increase in one of the mycolactone A/B fragment from m/z=565.4 
to 579.6. This ion represents the fragmentation product due to aromatization of the side 
chain at C1’-C6’. Due to the mass increase in this ion by 14 dalton in mycolactone D, the 
presence of a methyl group was suggested and its only possible location was C2’.296 
 
     The utilization of the same approach with the mycolactones identified in the ASL of 
M. ulcerans subsp shinshuense come to the conclusion that the three mycolactones in this 
extract detected at m/z of 777, 779 and 793 are not structurally similar to mycolactone D 
and are more likely to be related to mycolactone A/B. The presence of C2’ methyl can be 
immediately ruled out on the basis of the production of the m/z=565.4 fragment. Also 1H-
NMR and 2D-1H-1H COSY analysis of a mixture of these three molecules indicated the 
presence of three sets of coupled protons at δ1H=(2’CH at 5.96, 3’CH at 7.96 ppm), 
(2’CH at 5.88, 3’CH at 7.48 ppm) and (2’CH at 5.98, 3’CH at 7.52 ppm). No other off-
diagonal signals were detected between protons in the olefeinc region which may indicate 
the presence of methyl substitution at C8’. Unfortunately, due to the existence of multiple 
isomers in that mixture (as indicated from its HPLC chromatogram), further structural 
characterization was not possible at the time. 
 
     From our screening of MPM isolates, we observed that all M. ulcerans isolates 
(including subspecies shinshuense) produce mycolactones where the side chain reaches 
16 carbons in length. This length is consistent with a PKS-I enzyme with seven modules 
in addition to the loading domain. Differences in the side chain between M. ulcerans 
mycolactones were restricted two areas. First, the substrate of one or more module can 
change from malonate to methylmalonate resulting in an additional methyl branch (as in 
mycolactone D). Second, the C12’ hydroxyl which is added by a p450 monoxygenase 
may be absent (as in the case of mycolactone C). While M. ulcerans isolated from South 
America produces a mycolactone with a shorter side chain, mycolactoneE, longer chain 
analogues were also observed at m/z=763 and 761. This confirms the presence of a PKS-I 
with seven modules. In mycolactones produced by both frog and fish pathogens, the side 
chain length was C15 and C14 respectively. This suggests the presence of PKS-I of only 
six active modules in addition to the loading domain. Differences between mycolactone 
E, produced by the frog pathogen, and mycolactone F, produced by fish pathogens, were 
limited to the loading residue which is either methylmalonyl residue in the first or 
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malonyl in the latter. Some of these findings have been supported recently through an 
elegant genomic study by Pidot, S et al.292 
 
     These structural variations between different mycolactones are translated to different 
cytopathic activities of mycolactones in standard in vitro assays. Mycolactone A/B is 
known to cause G0/G1 cycle arrest and produce cytopathic activity (CPA) at 
concentration less than 1ng/ml.231 Mycolactone C which has the same chain length but 
lacks the hydroxyl group at C12’ demonstrates comparable CPA but at much higher 
concentration (800ng/ml).290 Shorter side chains (as in mycolactone E and F) are also 
associated with reduction in CPA. For example, mycolactone E (C15 side chain) 
produces CPA at concentration of 100ng/ml.254 With regards to their biosynthesis and the 
range of biological activities attributed to them, mycolactones are fascinating bacterial 
metabolites. Understanding their “structure activity relationship” as well as the genetic 
bases behind it should encourage researchers to develop combinatorial biosynthetic 
strategies targeted at the production of mycolactone analogs. Such effort will help further 
elucidate the effect of substitution on mycolactone biological activity and might produce 
novel drug candidates that can be used in the treatment of cancer or auto immune 
diseases. 
 
   
5.2 Case Study II:  Screening Mycobacterium tuberculosis Clinical Isolates for the 
Production of PGL 
 
 
5.2.1 Introduction 
 
     Phenolic glycolipids (PGL) have been previously isolated from M. leprae, M. 
kansasii, M. marinum, M. bovis and M. tuberculosis Canetti strain, a smooth colony 
variant of M. tuberculosis.144,145,260,262,303,304 In a previous chapter, we have reported the 
isolation of PGL from M. liflandii as well (section 3.3.4). The aglycon part of PGL is 
usually phenolphthiocerol-A, phenolphthiotriol-A or phenolphthiodiolone esterified to 
two molecules of mycocerosic acid. The glycon part which substitutes the oxygen of the 
phenol ring can be either monosaccharide, disaccharide or trisaccharide.149,262,303 
Examples of mycobacterial PGL were previously shown in Figure 1.11. 
 
     The aglycon part of PGL can be considered as an aromatic derivative of PDIM 
(section 1.4.3.6).  Different mutants of M. tuberculosis that are deficient in the 
biosynthesis of PDIM have been shown to be attenuated in a murine model by different 
research groups.146,305 However, the specific role of PDIM in virulence has not been fully 
elucidated. It has also been suggested that the apparent attenuation of PDIM deficient 
mutant is due mainly to gross structural modification of the cell wall.306  
 
     PGLs are associated with significant immune-modulatory effects that are well 
supported by plethora of evidence. PGL-I of M. leprae is the main antigenic component 
of this pathogen143,144 and the immune reaction to PGL-I is often used as a prognostic 
marker for early infections with leprosy.307 Recent reports have suggested PGLs 
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produced by M. tuberculosis as the cause of hypervirulence in isolates from the W-
Beijing lineage.153 Other recent studies, however, indicated that while PGL can modulate 
the host immune response and suppress production of Th2 cytokines, they do not confer 
hypervirulence in their own.174 
 
     Biosynthesis of PGL requires multiple enzymes in different pathways. These enzymes 
include PKS and fatty acid synthases involved in phthiocerol and mycocerosic acid 
biosynthesis, certain synthases like 4HB-synthase responsible for the production of 4-
hydroxybenzoic acid,308 glycosyl transferases which transfer of the sugar residues to the 
aglyon,152 and PKS1-15 which links the aromatic residue to the fatty acid chain.150 Most 
strains of M. tuberculosis are incapable of producing PGL due to a frame shift in the pks 
1-15 gene.147,150 Meanwhile, all strains of M. tuberculosis have the capability of 
producing PDIM and some forms of glycosylated benzoic acid esters like those detected 
by Perez and colleagues in the culture filtrate of M. tuberculosis H37Rv.152  
 
     In this study we investigated the production of PGL by different MDR clinical isolates 
collected from South Korea by the National Institute of Allergy and Infectious Diseases 
(NIAID) collected by Dr. Clifton E. Barry III and his research group. We also included 
some laboratory strains and other clinical isolates from the collection of the State of 
Tennessee health department. We used NMR-based lipid profiling to determine the 
production and the relative abundance of PGL in these strains and in the same time 
ensure stability in the concentration of other cellular lipids. 
 
 
5.2.2 Materials and Methods 
 
5.2.2.1 Growth conditions and lipid extraction 
 
     M. tuberculosis isolates were grown in Middlebrook 7H9 supplemented with 0.2% 
13C6-dextrose, 0.2% 13C3-glycerol, 0.05% Tween 80 and 5% BSA at 37°C with 
continuous shaking at 250 rpm. 94 isolates were used for this study including 85 from 
South Korea, 5 from the state of Tennessee, in addition to H37Rv, CSU93, HN878 and 
its ∆pks mutant stain. Cells were harvested by centrifugation at 3700xg for 10 minutes. 
Cell pellets were washed and extracted as previously described under section 3.2.1. 
 
5.2.2.2 Isolation of PGL from M. liflandii 
 
     M. liflandii cells were grown to stationary phase in Middlebrook 7H9, harvested by 
centrifugation, and subsequently extracted with ethanol. The ethanolic extract was dried 
in vacuo and the dried residue (80 mg) was re-suspended in CHCl3 and applied to a 
Biotage SP1 flash chromatography system equipped with a Biotage Si 12+M silica gel 
column. The column was eluted using a CHCl3-to-CHCl3/CH3OD 9:1(v/v) linear 
gradient. The major PGL was detected using silica TLC analysis with CHCl3/CH3OH 
(95:5, v/v) as the developing system (Rf = 0.7). Lipids were visualized using cerric 
ammonium sulfate in 2 M sulfuric acid after charring. Fractions containing pure PGL 
were pooled and dried in vacuo. 
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5.2.2.3 NMR acquisition and data processing 
 
    The 2D-HSQC spectra were recorded using Varian Inova 500MHz spectrometer at 
25°C degrees. The 2D-HSQC spectra were acquired for 256 increments and 60 transients 
using a 5mm trpfg sample probe or 10 transients using 3mm internal flow cell probe. For 
all NMR acquisitions, samples were shimmed, toned and other acquisition parameters 
were optimized. NMR data were processed using either VNMR or Felix-NMR software. 
Biomarker signals for different lipids were selected and their integral volumes were 
measured (δ1H=7.74, δ13C=133.64 ppm for menaquinone, δ1H=5.26, δ13C=70.74 for PL, 
δ1H=5.30, δ13C=69.31 for TAG, δ1H=0.67, δ13C=15.76 for TDM, δ1H=1.23, δ13C=45.54, 
for PIM and δ1H=5.13, δ13C=93.65 for ATs. Integration values obtained for different 
isolates were compared to the corresponding values in M. tuberculosis H37Rv after 
normalization to the integration value of the menaquinone signal which was used as an 
internal reference. The values of PL biomarker signals were used as a secondary 
reference to insure the quality of the data. 
 
 
5.2.3 Results and Discussion 
 
5.2.3.1 Selection for biomarker signals for PGL 
 
     Before screening for PGL production, it was necessary to define the set of biomarker 
signals to be used for this purpose. In choosing these biomarkers signals, it is important 
that they will not overlap with other signals from other lipid molecules. It is also essential 
to ensure that these signals are unique for the targeted molecule. Based on this latter 
criterion and upon considering what is known about the lipidome of M. tuberculosis, 
most signals in the phthiocerol part of PGL can not be considered as biomarker signals 
because they are present in PDIM as well. For similar reasons, most of the signals of the 
glycon part are not suitable because they are very similar to signals from the glycosylated 
benzoic acid esters produced by some M. tuberculosis strains. However, signals of the 
phenolic ring and the adjacent methylene (benzylic protons) can be of special utility in 
detection of PGL for several reasons. First, few mycobacterial lipids have aromatic 
nucleus thus the phenolic and benzylic signals are likely to fall in well-resolved area of 
the spectrum. Second, these signals appear at the junction between the glycon and 
aglycon part of PGL, therefore, the chemical shifts for these protons will uniquely reflect 
the chemical environment created by that link which is specific to PGLs. Third, the gene 
responsible for establishing this link, pks1-15, can be considered as the genetic marker 
for PGL production within Mycobacteria and among different strains of M. tuberculosis. 
Finally, a set of a parent and ∆pks1-15 mutant stains is available and can be used to 
demonstrate the possibility of PGL detection and ensure the right assignment of the PGL 
signals. 
 
5.2.3.2 Use of isolated standard for the assignment of PGL biomarker signals 
 
     A major obstacle in studying M. tuberculosis PGL is their relative low abundance 
when compared with other lipid molecules. Chemical structures of M. tuberculosis PGL 
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were proposed based upon 1H-NMR experiment and glycosidic linkage analysis by 
GC/MS. To assign PGL signals in the 2D-HSQC spectrum it is important to have the 
chemical shifts for both the proton and carbon atoms in PGL obtained from a 2D-
spectrum acquired under similar conditions to that used for our lipid profiling protocol. 
However, it not practical to grow large amounts of cells to isolate enough PGL for 2D-
HSQC structural assignment. To solve this issue, we used the isolated PGL produced by 
M. liflandii as our preliminary reference to assign most of the PGL signals in the lipid 
profile of M. tuberculosis HN878. As expected, signals for the phenolic rings and the 
benzylic carbon were well isolated. The two p-aromatic CH were detected at δ1H= 7.02, 
δ13C=117.6 ppm and δ1H=7.18, δ13C=129.7ppm while the benzylic protons were 
detected at δ1H=2.58, δ13C=46.8 ppm (Figure 5.7). To confirm the assignment, the lipid 
profile of HN878 was compared to that HN878 ∆pks1-15, a mutant strain where the pks1-
15 gene has been disrupted rendering the strain incapable of producing PGL. The two 
profiles were quite similar except for the absence of PGL signal from HN878∆pks1-15 
profile. These biomarker signals could not be detected also in the lipid profiles of M. 
tuberculosis H37RV and the CDC-1551 strains.  
 
5.2.3.3 Screening of other clinical isolates using 2D-NMR  
 
     In the previous experiments, lipid extract of CDC1551, HN878 wt and its ∆pks1-15 
mutant were obtained from 30mls culture (150mgs) and the corresponding lipid profiles 
were developed by prolonged NMR acquisition for 60 transients. For screening purposes, 
both the initial cell pellet weight and the NMR acquisition time have to be reduced. Some 
of the clinical isolate do not exhibit optimal growth behavior and the long NMR 
acquisition time will be inefficient when dealing with a large number of samples. To 
produce good quality spectra from smaller samples, we used 3mm NMR sample probe 
which effectively reduced the sample volume required to 160µl. Such volumes can be 
obtained from 10mls of cell culture grown to the mid exponential phase. Differences 
observed in 2D-profiles between HN878 and its ∆pks1-15 mutant obtained using the 
5mm probe were replicated using the 3mm sample probe in a shorter acquisition time of 
about 1 hour 40 minutes. 
 
     Lipid extracts from 94 M. tuberculosis isolates were obtained from a 10mls of cell  
culture as described previously and an HSQC lipid profile was obtained for each using 
3mm NMR sample probe. Immediately, two isolates (OA033 and OB239) were 
disregarded from further analysis after being identified as M. avium isolates by this 
method. Overall, the quality of the spectra was satisfactory except in few cases (6 isolates 
out of 94 tested).   
 
     Isolates from South Korea were easily confirmed to be from the W-Beijing strain by 
the abundance of their TAG compared to H37Rv strain. PGL signals were detected in the 
lipid profile of 48 cases of the 85 South Korean isolates and in none of the Tennessee 
State isolates. It was also observed that when compared to the H37Rv, each of the two 
different isolate collections displayed a specific pattern. While the Korean isolates 
displayed high levels of TAG (three times or higher), they also showed significantly 
lower levels of PIMs and ATs (at 40% their levels in H37Rv). On the contrary, all tested   
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Figure 5.7 Selection of Biomarker Signals of M. tuberculosis PGL 
 
A monosaccharide PGL isolated from M. liflandii was used to assign PGL signals in the 
2D-HSQC lipid profile of M. tuberculosis HN878. Inserts, marked as (a), show partial 
windows in both the PGL standard and the HN878 lipid profile where the benzylic 
signals at δ1H=2.58, δ13C=46.8 ppm of PGL are highlighted by solid circles. Inserts 
marked as (b), represent a partial windows where the aromatic signals of PGL at 
1H=7.02, δ13C=117.6 ppm and δ1H=7.18, δ13C=129.7ppm have been highlighted in 
dashed circles in both spectra.  
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Tennessee isolates showed significantly lower levels of TAG (2-15% of H37Rv levels) 
and to less extent lower levels of TDM (30-50% of H37Rv levels), while ATs, PIMs and 
PDIM were detected at comparable levels. Full results are outlined in Table 5.4. 
 
     Results from this screening are, to some extent, in agreement with the suggestion that 
PGLs may be, at least partially, responsible for the hypervirulence of the W-Beijing 
lineage as we were only able to detect PGL in strains that belong to this lineage. 
However, our screening results suggest that other factors might participate in such 
phenomenon since PGL were not detected at measurable levels in many of these isolates. 
In addition, we have found some other differences between of the lipid composition of 
the W-Beijing strains and strains that were obtained from other areas. 
 
 
5.3 Conclusion 
 
     Different spectroscopic and chromatographic techniques can be used for the targeted 
analysis of a specific lipid species. The selection of the analytical method to be used 
depends largely on the properties of the molecule to be investigated. Molecules that are 
readily ionizable are better analyzed via mass spectrometry while molecules that have 
low ionization potential are bad candidate for such analysis. In the later case, the analysis 
can be achieved through HPLC, GC or NMR. GC analysis requires that the target 
molecules must show some degree of volatility or to be derivatized before analysis to 
volatile derivatives. Depending on the type of HPLC detector used for analysis, HPLC 
analysis may require certain characteristics to be built in the targeted lipid species. For 
example, the most commonly used HPLC detector, UV-detector, requires a UV absorbing 
functionality to be present or to be added to the molecule targeted for analysis. NMR on 
the other hand has more universal detection but due to its low sensitivity it is better suited 
for the analysis of relatively abundant cellular components. Certain measures are also to 
be implemented during analysis of complex mixtures to insure good resolvability of the 
data points as well. In all cases, some effort has to be directed towards the standardization 
and optimization of the chosen strategy to enhance sensitivity towards the detection of 
the targeted molecules. 
 
     In this chapter, two chemically different molecules were targeted for screening in the 
lipid extract of different Mycobacteria and two different methods were chosen for this 
purpose accordingly. The first example, mycolactone, represents a virulence factor of a 
polyketide nature that is usually produced by MPM in relatively small amounts. 
Mycolactones are easily ionizable as sodium adduct and hence are great candidate for MS 
analysis. Moreover, MS analysis of complex lipid extract can easily identify analogues of 
mycolactone due to the presence of a distinct fragment that represent the conserved 
lactone ring at m/z 429. All mycolactones share also consistent fragmentation pathways 
Knowledge of these pathways can help in determining certain structural features of 
mycolactone as it is the case with our analysis of mycolactone D and other mycolactones 
isolated from M. ulcerans subsp shinshuense. 
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Table 5.4 Results from Screening M. tuberculosis Clinical Isolates for PGL Production 
 
Strain PGL TDM TAG PDIM AT PIM Remarks 
  aromatic benzylic       
A29 + + = +++ = - - PGL +ve 
B019 + + - - = - = PGL +ve 
B076   + +++ - - - PGL +ve 
B122   - - - - - Bad quality
B148  + = +++ - - =  
B183  + + +++ = = + PGL +ve 
OA002 + + = +++ - - - PGL +ve 
OA004   - - - - - Bad quality
OA015   ++ +++ = - -  
OA022   - +++ - - -  
OA023 ++ ++ = +++ - - - PGL +ve 
OA025  + +++ +++ - - - PGL +ve 
OA029 ++ + - + - - - PGL +ve 
OA030 + + = +++ = = = PGL +v e 
OA033 Signals at δ1H=7.2, δC=128.71 and δ1H=4.67,δC=55.36 ppm M. avium 
OA039 ++ ++ = +++ - - - PGL +ve 
OA040  + - - = - - Bad quality
OA046  + +++ +++ +++ - - PGL +ve 
OA049  + +++ +++ - - = PGL +ve 
OA054 ++ ++ = +++ - - - PGL +ve 
OA055  + = +++ - - -  
OA057 ++ ++ = +++ - - - PGL +ve 
OA062 + + +++ +++ = - - PGL +ve 
OA071  + = +++ + - =  
OA074  + = +++ = - -  
OA081   - - - - - Bad quality
OA086  + = +++ = - -  
OA090 + + = +++ - - - PGL +ve 
OA094 ++ + = +++ - - - PGL +ve 
OA108 + + = + +++ = + PGL +ve 
OA109 + + + +++ = - - PGL +ve 
OA110   - - - - - Bad quality
OA116 ++ ++ = ++ - - - PGL +ve 
OA119 + + = +++ - - - PGL +ve 
OA121   - + - - - Bad quality
OA122 ++ ++ + +++ - - - PGL +ve 
OB012  + = +++ - - = PGL +ve 
OB013  + + +++ = - -  
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Table 5.4 (continued) 
      
Strain PGL TDM   TAG PDIM AT PIM Remarks
  aromatic benzylic       
OB016  + = +++ - - -  
OB023 ++ ++ = ++ = - = PGL +ve 
OB026 ++ ++ - +++ - - - PGL +ve 
OB047  + = +++ = - -  
OB051  + = +++ - - -  
OB059 ++ ++ = +++ = - - PGL +ve 
OB066 + + ++ +++ = - - PGL +ve 
OB074  + = + - - -  
OB075   + ++ = = -  
OB076 ++ ++ = +++ = - - PGL +ve 
OB078 + + = +++ + - - PGL +ve 
OB085 + + + +++ - - - PGL +ve 
OB096  + - +++ = - -  
OB099 + + = ++ - - - PGL +ve 
OB104 + + = +++ = - - PGL+ve 
OB115 ++ ++ = ++ - - - PGL +ve 
OB123 + + = +++ = - - PGL +ve 
OB124 ++ ++ = ++ - - - PGL +ve 
OB125  + = + = - - Bad quality
OB126  + = ++ - - -  
OB127 + + - + - - - PGL +ve 
OB139 + + = +++ - - - PGL +ve 
OB140 ++ ++ = +++ = - - PGL +ve 
OB142  + - +++ - - -  
OB143 + + = +++ - - - PGL +ve 
OB145 + + = +++ = - - PGL +ve 
OB154  + = +++ - - -  
OB156  + = ++ - - -  
OB157  + ++ +++ = - =  
OB158 + + = + - - - PGL +ve 
OB161  + = ++ - - -  
OB170  + = +++ = - -  
OB178  + - + = - -  
OB179 ++ ++ ++ +++ - = = PGL +ve 
OB185 ++ ++ ++ +++ = = = PGL +ve 
OB192 + + = +++ - - - PGL +ve 
OB202 ++ ++ + +++ - = - PGL +ve 
OB206   = +++ = - -  
OB210  + = +++ = - -  
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Table 5.4 (continued)       
       
Strain PGL TDM  TAG PDIM AT PIM Remarks
  aromatic benzylic       
OB218   - +++ - - - Bad quality
OB227 + + = +++ - - - PGL +ve 
OB228 +  = ++ - - -  
OB229 + + - + - - - PGL +ve 
OB231 + + = ++ = - - PGL +ve 
OB235  + = +++ = - -  
OB239 Signals at δ1H=7.2, δC=128.71 and δ1H=4.67,δC=55.36ppm M. avium 
CSU93   = - = + =  
HN878 ++ ++ = +++ + = - PGL +ve 
878∆pks   = ++ = = -  
TN15   - - = + -  
TN18   - - = = =  
TN22   = - - = +  
TN26   - - = = =  
TN29   - - - = =  
 
Signal intensities for lipid molecules other than PGL are reported in comparison to 
H37Rv. (=), comparable to H37Rv at 60%-140% value, (+) at 140%-200% value, (++), at 
200%-300% value, (+++) at more than 300% value, and (-) at less than 60% of that signal 
in H37Rv.  Intensities of different biomarker signals were measured and normalized as 
described in section 5.2.2.3. Samples were judged to be PGL positive if more than one of 
the biomarker signals of PGL were detected in their corresponding spectra. 
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     Due to the presence of a polyene side chain in mycolactones, they are also good 
candidates for HPLC-UV analysis. The absorption wavelength of these molecules at 
360nm is relatively uncommon for other lipid molecules hence it is possible to use such a 
technique for mycolactone detection in total lipid extract. In addition, HPLC can succeed 
where MS analysis fail. While MS detect all geometric isomers as a single entity of the 
same mass, a well-developed HPLC gradient can differentiate between geometric isomers 
and provide information that are not attainable through MS analysis alone. 
 
     In the second case, screening for PGL represents a different challenge. The molecular 
mass of PGL is not a fixed value due to the possibility of the variation in the aglycon 
part. Both mycoserosic acid and phenolphthicerol exhibit variations in their structures in 
both chain length and the number of substituent. This variability causes great variation in 
the possible molecular weight of PGL. These molecules are also very hydrophobic in 
nature and their ionization under most MS ionization techniques is considerably poor. 
 
     2D-HSQC-based screening for PGL that we used here was quite successful in several 
aspects. We were able to determine biomarker signals that can be used for different 
analogues of PGL irrespective of the variation in their corresponding mass. We were also 
able to detect PGL in clinical isolates using only 10 milliliters of cell culture (and as low 
as 0.75 mg of dried lipid extract) in a relatively short time period. While screening for 
PGL in these samples, all other cell wall lipids can be measured simultaneously. This 
adds a great value to the data obtained as it can point out in some case to certain 
metabolic coupling processes. Unfortunately, some clinical isolates showed slow and 
erratic growth behavior which affected the amount of lipids available for analysis. In 
some cases, the lipid profiles were of such bad quality that deterred conclusive data 
interpretation. Due to the relatively low abundance of PGL in some isolates, in certain 
cases only one or two biomarker signals were detected for PGL instead of all three. 
Hence, a threshold based on multiple referencing is needed as an important measure to 
insure the quality of the spectrum and validate the conclusion drawn from it. 
CHAPTER 6. SUMMARY AND CONCLUSION4 
 
 
6.1 The Metabolomics Research Field 
 
 
6.1.1 The “Omics” Era 
 
     The introduction of global analysis techniques came as a natural sequel of our ability 
to decipher a whole genome sequence. With the availability of complete genomic 
sequence of several organisms, the “omics” era began with the introduction of 
microarrays in 1995309 as a tool to investigate the cellular transcriptome. Shortly after, 
the concept of proteome as the protein complement of the genome was introduced310 and 
followed by the introduction of the term proteomics in 1997.311 Several techniques have 
been introduced since then for these purposes and several modifications and 
improvements have followed. The result was unprecedented flood of information about 
transcription and translation regulation during different stages of cell cycle and in 
response to different environmental cues. 
  
     As researchers became accustomed to have a panoramic view of the cellular mRNA 
and the protein pool, the need to develop a parallel view of the cell metabolites became 
apparent. The term metabolome was introduced to describe the pool of small organic 
molecules that include cell metabolites, metabolic intermediates and small molecules 
involved in cellular signaling.312 The parallel terms metabolomics and metabonomics 
were then coined to describe the measurement of all endogenous metabolites in a cell or a 
body fluid. Changes in cellular metabolites can be regarded as the end product of the 
regulatory response of the cell to environmental stimuli.313-315 In that sense, 
metabolomics should provide a more direct representation of cellular events than those 
offered by genomics and proteomics.316 
  
     In Mycobacteria research, the “omics” era started with the completion of the whole 
genome sequencing of M. tuberculosis in 1998.221 Short after, whole genome sequences 
of different Mycobacteria species and strains have also been completed.222,257,317  
Microarrays and proteomics techniques have been successfully used in Mycobacteria 
research. Some interesting examples include the use of RNA microarrays to identify the 
mode of action of several anti-TB drugs.276,318,319 Through the use of such techniques, 
researchers have also identified the role that isocitrate lyase and nitrate reductase play in 
the metabolic shift of Mycobacteria to latency.275,277,320 Despite the availability of such 
information, we are still represented with the great challenge of deciphering the genome 
into the ultimate end products, the metabolome. 
 
                                                 
4 Parts of this chapter are adapted with permission. Mahrous, E.A., Lee, R.E. & Lee, R.E. 
A rapid approach to lipid profiling of Mycobacteria using 2D HSQC NMR maps. J Lipid 
Res. 49, 455-63 (2008).240 
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6.1.2 Challenges in Metabolomics 
 
     However, there has been limited development in the metabolomic field and it largely 
seems to be lagging behind the great advances of genomics and proteomics. This can be 
attributed in part to the relatively recent interest in the field and the many technical 
challenges it faces. Metabolomic studies include two main stages; first, the extraction of 
the cell metabolites then the detection of these small molecules in the extract which may 
require a prior step of chromatographic separation.321 The great diversity of the cell 
metabolites in terms of cellular abundance and chemical nature (carbohydrates, lipids, 
peptides and polyketides) represents a major challenge since there is no reliable 
extraction solvent or technique that can guarantee the extraction of all cell metabolites. 
On the other hand, most analytical methods do not have enough capability to deal with 
biological mixture with thousands of components of such diverse chemical structures and 
with wide range of cellular concentration. In fact, until now a combination of analytical 
methodologies has a limited power of analyzing few hundred metabolites which is a long 
way to go compared to microarrays that can depict the whole transcriptome.322 
 
 
6.1.3 The Field of Lipidomics 
 
     In order to partially overcome the problem associated with the chemical diversity of 
the cell metabolome, it can be subdivided and analyzed as separate pools; lipid pool, 
peptide pool, etc. One of the most significant metabolite pools is that of the cellular lipid, 
the main focus of this dissertation. All lipidomics techniques follow a general scheme 
that start with extraction of the cellular lipid with an organic solvent from a whole 
organism, body fluid or tissue then the lipid pool is analyzed by either a chromatographic 
or spectrometric method to produce a “lipid profile.”236  This lipid profile represents a 
panoramic view of cellular lipids which include among others; membrane lipids, cellular 
signaling molecules and biosynthetic intermediates.236 
 
     Genetic and metabolic differences in the starting materials, tissue or microorganism, 
should be reflected in their lipid profiles. The changes observed in these profiles when 
related to the initial variation of the analyzed samples are then used to formulate a 
hypothesis about a certain metabolic pathway. A combination of data obtained from such 
lipidomic approach together with data from genomics and proteomics can provide a 
complete picture of the cellular response and the regulatory process involved within. In 
that sense, it was encouraging that we were able to produce results that came in 
agreement with other observation obtained through molecular biology techniques. For 
example, our lipidomics characterization of M. liflandii was consistent with what is 
known so far about its evolutionary relation to M. marinum and M. ulcerans256,258 
(section 3.3.4). Also, our conclusion that Mycobacteria overproduces TAG during its 
shift to dormancy came in agreement with previous results that showed an up-regulation 
in M. tuberculosis’ TAG synthases when cells were subjected to low oxygen 
conditions.278 
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6.1.4 Designing a New Lipidomics Approach 
 
     Before designing a new approach to address lipid profiling it is important to consider 
several factors. In the extraction process, effort has to be made in the selection of the 
solvent and the extraction methodology to insure that all cell lipids are included in the 
lipid extract without bias toward certain class of lipids over the other. Multiple extraction 
steps and the use of solvent mixtures instead of a single solvent can help to reduce such 
bias. Choice of the analytical method in lipid profiling should require only minimum 
manipulation and avoid partitioning of the total pool as much as possible to avoid loss of 
some lipids or duplicating their presence (but with lower concentration) in multiple 
profiles. Data analysis and management should include a statistical validation of the 
acquired data, a scheme to relate data to results from other “omics” techniques, a clear 
plan to develop a high throughput analysis and a depository mechanism to share the 
massive amount of data generated.  
 
 
6.2 New Techniques in Lipidomics 
 
     Recent interest in lipidomics resulted in a vigorous search for the best tool to be used 
for such purpose. However, development of systems-level approaches for lipid analysis is 
still in its infancy and we have not reached the breakthrough that the genomic research 
arrived at with the development of microarray, or in proteomics through the 2D-
electrophories/MALDI-MS approach. The old techniques of lipid analysis so often 
included radiolabeling or fluorescent labeling of lipid precursors followed by 
chromatographic separation of the components of the lipid extract. The relative ratio of 
the lipid pool that can be analyzed through these experiments depends on the choice of 
the lipid precursors and the extent of the label incorporation. The most common 
technique involves the use of radiolabeled 32P- carbon precursors for the analysis of 
membrane phospholipids.236 However, with the great advancement of multiple analytical 
techniques, it became possible to develop more comprehensive and more accurate lipid 
analysis techniques. 
 
 
6.2.1 Mass Spectrometry (MS) 
 
     Several developments in mass spectrometry have eliminated most restrictions on the 
use of MS in lipid analysis. First, the development of soft ionization techniques such as 
electrospray ionization ESI and MALDI have greatly reduced the possibility of ion 
fragmentation and thus provide more simplified spectra.199,323,324 MALDI offers an added 
advantage of its tolerance to electrolytes and salt contamination which reduce sample 
manipulation. Atmospheric pressure chemical ionization (APCI) can also be used for 
analysis of some non polar lipids that show some difficulty in producing ions. In addition, 
development of powerful analyzers such as time of flight (TOF) has greatly enhanced the 
sensitivity of MS analysis.  
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     On the other hand, there are some problems that restrict the use of MS-based 
lipidomics to certain areas. Most MS analysis techniques demonstrate their greatest utility 
in analyzing polar lipids such as phospholipids (in the case of ESI) and complex 
glycolipids and lipoproteins in the case of MALDI.323-326 Other problems can also be 
encountered especially in the analysis of crude lipid extracts such as ion suppression 
which hinder the analysis of low abundance lipid molecules. Quantitative MS analysis of 
lipids hence requires careful sample preparation and the incorporation of lipid standards 
to overcome ion suppression.236 Prior separation of the individual components of the lipid 
mixture by HPLC is the most widely used approach for efficient and quantitative analysis 
of lipid mixtures.327,328  An alternative approach, shotgun lipidomics, was introduced by 
Gross, R.W.329-331 This approach avoids prior HPLC separation of the crude lipid extract, 
rather it uses tandem mass scanning to develop two dimensional MS-fingerprints for the 
cellular lipidome.332 Hundreds of individual lipid molecules were analyzed and quantified 
through this technique which requires sub picomolar concentration of lipids for efficient 
analysis.329,332,333 For example, shotgun lipidomics was successfully used to link 
depletion of some cellular lipids to mitochondria dysfunction in diabetic myocardium.334  
 
     One of the most important applications of MS in lipidomoics is its use for targeted 
lipid analysis. Anionic lipids like phospholipids, gangliosides, sulfatides and fatty acids 
are great candidates for such studies. Through the development of triple quadropole 
analyzer, it is now possible to use MS to quantitatively monitor a single molecule in a 
complex lipid mixture using MS-MS sequences.325 Multiple reaction monitoring can 
provide an accurate and highly sensitive method to detect and quantify a specific 
molecule.327,335-337 This analysis, however, necessitates the incorporation of an internal 
standard and a prior knowledge of the fragmentation pathway of the targeted molecular 
ion. With the continuous introduction of new MS technology during the past two 
decades, MS has established itself as a major tool for lipidomics studies. 
 
     In our hands, MS analysis was especially helpful in the analysis of Mycolactones. 
These molecules are polyketide in nature and their structure is often decorated with 
multiple ionizable groups (section 5.1). We successfully used MS for the rapid screening 
and detection of mycolactones in the ASL of different Mycobacteria. However, our 
attempts to use mass spectrometry in the analysis of other lipid species (like TDM) were 
not as successful. The presence of lipid molecules as a series of analogues with variable 
carbon chain length often complicates the MS spectrum. Moreover, any minor 
contaminant with favorable ionizability can appear as a major component in an extract 
when compared to the low ionizability of cellular lipids. Certain measures have to be 
implemented to overcome this problem.215 
 
  
6.2.2 Chromatographic Separation Methods HPLC and GC 
 
     Chromatography in general has preceded spectrometric methods and its development 
has initially enjoyed faster pace than that of MS and NMR. For this reason, 
chromatographic techniques, starting with TLC, have been used for metabolic analysis 
for several decades before spectroscopy. The simplicity of TLC and its low cost 
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guaranteed its wide spread and frequent use by researchers. However, it suffers from low 
sensitivity and questionable resolution. Meanwhile, HPLC provides very quantitative 
measurement but most HPLC detectors are either irresponsive to most lipids (UV 
detector) or have low sensitivity (refractive index).236 The most commonly used HPLC 
detector for lipid analysis is MS but it usually necessitates certain treatment at the LC/MS 
interface to eliminate electrolytes and reduce the possibility of ion suppression. The 
technical advancement in development of universal detectors like evaporative light 
scattering and suppressed conductivity, was received with great enthusiasm from 
researches and they have been successfully used for global lipid analysis.338-340  
 
     Gas chromatography is most commonly used for analysis of fatty acids. Although 
analysis of lipids with GC requires a prior step of derivatization, the technique is very 
well established that the entire process is fully automated and is frequently used in the 
medical research field for diagnostic purposes.210 Other than fatty acid analysis, GC/MS 
can be used to help in the structural determination of some lipids particularly lipoproteins 
and glycopeptidolipids. 
 
     HPLC analysis was of a special use to us in our analysis of mycolactone (section 
5.1.3.2). Due to the presence of mycolactones as equilibrating mixture of double bond 
isomers, MS analysis does not reveal such heterogeneity in the analyzed sample as all 
isomers have the same molecular weight. Moreover, the presence of such isomers can 
complicate the NMR spectrum and deter data interpretation. We have successfully used 
traditional UV-HPLC to understand the isomeric nature of different mycolactones. Others 
have used chiral HPLC column as a part of a complete synthetic strategy to assign the 
complete stereochemistry of different mycolactones as well.297 
 
 
6.2.3 NMR spectroscopy 
 
     NMR represents a powerful analytical technique that offers a plethora of structural 
information. Although it has been well established a long time ago as an indispensable 
tool in organic chemistry, it keeps on offering researchers new opportunities in multiple 
and diverse fields. In lipidomics, beside its traditional role as a structural analysis tool, 1H 
and 32P-NMR have often been used for global analysis of phospholipids.341,342 
Theoretically, NMR is a quantitative and universal technique by nature, thus it offers 
great opportunities for application in the analysis of complex biological mixtures with 
chemically diverse components. Recently, it has been successfully used for some 
metabolomic studies.343,344 
 
     However for most biological research, the sensitivity of NMR is still considered to be 
unsatisfactory for many applications and it shows bias to abundant metabolites. For lipid 
analysis, structural membrane and energy storage lipids are good candidates for NMR-
based lipid profiles due to their high natural abundance. While NMR analysis for less 
abundant lipids like cell signaling molecules does not seem to be feasible at this stage. 
With the vigorous effort deployed to advance NMR spectroscopy to its full potential, it is 
expected that it will be a major contributing factor in lipidomics studies. 
130 
 
     Our NMR methodology was quite successful in the analysis of the mycobacterial lipid 
pool considering that most of these lipids are structural components of the cell therefore 
they are relatively abundant. Most lipid classes previously reported in Mycobacteria were 
detected through this methodology regardless of their chemical class. However, when we 
started to fractionate our lipid pool into polar and nonpolar fractions, it became clear that 
more polar and less abundant lipids were underrepresented in the total lipid profile that 
was dominated by signals of TAG and fatty acids (section 2.3.6). So, it can be concluded 
that while all lipid classes were represented in our NMR lipid profile, the study of cellular 
lipids of low abundance remains challenging. Also, in drawing conclusion from these 
NMR profiles, the detection limit of the methodology has to be considered.  For example 
in our PGL screening (section 5.2.3), we can firmly conclude that certain strains do 
produce PGL while we can not exclude its production by other strains considering its 
overall low abundance and the detection limits of the method.  
 
 
6.3 Summary of the Research 
 
 
6.3.1 Method Development 
 
     In the previous chapters, the development of a new NMR-based method for the global 
analysis of the Mycobacteria lipid pool was discussed. Several concepts were integrated 
to develop a complete approach that would provide mycobacteriology research with a 
new tool for investigating the role and the biochemical interaction of the cell wall 
components. The method is summarized as a one step CD3OD:CDCl3 extraction of the 
D2O washed cells followed by 2D-HSQC NMR acquisition. The purpose of the method 
was to provide a global lipid analysis technique to complement the previously developed 
HR-MAS based analysis of the cell wall polysaccharides.  
 
     For such a technique to provide maximum utility, several factors were considered for 
method development. First, the simplicity of the procedure that includes only minimal 
sample manipulation and hence requires limited personal skills and minimizes artifacts 
during sample preparation. Second, the choice of the lipid profile format to be a simple 
2D-HSQC NMR spectrum insures the possibility of wide application since it requires 
only a high field NMR spectrometer and a simple pulse sequence. Third, the enrichment 
of the cell metabolites with 13C-isoptope eliminates some of the problems associated with 
NMR low sensitivity and greatly reduces the NMR acquisition time. Fourth, the fact that 
every molecule is represented by multiple signals rather than one signal, greatly reduces 
data ambiguity and positively increases confidence in data interpretation.  Fifth, despite 
some complexity in the spectrum each molecule can be identified by at least one signal 
“biomarker signals”, which can be assigned to each molecule either through literature 
search or through developing lipid profiles of isolated standard. Some highly congested 
area in the spectrum still can be resolved by three dimensional NMR experiments such as 
HCCH-TOCSY and HCCH-COSY in order to establish absolute clarity in data 
interpretation. Sixth, a semi-quantitative analysis of the signal can be achieved by 
normalization of biomarker signals intensity to that of a previously added standard.  
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Finally, the method can provide a complementary approach to the HR-MAS profiling of 
the cell wall AG and LAM.189 Hence, from the same starting material (13C-enriched cells) 
a more complete metabolic picture can be developed by combining the two techniques; 
lipid profiling which provides a representation of cellular lipid and HR-MAS which 
provides a representation of cell wall AG and LAM.  
 
 
6.3.2 Method Validation 
 
     The first validation of this NMR-based method came through developing a limited 
library of lipid profiles of some Mycobacteria species that have been thoroughly studied. 
As discussed in chapter.3, the lipid profiles of these species were reflective of the general 
features of Mycobacteria and also of the unique characteristics of certain species. When 
genes responsible for the production of a certain lipid were knocked out, signals 
corresponding to this lipid disappeared from the corresponding lipid profile of the mutant 
strains. For example, when pks1-15 gene was knocked out in M. tuberculosis HN878, we 
observed the loss of the phenolic glycolipid signals in the lipid profile of the ∆pks 1-15 
mutant strain (section 5.2.3.2). Also in our first attempt to use NMR for mycolactone 
analysis, we observed the disappearance of mycolactone signals from the lipid profile of 
avirulent M. ulcerans 1615A when it was compared to its parent strain, the virulent strain 
1615. However, such results were obtained through MS analysis and HPLC profiling in 
much shorter time. 
 
     Prior to the use of such method for more quantitative analysis, certain criteria have to 
be established. These include the reproducibility of the data obtained from lipid profiles 
under fixed growth, extraction and acquisition conditions and the inclusion of a reference 
to facilitate the comparison between lipid profiles obtained by different personnel in 
different laboratories. In this work, we used a specific signal produced through the 
addition of a specific molecule (DMSO) to the lipid extract based on the weight of the 
cell pellet as a referencing point. A demonstration of the use of 1H-13C 2D-HSQC for 
quantitative measurement of metabolites in plant extract has been already published,344 
which opens the opportunities for similar use in bacterial metabolites. For spectral 
referencing, other small molecules can be used as long as they do not overlap with signals 
in the spectrum. Trimethoxybenzene (TMB) can be used for this purpose, however it will 
produce two discrete signals in two different area of the spectrum, which can then be 
used for the alignment of multiple spectra for comprehensive comparative analysis.    
 
 
6.3.3 Method Application 
 
     The purpose of this research was to develop a new tool that will help researchers 
better understand the chemistry and biological function of the Mycobacteria cell 
components for the ultimate goal of defining new drug targets and developing new 
treatment option to control the spread of some devastating human and animal diseases. 
There are several areas where the integration of such methodology with other genetics 
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approach can greatly advance our understanding of Mycobacteria metabolism, virulence 
and resistance. Some of the potential areas of method application are discussed below. 
 
6.3.3.1 Gene annotation 
 
     The genome of Mycobacteria contains hundreds of genes that are involved in lipid 
biosynthesis and lipid metabolism and hundreds other that have no known function and 
need to be investigated for potential roles in survival and virulence for the purpose of 
identification of new molecular drug targets.221 Now with the availability of new 
molecular tools, a library of targeted mutant strains can be developed with relative ease 
and manageable cost. Screening of these libraries for changes in the lipid profiles should 
identify the lipid species affected by a specific mutation and offer the first steps to 
identify a role of the mutated gene in lipid biosynthetic pathways. Complementation of 
this lipid profiling technique with HR-MAS profiling of AG and LAM expand the area of 
metabolites that can be covered and facilitates the identification of genes involved in cell 
wall metabolism.  
 
     It is to be noted that changes observed in the HR-MAS and lipid profiles can be either 
direct effects due to investigated gene mutation or an indirect result due to cell adaptation 
to this mutation and accumulation of biosynthetic intermediates. Significant follow up 
investigation at both the genetic and biochemical levels is necessary to identify the direct 
gene function and distinguish it from other secondary effects. These secondary adaptive 
responses are nonetheless valuable in identifying points of conversions and diversions in 
the metabolic pathway and outlining compensatory mechanisms by which Mycobacteria 
respond to physiological stress due to gene mutation. 
 
     A direct demonstration of such application includes mutation of Rv3792 gene in C. 
glutamicum which resulted in disappearance of HR-MAS 2D-HSQC signals of all 
arabinan residues in the AG structure (Figure 6.1). In the lipid profile, however, some 
signals for acylated hexoses were observed in unusual abundance. Molecular biology and 
chemical analysis concluded that Rv3792 encodes a new arabinosyl transferase, 
designated aftA, that is responsible for transferring arabinose residue to the galactan core 
of AG macromolecule82 which is in total agreement with the results from the HR-MAS 
profile. From the lipid profile, it is apparent that the loss of a significant part of the 
structural integrity of the cell wall may be compensated for by the accumulation of 
hexose glycolipids.    
 
6.3.3.2 Drug action and drug resistance  
 
     In vitro whole cell screening of chemical libraries is a useful strategy used by many 
investigators to identify new drug candidates that are effective against the tubercle bacilli. 
However, after identification of a viable drug candidate by this method comes the 
daunting task of deciphering the new drug’s mode of action and its effects on cellular 
functions and metabolism. In the case of many anti-TB agents, this has never been an  
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Figure 6.1 Effect of Gene Mutation on the Cell Wall of C. glutamicum 
 
HRMAS profile of C. glutamicum wt, (a), and C. glutamicum ∆ aftA, (b). Arabinan 
signals (circled in red) were totally absent from the HR-MAS profile of the mutant strain. 
Spectra (c) and (d) are partial windows of the 2D-HSQC lipid profile of C. glutamicum 
wt, (c), and the ∆ aftA mutant, (d). Adaptive changes were observed upon mutation by 
the appearance of multiple signals for what appears to be a trehalose based glycolpids in 
the lipid profile of the ∆ aftA mutant signals (circled in blue).
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easy task. For example, after the discovery of isoniazid in 195221 by three different 
research groups, its mechanisms of action have been investigated by several groups as 
well.345-349 and several reasonable mechanisms of action have been reported. Although it 
is clear by now that INH has multiple cellular targets, it is unclear which of them is 
responsible for INH killing mechanisms. Ethambutol, another front line anti-TB drug, 
was discovered in 1961 through screening.350 Its mechanism of action has been widely 
speculated as well.345,346,351 Currently and after more than three decades of investigation, 
most researchers agree that the mechanism of action of ethambutol involves inhibition of 
arabinan biosynthesis, an event that leads to the inhibition of mycolic acids attachment to 
the cell wall and the subsequent accumulation of trehalose mycolates.67,352,353  
 
     We were able to reproduce these results following ethambutol treatment in M. 
smegmatis using both HR-MAS and lipid profiling methods in an unequivocal manner 
and in a very short period of time. Treatment of the cells with increasing concentration of 
ethambutol resulted in gradual disappearance of the branched structure of AG as 
indicated from the HR-MAS spectrum (Figure 6.2a-c). Meanwhile in the HSQC lipid 
profiles, there was a parallel gradual accumulation of trehalose dimycolate in the cellular 
lipid pool (Figure 6.2d-f). These results are in accordance with the reported  
literature and further underscore the argument for the mode of action of ethambutol 
through inhibition of arabinan synthesis.345,346,351 
 
6.3.3.3 Identification of virulence determinants 
 
     Due to the worldwide spread of tuberculosis, there has been meticulous collection and 
documentation of many clinical strains. These clinical strains often demonstrate different 
transmitability, drug resistance and virulence. For example among the frequent outbreaks 
in different communities such as prisons, hospitals, schools and homeless shelters, 
different rates of transmission have been reported.354 An outbreak in clothing factories in 
Tennessee was associated with unusual high rates of transmission from the primary 
source as well as secondary sources.355 Investigation of the causative strains designated 
as CDC-1551 or CSU93 found out that although the strain displayed usual rates of initial 
implantation in a murine model, it was able to grow faster and to a lager extent than most 
laboratory strains which translates to a higher rate of transmission.355,356 Another strain 
responsible for an outbreak in a Texas prison, HN878, was found to be hypervirulant in 
mice when mice failed to induce appropriate immune response to the infection.357 In both 
cases, the variability in transmission and virulence was traced to specific changes in cell 
wall lipids.153,358 
 
     It is also well known that variable degrees of pathogenicity and virulence among 
different clades of M. tuberculosis can stem from certain structural polymorphism in its 
genome.357,359,360 Even of more interest to mycobacteriology scientists, is the notion that 
M. tuberculosis has evolved to develop strain compatibility to different human 
demography in different geographical regions.360,361 All of this genetic variability is 
ultimately represented as variability in cellular proteins and cellular metabolites and some 
of them can be detected by global analysis techniques, which include proteomics, 
metabolomics and lipidomics as well.  
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Figure 6.2 Effect of Ethambutol Treatment in the Cell Wall of M. smegmatis 
Panels a-c, 1H-13C HSQC HR-MAS spectra (δ1H, 3.4-5.3 ppm,  δ13C, 64-110 ppm) of 
live M. smegmatis cells in absence of ethambutol, (a), treated with ethambutol at 
0.1μg/ml, (b), and 0.2μg/ml, (c). All spectra were referenced to the anomeric signal of 6-
β-Galf (δ1H 5.28 ppm, δ 13C106.98 ppm). Gradual decrease in the intensity of signals 
corresponding to the branching of the Ara6 motif of AG; 3,5-α-Araf (I) and 2-α-Araf 
→3(II) can be observed. 
 
Panels d-f, 1H-13C HSQC spectra (δ1H, 0.6-2.6 ppm,  δ13C,13-60 ppm) of total lipid 
extract from M. smegmatis cells in absence of ethambutol, (d), treated with ethambutol at 
0.1μg/ml, (e), and 0.2 μg/ml, (f). All spectra were referenced to the fatty acid terminal 
methyl signal (δ 1H=0.82 ppm, δ13C=17.82 ppm). Gradual increase in intensity of signals 
corresponding to trehalose mycolates can be observed at (δ 1H=2.38 ppm, δ13C=56.73 
ppm) and (δ 1H=1.32 and1.54 ppm, δ13C=38.17 ppm).  
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     In our effort to use our NMR-based methodology to screen for certain virulence 
determinants, we screened more than 90 Mycobacteria tuberculosis isolates for PGL 
production. In the process of doing so, we were able to detect the production of PGL by a 
high percentage of clinical isolates from the W-Beijing lineage. Moreover, we were able 
to detect certain characteristics that distinguish these isolates from our laboratory M. 
tuberculosis strains and other isolates obtained from the State of Tennessee strain 
depository which did not produce PGL (section 5.2.3.3). Such results demonstrate the 
value of using such global technique which allows the simultaneous monitoring of 
multiple metabolites in studying variabilities in strain virulence. 
 
 
6.4 Future Development 
 
     The research discussed in this dissertation represents the first steps towards the 
development of a novel “omics” approach designed specifically for the analysis of the 
mycobacterial cell wall metabolites. Also, it can be used for the investigation of other  
bacterial metabolites as long as these bacteria can grow in the laboratory in well defined 
growth media. Like other metabolomics methods, the extent to which our proposed 
methodology can be applied will depend on result-validation and reproducibility as well 
as user convenience. Convenience does not only include simplicity of the procedures but 
extends also to data analysis and data sharing.  Based on our knowledge of previous 
experiences in the development of other “omic” approaches, future research efforts for 
this approach are likely to be directed to each of three main areas. 
 
 
6.4.1 Assignment of the 2D-HSQC Signals 
 
     With decades of research directed towards Mycobacteria cell wall lipids, there is no 
shortage of structural data concerning cell wall lipids. However, the available information 
may not be extrapolated to the 2D-HSQC lipid profiles due to variation in the data 
acquisition parameters like the solvent used, acquisition temperature, etc. So before 
overlaying old data on the 2D-lipid profile, it has to be assured that the acquisition 
parameters for both spectra can be matched or at least accounted for. In some cases like 
tracking a specific lipid molecule (as in section 5.2.3.1), it is possible to direct some 
effort towards isolating this molecule or a close analogue and develop its standardized 
2D-HSQC spectrum for subsequent assignment. Also some advanced NMR experiments 
such as 3D-HCCH -TOCSY can help establish relationships between signals in the 2D 
spectrum and aid towards establishing a complete assignment.  
 
     However, there are also countless reports of lipid species that were isolated from a 
single specific strain which make handling of such amount of data a challenging task. 
Cooperative efforts between different research groups that include sharing of data and 
isolated standards will be necessary to complete signal assignment. A small scale 
initiative similar to the whole genome sequencing projects may be a good way to enhance 
and organize efforts in that area. 
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6.4.2 Method Standardization and Data Analysis 
 
     One of the main challenges of metabolomics and lipidomics methods is to develop a 
valid statistical methodology to insure validity of the data and allow for data comparisons 
between different research groups. Internal standard has to be added for spectral 
alignments and at least three replicates are required to validate the reproducibility of the 
data. Raw data have to be normalized to the internal standard and an average of multiple 
experiments has to be created. These requirements of multiple experiments and additional 
processing steps represent a computational challenge especially with the extraordinary 
complexity of the raw data. Statistical software might be necessary for the comparative 
analysis between two spectra that may display variability in the background noise or 
signal intensity. As it is the case with all “omics” techniques, an arithmetic algorithm is 
needed to represent the data in a bioinformatics-friendly manner. For MS and HPLC 
methods certain statistical soft wares are now available and some algorithm has been 
suggested to facilitate data representation. 
 
 
6.4.3 Data Depositing and Sharing 
 
     The great advancement in science in the past two decades has resulted in the 
accumulation of an unprecedented amount of information. For this information to be 
handled and put to the maximum use by every researcher, bioinformatics science was 
developed. With the introduction of the World Wide Web, bioinformatics has matured, 
flourished and become an indispensable tool since then. Bioinformatics offered 
researchers the possibility of an instant information sharing and rapid effective data 
search. The ultimate result was an explosion of scientific data which in turn necessitated 
the creation of organized depository databases and the development of data mining tools 
to facilitate navigation through the deposited data.  
 
     In the lipidomics and metabolomics fields several depository web sites have been 
established. For example for the “human lipidome” there is several initiative and 
depository database like LIPIDMAPS for analysis of human lipid pool and biosynthetic 
pathways. For maximum utility of any new lipidomics technique, the data generated from 
the technique has to be deposited in an organized database that allows researchers to 
navigate the information. Such availability of information can encourage researchers to 
use the technique and apply this methodology in their own investigation and eventually 
deposit more data. Organized data sharing quite often deters duplication of efforts and 
speeds up the process of knowledge gain towards the goal of improving our 
understanding of the world around us. 
 
 
6.5 How Metabolomics May Change Life Science 
 
    Unlike genomics which deals primarily with macromolecules and utilize molecular 
biology tools, metabolomics deals with small organic molecules and utilizes primarily 
analytical chemistry tools. Currently, major ideas for the development of lipidomics 
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techniques are falling in the foot steps of the proteomics science. Although this may be 
considered as a jump start for lipidomics, the different chemical nature of lipids, as 
opposed to proteins, will eventually led us to explore new territories in analytical 
chemistry. Comprehensive metabolomics are by nature hybrid biological/chemical 
experimentation. For example, to investigate the role of certain gene in regulation of cell 
metabolism, this gene has to be knocked out first and the elimination of the gene function 
has to be validated by the absence of its direct gene products (most likely a cellular 
protein ) and its final product (usually a small molecular weight metabolite). Hence the 
ultimate goal of establishing a relationship between a certain gene and a certain 
metabolite requires knowledge of molecular biology, organic chemistry, analytical 
chemistry as well as biostatistics. Such experiments are usually achieved through a team 
of scientists from these different science fields but it remains essential that each member 
of the team has a basic level of knowledge in all these disciplines to facilitate the process 
of communication and flow of data. 
 
     For maximum utility of these metabolomics experiments, a generation of scientists is 
needed who are trained to develop a thorough understanding of organic and analytical 
chemistry and cellular and molecular biology as well. These scientists should be regarded 
as the connecting bridges between chemists and molecular biologists who have been 
trapped by the lack of communication for so many years because they don’t understand 
each other languages. This lack of communication is a result of the pressure on scientists 
to develop and adhere to specific specialties and subspecialties because for so long we 
held specialists in much higher regards. Not all scientists have to abandon the specialist 
culture but at least enough of them should abandon it in order to build bridges between 
multiple disciplines. These scientists should also be held in high regards as they 
contribute to the common good of our human society. 
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APPENDIX A. SUPPLEMENTARY FIGURES FOR CHAPTER 2 
 
 
 
 
Figure A.1 Effect of Different Acquisition Time on the Quality of the 2D-HSQC Lipid 
Profiles 
 
2D-HSQC lipid profiles of M. smegmatis acquired for (a), 2 transients, 20 minutes, (b), 4 
transients, 40 minutes, (c), 12 transients, 120 minutes and, (d), 60 transients, 10 hours. 
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Figure A.2 Effect of Different Growth Conditions (Liquid Media Versus Solid Media) 
 
Lipid profiles of M. avium growing in Middlebrook 7H9, (a), or growing on Middlebrook 
7H11 agar, (b).  
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Figure A.3 Lipid Profiles of M. bovis BCG in the Early Exponential Phase 
 
Cells were harvested and extracted at O.Dλ600=0.29. 
 
 
 
 
 
 
Figure A.4 Lipid Profiles of M. bovis BCG of Cells in the Late Growth Phase 
 
Cells were harvested and extracted at O.Dλ600=1.2. 
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Figure A.5 Effect of 13C-acetate Labeling on the Lipid Profile of M. ulcerans 
 
Cells were grown in Middlebrook 7H9 where 13C6-dextrose and 13C3-glycerol were used, 
(a), or in regular Middlebrook 7H9 where 0.2% 13C2 sodium acetate have been added, (b). 
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Figure A.6 Effect of Using Different Culture Volumes for Lipid Extraction 
 
M. bovis BCG were harvested and extracted from 20mls culture, (a), or from 50 mls 
culture, (b), to a final extract volume of 600µl. Both profiles were acquired using 5mm 
trpfg NMR probe. Low abundance lipids were better represented in the first spectrum due 
to the presence of lower amounts of TAG and PL. 
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Figure A.7 Lipid Profiles Obtained from the Extraction of 10mls Culture 
 
Lipid profiles were acquired using 3mm IFC NMR probe of M. avium, (a), and M. 
tuberculosis , (b). 
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Figure A.8 Effect of Different Extraction Time on the Quality of the Lipid Profiles 
 
M. smegmatis cells were harvested and extracted for 20 minutes, (a), 40 minutes, (b), 90 
minutes, (c), and 120 minutes, (d). All profiles were acquired for 40 minutes. 
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Figure A.9 Lipid Profiles Produced by the Extraction of the Washed Cell Pellet with 
Acetone-d6 
 
M. ulcerans cells were extracted for 90 minutes with either acetone-d6, (a) or 2:1 mixture 
of CDCl3:CD3OD, (b).  
 
 
 
 
 
 
Figure A.10 Effect of Extraction with Benzene-d6 
 
Lipid profile of cells extracted with benzene-d6 included only signals of fatty acids. 
Shown above is the lipid profile obtained when a 2:1 mixture of CDCl3:CD3OD was used 
for re-extraction of the pellet remaining after extraction with benzene. 
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Figure A.11 Effect of Solvent Partition on the Lipid Profiles of M. tuberculosis H37Ra 
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Figure A.12 Effect of Solvent Partition on the Lipid Profiles of M. smegmatis 
 
Total lipid profile is shown in (a), apolar lipid profile is shown in (b), and the polar lipid 
profile is shown in (c).
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APPENDIX B. SUPPLEMENTARY FIGURES FOR CHAPTER 3 
 
 
Figure B.1 HR-MAS 2D-HSQC Spectrum of Live M. abscessus 
 
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line 
box), the presence of phosphoinositol caps (very low intensity signal indicated by a black 
arrow) and the presence of high levels of TAG (enclosed in dashed-line circles). 
178 
 
 
 
Figure B.2 HR-MAS 2D-HSQC Spectrum of Live M. avium 
 
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line 
box), the presence of mannose caps (indicated by a black arrow) and the presence of low 
levels of TAG (enclosed in dashed-line circles). 
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Figure B.3 HR-MAS 2D-HSQC Spectrum of Live M. bovis BCG 
 
Highlighted in this figure is the presence of high LAM levels (enclosed in a solid-line 
box), the presence of mannose caps (indicated by a black arrow) and the presence of low 
levels of TAG (enclosed in dashed-line circles). 
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Figure B.4 HR-MAS 2D-HSQC Spectrum of Live M. fortitum 
 
Highlighted in this figure is the presence of moderate LAM levels (enclosed in a solid-
line box), the presence of phosphoinositol caps (indicated by a black arrow) and the 
presence of high levels of TAG (enclosed in dashed-line circles). 
 
 
 
 
 
181 
 
 
 
Figure B.5 HR-MAS 2D-HSQC Spectrum of Live M. liflandii 
 
Highlighted in this figure is the presence of moderate LAM levels (enclosed in a solid-
line box), the presence of mannose caps (indicated by a black arrow) and the presence of 
low levels of TAG (very weak signal enclosed in dashed-line circles). 
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Figure B.6 HR-MAS 2D-HSQC Spectrum of Live M. marinum 
 
Highlighted in this figure is the presence of moderate LAM levels (enclosed in a solid-
line box), the presence of mannose caps (indicated by a black arrow) and the presence of 
low levels of TAG (enclosed in dashed-line circles). 
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Figure B.7 HR-MAS 2D-HSQC Spectrum of Live M. phlei 
 
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line 
box), the presence of phosphoinositol caps (indicated by a black arrow) and the presence 
of high levels of TAG (enclosed in dashed-line circles). 
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Figure B.8 HR-MAS 2D-HSQC Spectrum of Live M. smegmatis 
 
Highlighted in this figure is the presence of low LAM levels (enclosed in a solid-line 
box), the presence of phosphoinositol caps (indicated by a black arrow) and the presence 
of high levels of TAG (enclosed in dashed-line circles). 
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Figure B.9 HR-MAS 2D-HSQC Spectrum of Live M. tuberculosis H37Ra 
 
Highlighted in this figure is the presence of high LAM levels (enclosed in a solid-line 
box), the presence of mannose caps (indicated by a black arrow) and the absence of TAG 
(enclosed in dashed-line circles). 
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Figure B.10 HR-MAS 2D-HSQC Spectrum of Live M. ulcerans 
 
Highlighted in this figure is the presence of high LAM levels (enclosed in a solid-line 
box), the presence of mannose caps (indicated by a black arrow) and the absence of TAG 
(enclosed in dashed-line circles). 
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Figure B.11 2D-HSQC Lipid Profile of M. avium 
 
Highlighted in the figure are signals of cyclopropyl mycolates (enclosed in a rectangular 
box) and signals of the GPL core (enclosed in dashed-line circles). 
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Figure B.12 2D-HSQC Lipid Profile of M. abcessus 
 
Highlighted in the figure are signals from the GPL core, enclosed in dashed-line circles. 
Also noticeable, is the absence of cyclopropyl signals (as indicated by the rectangular 
box) and the presence of low intensity signals of methyl-branched fatty acids, indicated 
by a small arrow. 
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Figure B.13 2D-HSQC Lipid Profile of M. smegmatis 
 
Highlighted in the figure are signals from the GPL core, enclosed in dashed-line circles. 
Also noticeable is the absence of cyclopropyl signals (as indicated by the rectangular 
box) and the absence of signals indicative of methyl-branched fatty acids, indicated by a 
small arrow. 
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Figure B.14 2D-HSQC of Purified Phenol Phthiocerol Isolated from M. ulcerans 
 
 
Highlighted in the 2D-HSQC spectrum and in the corresponding phenol phthiocerol are  
selected biomarker signals from different parts of the molecule.  
 
 
 
 
191 
 
 
 
Figure B.15 2D-HSQC Lipid Profile of M. ulcerans 
 
Highlighted in the figure are signals of phenol phthiocerol (enclosed in dashed-line 
circles). The absence of TAG signal from the lipid profile is indicated by a small arrow. 
 
 
192 
 
 
 
Figure B.16 2D-HSQC Lipid Profile of M. liflandii 
 
Highlighted in the figure are signals of phenol phthiocerol and its corresponding PGL 
(enclosed in dashed-line circles, the aromatic signals of PGL are recorded at significantly 
higher intensities). The presence of low amount of TAG in the lipid profile is indicated 
by a small arrow. 
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Figure B.17 2D-HSQC Lipid Profile of M. marinum 
 
Highlighted in the figure are signals of phenol phthiocerol and its corresponding PGL 
(enclosed in dashed-line circles, the aromatic signals of PGL are recorded at significantly 
higher intensities). The presence of high levels of TAG in the lipid profile is indicated by 
a small arrow. 
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Figure B.18 2D-HSQC Lipid Profile of M. bovis BCG 
 
Highlighted in the figure are signals indicative for cyclopropyl mycolates (in solid-line 
rectangle), methyl-branched fatty acids (in solid line circles), Mycoside B (the aromatic 
signal in dashed-line circles) and TAG (indicated by a black arrow). 
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Figure B.19 2D-HSQC Lipid Profile of M. tubrerculosis H37Rv 
 
Highlighted in the figure are signals indicative for cyclopropyl mycolates (in solid-line 
rectangle), highly abundant methyl-branched fatty acids (in solid line circles), and low 
levels of TAG (indicated by a black arrow). The absence of mycoside B is indicated by 
the absence of its aromatic signal (dashed-line circle). 
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Figure B.20 2D-HSQC Lipid Profile of M. phlei 
 
The bottom insert show the area where signals for trehalose phleiates can be observed. 
Phleic acid is a polyunsatured fatty acid. 
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Figure B.21 2D-HSQC Lipid Profile of M. fortitum 
 
Highlighted in the figure are signals specific to M. fortitum that are likely to be associated 
with its unique glycolipid , Mycolactone F. 
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Figure B.22 2D-HSQC Lipid Profile of M. tuberculosis H37 Ra 
 
Highlighted in the figure are signals indicative of methyl-branched fatty acids (reported at 
relatively low intensity and highlighted in dashed-line circles), and low levels of TAG 
(indicated by a black arrow).  
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Figure B.23 2D-HSQC Lipid Profile of M. tuberculosis Erdman’s Strain 
 
Highlighted in the figure are signals indicative of methyl-branched fatty acids (reported at 
relatively higher intensity and highlighted in dashed-line circles), and low levels of TAG 
(indicated by a black arrow).  
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Figure B.24 2D-HSQC Lipid Profile of M. tuberculosis CDC1551 Strain 
 
The presence of very low TAG levels is highlighted by a black arrow. 
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Figure B.25 2D-HSQC Lipid Profile of M. tuberculosis HN878 Strain 
 
Highlighted in the figure, are signals indicative for M. tuberculosis PGL (signals for PGL 
are enclosed in dashed-line circles). Also highlighted by a black arrow are relatively 
higher levels of TAG. 
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